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ABSTRACT 
T cells recognize antigenic peptide-M}IC complexes on the surface of antigen-
presenting cells. This interaction plays a crucial role in determining the outcome of 
parasitic infection in terms of both protective immunity and immunopathology. The 
understanding of parasite-specific immune responses and the development of vaccines 
require the identification and characterization of parasite antigens recognized by host T 
cells. However, the major T cell antigens of filarial species such as Brugia malayi are 
still undefined, partially due to present difficulties identifying CD4 T cell-stimulating 
antigens. 
Genome projects represent a total departure from the way genes have been 
studied in the past. In recent years, the genomic sequences of a number of pathogens 
have been completed and an entire field of functional genomics has developed around 
the use of these sequence data for evolutionary genetics, new gene and drug discovery. 
However, there has been much less attention on the use of these sequence data in 
immunology. The Filarial Genome Project is now established and has already 
provided a large number of sequences. I believe it is well worth pursuing these to 
exploit filarial genomic information for immunology. 
The majority of this thesis deals with the identification, gene cloning, protein 
expression, molecular function and vaccine development of major T cell antigens in 
B.malayi. Immunization of microfilariae (MO proteins with different adjuvants 
selectively induced antigen-specific Thi and Th2 responses in vivo. Mf-specific T cells, 
including Thi and Th2 cells, were used to identify MI protein fractions separated by 
fast protein liquid chromatography and SDS-polyacrylamide gel electrophoresis-elution. 
This revealed a restricted number of major T cell antigens from Mf, a minority of which 
were insoluble. A novel serine proteinase inhibitor (serpin) gene (Bm-spn-2) was 
cloned by screening an Mf cDNA library with antisera against one Mf protein fraction 
which was highly potent at inducing antigen-specific T cell proliferation and cytokine 
production, while only the paramyosin gene was cloned using antisera against whole 
Mf proteins. Bm-spn-2, a single copy gene consisting of seven exons, was abundantly 
(>2% of total mRNA) and exclusively expressed by the Mf stage. This sequence 
analysis has been broadened into a genome data bank-based review of intron and exon 
sequences in B.malayi, which revealed an extended and conserved 3' splice site in all 
recorded B.malayi genes and relatively large introns compared with Caenorhabditis 
elegans. Bm-spn-2 contains 428 amino acids with a putative signal peptide and its 
native protein was 47.5 Wa, one of the largest of the 93 known serpins. The 
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recombinant Bm-SPN-2 protein was expressed in bacteria and purified to determine 
biological function. A panel of mammalian serine proteinases, which are involved in a 
wide range of biological processes, were screened and Bm-SPN-2 protein found to 
specifically inhibit enzymatic activities of human neutrophil cathepsin G and human 
neutrophil elastase, but not a range of other serine proteinases. This suggests that Bm-
SPN-2 may directly interfere with human immune function. Human neutrophil 
cathepsin G and elastase mediate multiple host defence functions such as interleukin 
processing, chemokinetic stimulation for T lymphocytes and chemoattractation for 
monocytes. We hypothesize that neutrophils, which represent 55% of human blood 
leukocytes, would be the primary cell type to interact with B.malayi Mf, and that 
release of Bm-SPN-2 neutralizes the immune-stimulating properties of neutrophil serine 
proteinases. This is the first reported functional serpin gene characterized from 
nematodes. Moreover, Bm-SPN-2 protein induced a Thi-biased response and 
vaccination with Bm-SPN-2 protein in mice resulted in a substantial decrease in the Mf 
load. Bm-spn-2 was subcloned into a new mammalian expression vector and induced 
strong antigen-specific immune response in vivo by DNA vaccination. These results 
demonstrated that Bm-SPN-2 is a very good candidate for a protective vaccine. 
Interestingly, Bm-SPN-2 specific IgG4 and IgGi (but not IgG2 and JgG3) were found 
in all tested microfilaremic patients and decreased dramatically after DEC treatment, 
which arise a possibility that immunity to Bm-SPN-2 may neutralize its immun-
regulation and damage the function of host serpins as well. 
A further part of this thesis seeks to find possible immune evasion genes such 
as homologues of the human cytokine genes from B.malayi by analysing the Filarial 
Genome Project and other databases. This revealed a novel gene Bm-mif-2, a 
homologue of the human cytokine macrophage migration inhibitory factor, from 
B.malayi. Bm-mif-2 is expressed at all stages of development. Recombinant Bm-
MW-i and 2 was extremely soluble when expressed in bacteria and purified by affinity 
chromatography, with potential for structure crystallisation and ligand identification. 
Purified Bm-MIF-2 had extremely high levels of dopachrome tautomerase enzyme 
activity with specificity for D-dopachrome, suggesting Bm-MIF-2 has a role in 
immune-regulation. By protein sequencing, it was shown that the N-terminal 
methionine of Bm-MIF-2, like mammalian native MIFs, was cleaved and the next 
residue proline was exposed. By sequence alignment, the proline residue was shown 
to be invariant among all known members in MW family, which suggested the N-
terminal proline may serves as a key base for activity. The 4 proteins (Bm-MIF-2 and 
mutant, Bm-MIF-1 and mutant) are used to exploit the relationship between activity and 
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Chapter 1 Introduction 
1.1 Life cycle, morphology and epidemiology 
All eukaryotic parasites have elaborate life cycles in comparison to prokaryotes 
and viruses. These provide a considerably more complex set of interactions with the 
host immune system. Like all nematode parasites, which share a highly conserved 
developmental sequence, filarial parasites have complex life cycles (Schmidt and 
Roberts, 1996; Zaman and Keong, 1990). The life cycles of B. malayi and W. 
bancrofti are essentially identical (Figure 1). Infective third stage larvae (L3) enter host 
tissues via the bite wound at the site of the mosquito blood meal. These larvae then 
enter the blood stream and migrate to the afferent lymphatics, where they moult twice 
more and mature to become dioeceous adults. Adult worms are elongated and slender. 
In B. malayi, the male measures 10-20 mm long and 70-80 jim wide. The females are 
30-50 mm long and 100 gm wide. W. bancrofti is similar to B. malayi but somewhat 
larger. Infection is chronic in nature and adults can live for over 10 years in the 
lymphatics, apparently unaffected by the immune system of the host. Around three 
months after infection female worms start producing large numbers of sheathed first 
larval stage microfilariae (MO into the peripheral blood stream. The presence or absence 
of microfilariae in the peripheral blood of the mammalian host varies depending on the 
feeding times of the species of mosquito vector in a given geographical area. When the 
circulating Mf are ingested by an appropriate species of mosquito, they penetrate the 
thoracic musculature where they undergo two successive moults to become infective 
stage larvae in 10-14 days. These then emerge from the mouthparts during feeding to 
enter the mammalian host. Many species of mosquito can serve as intermediate hosts 
for filarial nematodes, including those in the genera Anopheles, Aedes, Culex, and 
Mansonia. 
Lymphatic filariasis is a parasitic disease of humans, mainly caused by two 
species of helminth, the filarial nematodes Brugia malayi and Wuchereria bancrofti. 
Filariasis is mosquito-transmitted and is a widespread condition throughout the tropics, 
infecting up to 120 million people (Ottesen et al., 1997). Infection typically results in 
high morbidity in chronically infected individuals and can cause a range of pathology, 
the most severe being the disfiguring condition of elephantiasis. Although dwelling at 
the 'heart' of the immune system in the lymphatic vessels, these parasites can survive 
for many years (Kazura et al., 1993). The mechanisms that are responsible for long- 
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term survival of the parasites within the immuno-competent host and those that cause 
disease and pathology, are poorly understood. 
W. bancrofti is the most widely distributed filarial infection, occurring in the 
Far East, major portions of Africa, and South and Central America. B. inalayi is less 
widespread being restricted to the eastern regions of India and to Southeast Asia. W. 
bancrofti has no known animal reservoir, as a consequence, parasite material is very 
scarce and studies on this parasite are limited. However, the other major human filarial 
parasites B. malayi can parasitise a more diverse range of animals, including jirds, 
dogs, cats and monkeys. 
IDay8I 
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Figure 1-1. Schematic representation of the life cycle of the human 
lymphatic filarial parasites Brugia and Wuchereria spp. 
1.2 Genome and genome project 
The chromosomes of Brugia are visible by light microscopy because they 
condense during cell division. Moreover, differences in chromosome size, shape, 
centromere position and banding pattern allow the individual chromosomes to be 
identified, facilitating karyotype analysis. The haploid and diploid chromosome 
numbers of B.malayi are 5(n) and 10 (2n) in both sexes (Sakaguchi et al., 1983). The 
IN 
diploid component consists of one large, one medium and eight small elements in the 
male, whereas the female possesses two large and eight small elements (Fig 1-2). The 
genome size of B.malayi is about 100 million base pairs (100 Mb), about the same as 
that of C.elegans (Consortium, 1998). The chromosomes are therefore too large to be 
separated significantly by current pulsed-field gel technologies (Fig 1-2). The Brugia 
genome appears to be stable, chromatin diminution (fragmentation and elimination of 
germ-line-specific chromatin), which is common in ascarid nematodes and can make the 
production of representative DNA libraries difficult, does not occur and transposable 
elements have not been reported. Interestingly, Brugia is known to carry a Wolbachia-
like endosymbiont within its cells (Sironi et al., 1995) and the presence of this 
"foreign" genome may complicate analyses, necessitating a parallel, endosymbiont 
genome initiative. 
The genome of B.malayi contains at least two major repetitive DNA elements, 
termed the Hha I (McReynolds et al., 1986; Xie et al., 1994) and Mbo I families 
(Natarajan et al., 1990). The Hha I family consists of 104-105 tandemly arrayed copies 
per haploid genome of a monomer of 322 base pairs and comprise about 10% of the 
genome. The Mbo I family consists of at least 100-200 copies per haploid genome. 
The genome of B.malayi is very AT rich (75%), but protein-coding sequences tend to 
be of lower AT content (-65%) than intronic or intergenic regions (-80%). 
The number of protein-coding genes in B.malayi is estimated to be about 
18,000, which is the same magnitude in C.elegans based on genetic and sequence data. 
By the end of 1994, however, only about 100 filarial genes had been identified. The 
reasons for this slow progress included the difficulty of working with these obligate 
parasites, a lack of high-quality reagents such as good cDNA libraries, and the 
methodologies used to identify genes of interest limited the sorts of molecules found. 
Four years ago, the genome project for B.malayi (the Filarial Genome Project) was 
initiated (Blaxter, 1995). Genome projects represent a total departure from the way 
genes have been studied in the past. Genome studies do not attempt to identify 
particular genes, but rather have as their goal the identification, cloning and mapping of 
all the genes in the organism. The filarial genome project takes as its aims gene 
discovery for drug target and vaccine candidate identification, genome mapping, 
dissemination of genomic data to the world community, and training of endemic 
country partners in genomic research. Unlike the other parasite genome projects, the 
filarial initiative had a well characterized model with which to compare and contrast: 
C.elegans. The genome of this free-living nematode has been studied extensively by 
genetic, developmental, neurobiological and biochemical investigators, and the entire 










Figure 1-2. Chromosomes of B.malayi. 	A) karyotype analyses of 
spermatogonial and oogonial metaphases from B.malayi after Giemsa 
staining (after Sakaguchi et a!, 1983). B) Fractionation of B.malayi 
chromosomes by pulsed-field gel electrophoresis. Four discrete bands 
numbered in order of decreasing mobility (after Sim et a!, 1987). 
Up to now, eight directionally cloned Brugia cDNA libraries, including 5 
conventionally constructed libraries and 3 PCR-SL 1 constructed libraries, have been 
made in 2 Zapil from the following developmental stages: Mf, L2, L3, moulting L3, 
L4, adult male and adult female (Fig 1-3). These libraries were to serve as substrates 
for expressed sequence tag (EST) analysis which is a rapid and informative method for 
analysing the expressed genes of an organism. EST is a unique DNA sequence derived 
from a cDNA library, therefore from a sequence which has been transcribed in some 
tissue or at some stage of development. The EST can be mapped, by a combination of 
genetic mapping procedures, to a unique locus in the genome and serves to identify that 
gene locus. Moreover, a bacterial artificial chromosome (BAC; mean insert size —75 kb) 
genomic library has been constructed and a yeast artificial chromsome (YAC) library, 











Second-stage larvae (day 6) 
JHU96SL-BmL2 
mosquito 
L9 ___ Third-stage larvae (day 10 vector) 
JHU93SL-BmL3 & SAW94WL-Bm-L3 
Third/Fourth-stage larvae (day 6 host) 
SAW97MLW-Bm-L3_6 
Figure 1-3. Participating laboratories of the filarial genome project. The 
JHU.. and SAW... names are those used in dbEST to indicate the origin 
of the ESTs. The JHU libraries were constructed using PCR-SL1 
techniques while the SAW libraries constructed by conventional 
techniques (after Blaxter et a!, 1999). 
EST analysis has been the major activity of the filarial genome project to date. 
The filarial genome project has submitted over 16,000 ESTs containing over 5 million 
base pairs of Brugia sequence data to the public sequence databases (Blaxter, 1999) 
(Blaxter, 1998). It is estimated that about 5,000 different Brugia genes can be found 
from these 16,000 ESTs. The B.malayi ESTs can be grouped into four classes: (1) 
25% are homologues of functionally-identified nematode genes; (2) 17% are 
homologues of C.elegans open reading frames that have no ascribed function; (3) 20% 
of the clones are homologues of known non-nematode genes but do not have a 
C.elegans counterpart; (4) 38% appear to be entirely novel to the filarial dataset. The 
ESTs with informative similarities to known genes represent a wide range of different 
functions: proteins involved in transcription and translation, enzymes and structural 
proteins. In terms of potential drug targets, those encoding kinases, proteases and 
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protease inhibitors, chaperones and immunophilins are worthy of attention. A set of 
clustering algorithms could be used to group ESTs by sequence identity. The clusters 
are presumed to derive from a single gene, and the overlapping EST sequences are used 
to derive a consensus that can then be used in database search. Interestingly, it is 
estimated that 125 of the identified clusters may play roles in host-parasite interaction 
although there is no direct evidence available at the moment. About 38% of ESTs are 
novel and have no significant match in the databases, which represent a vast pool of 
genes that include nematode-specific and filarial-specific genes. This novel gene pool is 
likely to include many genes that will eventually prove valuable as vaccine candidates or 
drug targets. 
The Brugia chromosomes are too large to be separated by current pulsed-field 
gel technologies; therefore, individual chromosomes can not be isolated. This means 
that chromosome-specific analyses can not be undertaken and that physical mapping 
strategies are restricted to chromosome walking techniques (which are relatively 
inefficient) or to global shotgun approaches (a massive undertaking on genomes of this 
size). The resources required for full-scale analysis of helminth genomes such as 
Brugia would be comparable to, or greater than, those required by the C.elegans project 
(Johnston et al., 1999). Two complimentary physical mapping strategies will be used in 
Brugia (Johnston et al., 1999): (1) probing BAC library grids with 5,000 ESTs to 
provide sequenced marker loci; (2) screening of BAC libraries with BAC end probes to 
assemble contigs (in this approach, BAC clones are selected at random and probes 
generated from the end (Blaxter, 1999). The endosymbiont genome is also targeted for 
mapping. To date, approximately 100 YAC clones have been mapped to the 
schistosome karyotype by fluorescent in situ hybridisation (FISH) to anchor and 
orientate the future physical map and primed in situ hybridisation techniques are being 
optimised to increase the sensitivity of chromosome mapping. Such techniques are also 
applicable to Brugia but have not yet been used. 
Perhaps the most exciting prospects are for gene analysis by in vivo genetic 
manipulation (gene-knockout, transgenics, etc), both for mass screening assays to 
identify functionally important genes and for analysis of individual genes. For Brugia, 
it may be possible to use its endosymbiont as a vehicle for gene delivery, and it is also 
possible to express Brugia genes in C.elegans. 
In the past 3 years, the genomic sequences of at least 8 pathogens have been 
completed and an entire fileld of functional genomics has developed around the use of 
these sequence data for new drug discovery. Much less attention however has been paid 
to the use of these sequence data in immunology, for example in vaccine development. 
At present two helminth parasite genome projects are well under way: Brugia malayi 
and Schistosoma mansoni (Johnston et al., 1999), which have already provided a huge 
number of sequences. We believe it is time to start exploiting genomic information in 
helminth parasite vaccines with a similar view to that emerging in malaria (Hoffman et 
al., 1998). 
1.3 Pathology, diagnosis and treatment 
Lymphatic filariasis as a chronic disease, gives rise to a wide spectrum of 
clinical syndromes associated with a sequence of events after infection, as illustrated in 
Fig 1-4. Classically, people in an endemic area are separated into three distinct groups 
based upon clinical condition and level of active infection (Ottesen, 1989; 
Yazdanbakhsh et al., 1993): (1) 'Endemic normals'. 'Endemic normals' are those 
individuals that are exposed to infection in an endemic area but display no outward sign 
of infection, also sometimes termed 'asymptomatic amicrofilraemics'. Generally, these 
individuals also display active cellular responses to the parasite; (2) Microfilaraemics. 
Microfilaraemics typically have high parasite burdens, down-regulated cellular 
responses and minor pathology; and (3) Elephantiasis. Individuals with elephantiasis 
(and other chronic pathologies related to infection such as oedema) generally harbour 
few parasites and have active cellular responses, with vigorous specific immune 
responses. However, classification of individuals in an endemic area into these three 
groups is an oversimplification of what is actually a complex range of infection states 
without obvious boundaries of definition (Maizels et al., 1995). This simplification may 
neglect to include individuals such as those that harbour low level parasitemia, or those 
that have recently cleared infection. Indeed, the use of new techniques such as 
ultrasound to identify adult worms in the absence of detectable circulating microfilariae, 
shows that amicrofilaraemic individuals may harbour active infection. Such information 
reinforces the hypothesis that the perception of the endemic normal as a resistant, 
infection-clear individual does not adequately reflect the true situation (Day et al., 
1991). 
Pathogenesis of lymphatic filariasis can be separated into three clinical phases 
(Fig 1-4): (1) The incubation stage. This stage is generally symptomless, and 
represents the time between infection and the appearance of microfilariae in the blood. 
There may be mild fever with transient lymphatic inflammation; (2) The acute stage. 
This stage of the disease is related to the development of the worms in the lymphatics 
and the first release of microfilariae. Infected individuals may have inflammation of the 
lymphatic vessels (lymphangitis) and of a lymph node or lymph nodes (lymphadenitis). 
Lymphangitis can sometimes be severe and result in high fever and headache, 
occasionally requiring hospitalisation. Inflammation of the .testis and epididymis may 
also occur at this stage. These symptoms usually subside after a few days, but may 
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recur; and (3) the chronic stage. It is the chronic stage of infection that causes the 
greatest amount of pathology. It may take several years from the time of infection for 
chronic disease to be manifest. This phase is marked by dilation of the lymph vessels 
(varices), oedema and lymph in the urine (chyluria) and can ultimately lead to the 
disfiguring condition known as elephantiasis. There is commonly a decline in 
microfilaraemia associated with this stage, and often individuals with extreme chronic 
pathology have a total absence of circulating larvae. 
Lymphatic filaria 
ENDEMIC NORMALS 
exposed to parasites 
low/no infection 





low cellular responses 
low/no disease 
ELEPHANTIASIS 
usually no MI 
low/no infection 
active cellular responses 
disease 
Figure 1-4. Simplified diagram of the spectral nature of lymphatic 
filarial disease. 
The pathology of filariasis is generally complex (Maizels, 1999). It has been 
generally believed: (1) The acute symptoms (fever, adenolymphadenitis) may be purely 
immunological responses to filarial parasites, but it is unclear whether these events are 
triggered by new filarial infection, by natural death of resident parasites (perhaps 
thereby releasing antigens) or by some secondary precipitating factor. (2) The chronic 
symptoms (oedema, obstruction, fibrosis, elephantiasis) are thought to depend upon 
physiological failure of the lymphatic system creating lymph stasis and fluid 
accumulation, and causing susceptibility to opportunistic secondary infection. 
However, whether this lymphatic failure is due to direct parasite damage, or immun-
mediated damage, or some other process, remains contentious. The notion that the 
pathology is immunologically dependent is supported by epidemiological evidence such 
as the higher rates of elephantiasis in adult immigrants into an endemic area compared to 
native residents or children born to migrants after settlement (Partono, 1984), and by 
observations on animal models in which, for example, oedema is highest in 
amicrofilaraemic dogs with highest serum antibodies to filarial antigens (Snowden and 
Hammerberg, 1987). However, this notion has been challenged, because some field 
studies show a remarkable stability of clinical phenotype, with some 80% of 
microfilaraemic carriers remaining disease-free over a 16-year period (Meyrowitsch et 
al., 1995). So alternative hypotheses and new concepts in this area are clearly needed. 
The most common method of confirming filarial infection is to find the 
microfilariae in the peripheral blood which is taken at the appropriate time of day or 
night depending on the periodicity of the infection. This is not satisfactory as the 
method does not detect people with prepatent infection, those with low parasitaemia or 
those with occult filariasis who are amicrofilaraemic. More recently, the presence of 
circulating IgG4 antibody to filaria has been suggested as a marker of active infection 
(Kurniawan et al., 1993). 
Vector control and drug treatment strategies have been combined to reduce the 
transmission of filarial disease (Ottesen et al., 1997). Diethylcarbamazine citrate (DEC) 
is a highly effective human treatment, killing both adult and microfilarial life cycle 
stages of the parasite, although adverse side effects commonly result from this 
treatment, which may be due to release of high levels of antigen from dying parasites 
(Maizels and Denham, 1992). Single or co-administration of DEC with the 
microfilaricide ivermectin, or with albendazole, has proved highly effective at reducing 
parasitaemia. Based on this, the WHO has recently targeted filarial infection as a 
priority for eradication within the near future. However, recent examples of emerging 
drug resistance to other helminth diseases such as praziquantel in schistosomiasis 
(Fallon et al., 1996) have provided a blunt warning that DEC treatment, although 
effective for the moment, may not remain so indefinitely. 
1 .4 Immunological features of lymphatic filariasis: antibodies, 
Thl/Th2 and cytokines 
Lymphatic filariasis is commonly regarded as one of the most immunological 
complex infections of humans combining elements of tolerance, immunopathology and 
extended dynamics of infection. 
One feature of humoral responses in human lymphatic filariasis is the selective 
expression of IgG4 and IgE antibodies (Maizels et al., 1995). High levels of 
antiparasite IgE and IgG4 are produced in filariasis patients, generally accompanied by 
eosinophilia. The role that these infection-dominant antibodies play is still unclear. 
IgG4 levels, normally comprising approximately 5% of total serum IgG, can rise to up 
to 95% of specific antibody in microfilaraemic individuals (Kwan-Lim et al., 1990; 
Ottesen et al., 1985). Further, asymptomatic microfilaraemics have much higher ratios 
of filarial specific IgG4 to IgE than chronically infected elephantiasis patients, where the 
most significant antibody isotype appears to be IgE (Kurniawan et al., 1993). Indeed, 
high levels of anti-filarial IgE have been related to chronic pathology, particularly 
tropical pulmonary eosinophilia (Hussain et al., 1981). IgG4 has been shown to have 
anti-allergic blocking' activity in human filariasis (Hussain et al., 1992). Thus, chronic 
pathology in elephantiasis patients may be due to an increased IgE-mediated 
hypersensitivity response in the presence of insufficient blocking antibody, similar to 
the situation that has been described in human schistosomiasis. IgGi, 2 and 3 present a 
different profile, in that these isotypes are very minor components of the 
microfilaraemic humoral responses, but are far more prominent in individuals with 
chronic pathology (Kurniawan et al., 1993). 
CD4 T helper cells (Th) play a central role in most immune reactions and are 
required for induction of cytotoxic T cell and most B cell responses (Abbas et al., 1996; 
Allen and Maizels, 1997; Carter and Dutton, 1996; Mosmann and Sad, 1996; Murray, 
1998). Based on the cytokines they secrete, Th cells have been classified as belonging 
to three distinctive subsets: ThO, Thi and Th2. ThO cells are considered to be the 
precursors, and they mainly secrete IL-2. Following antigenic stimulation, ThO cells 
differentiate down two pathways such that cells with one of two possible cytokine 
profiles emerge. The Thi subset, which secretes IL-2, TNF-13 and the signature Thl 
cytokine IFN-y, preferentially promotes cell-mediated immunity and IgG2a production 
by B cells; while the Th2 subset, which secretes IL-S. IL-b, IL-13 and the signature 
Th2 cytokine IL-4, induces humoral immunity and IgGi and IgE isotypes production. 
Moreover, CD4 T cells producing high amounts of TGF-P have been termed Th3 
(Chen et al., 1994) although it has not been accepted widely. The characteristic 
cytokine products of Thl and Th2 cells are mutually inhibitory for the differentiation 
and effector functions of the reciprocal phenotype (Morel and Oriss, 1998). Thus, IFN- 
y selectively inhibits proliferation of Th2 cell, and IL- 10 inhibits cytokine synthesis by 
Thi cells. An important aspect of the ThlITh2 dichotomy is the insight this concept 
provides into immunological determinants of diseases (Abbas et al., 1996; Allen and 
Maizels, 1997; Mosmann and Sad, 1996). The outcomes of a wide range of 
pathological processes, including infectious, allergic, autoimmune disorders and 
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tumours, have been linked to Thi or Th2 cytokine expression patterns, and, by 
inference, to the particular T cell subset induced. Experimental mirine leishmaniasis 
provides an example of the relation between Th cell development and disease-
resistance/susceptibility (Guler et al., 1996; Hsieh et al., 1995). Mice of the BALB/c 
strain produce Th2 responses to L.major that fail to promote resistance, whereas other 
strains, including B1O.D2, produce Thi responses and are resistant. It has been 
accepted that the balance between Thi and Th2 responses to an infectious agent can 
influence both pathogen growth and immunopathology. It has been tempting to apply 
the Thl/Th2 paradigm to human filariasis. 
It is generally believed that human filarial infection is associated with an immune 
response that is skewed toward a Th2 response although interpretation of cytokine 
production in response to filarial infection is hampered by the complex range of 
infection states that are apparent in human filariasis. It has been found that actively 
infected microfilaraemics show reduced IFN-y and IL-2 production (King and Nutman, 
1991; Sartono et al., 1997) in comparison to other clinical groups, whereas IL-4 
secretion in response to parasite antigen is not diminished in actively infected 
individuals (Yazdanbakhsh et al., 1993). Some studies showed that spontaneous and 
antigen-specific IL-10 production appear to be elevated in peripheral blood cells from 
infected individuals (Baize et al., 1997) although the involvement of this down-
regulatory cytokine in the induction of hypo-responsiveness by filarial infection remains 
an area of debate (Mahanty and Nutman, 1995). However, even though filarial 
infection is associated with generation of IL-4 and IL-5 producing T cells the levels of 
the Th2-type cytokine EL-5 are actually reduced in microfilaraemic individuals (Sartono 
et al., 1997). This suggests that both Thi and Th2 responses are to some extent down-
regulated during active infection. Furthermore,treatment with DEC results in enhanced 
IFN-y production in individuals from all clinical groups, whereas IL-4 production does 
not change significantly following therapy (Sartono et al., 1995). 
Murine infection models have been used to provide information about many 
areas of the immunology of filariasis and in doing so have helped provide clarity and 
new direction for human studies (Lawrence, 1996). Consistent with observations from 
human studies, Brugia infection of mice has been shown to induce a strong Th2-type 
response characterised by elevated production of Th2-type cytokine IL-4, marked 
eosinophilia, and high levels of IgE (Bancroft et al., 1993; Lawrence et al., 1995; 
Lawrence et al., 1994). Moreover, infection of mice with single life cycle stages has 
dissected the immune response to filariae further and revealed that adult and L3 
parasites are the driving force for Th2-polarisation through induction of IL-4 (Lawrence 
et al., 1995; Osborne et al., 1996). In contrast, live Mf infection in the absence of 
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adults or L3, initially induces a Thi-type response (Lawrence et al., 1994). This Thi 
response is only evident in the unnatural situation of infection with Mf alone, being 
normally eclipsed by the dominant Th2-type response to the other life cycle stages. 
Although the response to Mf alone is initially Thi-type in nature, a Th2-type response 
may eventually develop as a result of chronic exposure (Lawrence et al., 1994; 
Pearlman et al., 1993). 
Many studies of Thl/Th2 and cytokines have been done in human filarisis and 
animal models, However, up to now, there is no data available to compare 
systematically different cytokines expression on I cells stimulated with filarial paraaites 
or individual filarial antigen. 
Although helminth parasites usually induce strong Th2 responses, the cause for 
such a bias is unclear. Interestingly, recently work found that B.malayi Mf antigens 
alone induced proliferation and IFN-y and IL-5 production in unsensitized human 
CD45RACD4 cells (Steel and Nutman, 1998), indicating the ability of filarial antigen 
itself to prime human naive T cells in the absence of exogenous cytokines and dendritic 
cells. L3 of B.pahangi can trigger an unusual double-negative T cell population to 
secrete IL-4 at the very outset of infection (Osborne and Devaney, 1998). Recent work 
on animal models suggest host NK cells are required for the growth of B.malayi in 
mice (Babu et al., 1998). Over the coming few years, we expect more examples of 
interaction between immune cells and filarial parasites. 
1 .5 T cell hyporesponsivenes in lymphatic filariasis: facts and 
hypothesis 
A striking feature of active filarial infection (as indicated by the presence of 
circulating microfilariae) is the induction of antigen specific hypo-responsiveness in the 
proliferative reaction of host T cells to the parasite (Maizels et al., 1995). This has been 
consistently demonstrated in human studies (Piessens et al., 1980; Yazdanbakhsh et al., 
1993), where peripheral blood mononuclear cells taken from microfilaraemic 
individuals fail to proliferate to filarial antigen in vitro but are still able to respond in an 
antigen specific manner as measured by cytokine production. Conversely, individuals 
with chronic lymphatic pathology, who rarely exhibit blood microfilaraemia, generally 
mount stronger filarial-specific cellular proliferative responses. Epidemiological studies 
have indicated that hypo-responsiveness caused by filarial infection affects only 
antigen-specific responses, as proliferative responses to both mitogens (such as PHA) 
or non-parasite antigens (such as PPD) have been shown to be similar in individuals 
from any of the filarial clinical groups (Yazdanbakhsh et al., 1993). 
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T cell hyporesponsivenes is a well-know corollary of human filarial infection. 
However, the mechanisms for such hyporesponsivenes are unclear at the moment. A 
few interesting hypotheses have been raised (Maizels et al., 1999): 
High antigen load, released from filarial parasites, may in itself generate a 
state of high zone tolerance. In fact, like filariasis, many other chronic infectious 
diseases, 	paracoccidiomycosis, 	leprosy, 	tuberculosis, 	leishmaniasis 	and 
schistosomiasis, show a similar pattern of down-regulated inflammatory responses. 
Interestingly, in many of these infections, T cell responses are restored following 
appropriate chemotherapy, strengthening the causal link between infection and immune 
depression. Mouse models indicate that T cells uncouple receptors in conditions of high 
antigen load (receptor occupancy) and do not restore responsiveness until antigen levels 
subside (Ramsdell and Fowikes, 1992). This would be compatible with recovery of I 
cell proliferative responses after chemotherapy (Piessens et al., 1981; Sartono et al., 
1995), and would argue that the vigorous T cell reactivity in most elephantiasis patients 
is a result of, rather than the cause of, the loss of blood microfilaraemia. 
Various forms of direct down-regulation have been postulated. During the 
past few years it has been shown that "immune privileged" tissues, such as the cornea 
and the testis, and some tumours express high level of Fas-ligand (CD95L) which 
binds T cell surface CD95 (Fas) and induces programmed cell death in those T cells 
(Bellgrau et al., 1995; Griffith et al., 1996; O'Connell et al., 1996), enabling these 
tissues and tumour cells to avoid immune attack. In filariasis, some experimented 
results indicate that there is a higher level of apoptotic death in mice infected with 
microfilariae. An interesting hypothesis, therefore, would be that helminth parasites 
take advantage of the same mechanism, expressing a Fas ligand-like protein or Fas-
binding protein, and induce host T cell apoptosis. Although interesting, however, this 
hypothesis seems unlikely, because deletion by apoptosis would not, however, account 
for the IL-4 response seen in "tolerant" patients challenged with filarial antigen. 
Moreover, the C.elegans genome project, which has been finished recently, has not 
found any Fas ligand-like protein or Fas-binding protein, and it is unlikely that 
B.malayi genome would contain such a gene. 
A third model for lymphocyte down-regulation has been proposed by 
Harnett who has found that phosphoryicholine (PC)-conjugated macromolecules 
secreted by the filarial parasite Acanthocheilonema viteae directly block B cell 
proliferation (Harnett and Harnett, 1999). There are a few reports that B.malayi 
directly inhibit host cell proliferation, for example, Wadee et al found that B.malayi 
Mf extracts showed inhibition of Concanavalin A (Con A)-induced lymphocyte 
proliferation (Wadee et al., 1987); Rao et al found that 13.malayi adult female 
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suppressed the growth and proliferation of human endothelial cells in vitro (Rao et al., 
1996) while Lal et al reported that phosphocholine from B.malayi suppressed 
phytohemagglutinin (PHA)-driven T cell proliferation in patients with filariasis and 
control individuals as well (Lal et al., 1990). More recently, a filarial-derived antigen 
with homology to cystatin C, a cysteine protease inhibitor that belongs to the cystatin 
superfamily, was found to be able to non-specifically down-regulate T cell proliferation 
(Hartmann et al., 1997). Perhaps more interestingly, this effect coincided with 
enhanced IL-10 production. Homologous antigens have been found in B. malayi 
(Gregory et al., 1997) and 0. volvulus (Lustigman et al., 1992). However, the 
B.malayi molecules and mechanisms for such direct suppression on host cells have 
not been studied in detail. 
Parasite cytokines and their receptors. This idea is raised from recent 
findings that some viruses have incorporated genes encoding mammalian cytokines 
and/or their receptors into the viral genome, as a result of gene capture, and that these 
viral proteins interact, mimic or block mammalian cytokines and/or their receptors. With 
parasites, however, the possibility exists that parallel evolution of genes derived from a 
common ancestor may have occurred. For example, the down-regulatory cytokine 
TGF-13 belongs to an ancient superfamily responsible for intercellular signalling in 
nematodes, insects and vertebrates. The homologues of TGF-13 and its receptor from 
Brugia (Gomez-Escobar et al., 1998; Gomez-Escobar et al., 1997) and from 
Schistosoma mansoni (Davies et al., 1998) have been reported. More recently, we have 
found B.malayi has two homologues of human macrophage migration inhibitor factor 
(MIF), a unique immune-regulated cytokine. Host MIF acts as an important factor in 
immune response and in disease pathogenesis as well. It is possible that the parasites 
produce MW to attract host macrophages as the first step in a process that leads to 
alterations in their induction and/or effector functions. 
Antigen presentation is compromised. One of the classic models for 
tolerance induction is incomplete antigen presentation, in which essential co-stimulatory 
signals are missing. However, co-stimulatory signals seem normal in T cells from 
filariasis patients. Studies in the mouse model of filarial infection showed that 
peritoneal cells from infected mice stimulated antigen-specific I1L-4 responses but 
remarkably blocked the proliferative response (Allen et al., 1996), demonstrating that 
inadequate presentation or co-stimulation was not an explanation for 
hyporesponsiveness seen in filarisis. Some intriguing evidence recently obtained 
indicates that an cysteine proteinase inhibitor, secreted from B. malayi L3, can block 
antigen presentation in human B cells in vitro (Gregory, personal communication), 
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suggesting a further interesting hypothesis that helminth parasites might secrete some 
molecules to actively block antigen presentation. This suggestion is well worth 
pursuing. 
1.6 	Genetic control: polymorphism, variation and conservation 
It is an attractive hypothesis that the existence of polymorphisms within 
populations imports selective advantages for survival to different alleles under various 
evolutionary pressures. Among the selective pressures that have been examined in this 
regard have been tumours and infectious diseases of humans. It is not surprising that 
extensive polymorphism of the human major histocompatibility complex (MHC) locus 
have been found to be associated with a variety of diseases . Filariasis research, 
however, has been conducted in the dark with respect to (1) how human genetic 
polymorphisms affect susceptibility to infection and likelihood of developing clinical 
disease, and (2) the level of antigen variation or conservation among different isolates 
or strains of Brugia and Wuchereria. 
Certain MHC class II alleles show significant association with a pathological 
outcome to Onchocerca volvulus infection (Brattig et al., 1986; Meyer et al., 1994). 
The alleles of the DQ loci were found to be the most pronounced differences among 
three groups with generalized onchocerciasis, localized onchocerciasis, or putatively 
immune. The haplotype DQA1*0501DQB1*0301  was significantly more frequent 
among putatively immune individuals than among patients with generalized or localized 
disease. Conversely, DQAl*0101DQB1*0501  and, independently, the allele 
DQB 1*0201  were more frequent in generalized disease than in localized disease or 
putative immunity. The findings indicate that HLA-D variants influence the course of 0. 
volvulus infection and help to define a state that may reflect protective immunity. In 
schistosomiasis, severe clinical disease is often the consequence of heavy infection 
which, in several endemic areas, are determined largely by the susceptibility/resistance 
of individuals. The evidence has been put forward for a "resistance gene", SM], found 
by a study carried out in an endemic area in Brazil where segregation analysis of 
informative families was followed by a genome-wide search (Marquet et al., 1996). 
Interestingly, SM] is located on human chromosome 5 5q31-33 region and this region 
contains several candidate genes encoding immunological molecules that were shown to 
play important roles in human protection against schistosomes. A genetic component 
has been reported in several studies on lymphatic filariasis, but MIHC linkage has either 
been inapparent, or associated with different alleles in different studies (Yazdanbakhsh 
et al., 1995). It seems now that MHC products may not be the most important influence 
on the course of lymphatic filarial disease, and that a genome-wide search such as that 
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conducted on S.mansoni-infected populations individuals (Marquet et al., 1996) should 
be undertaken. 
There are currently no data on antigenic variation or conservation among 
different isolates or strains of Brugia , although quite distinct biotypes of each species 
exist characterised by differential vector preference, periodicity, infectivity to animal 
hosts, and behaviour of the sheath during laboratory manipulation. However, there is 
now the first evidence, from infections with Wuchereria bancrofti, that microfilariae 
from different individuals show varying surface antigen characteristics (Ravindran et 
al., 1994). Although serum antibodies from microfilaraemic patients never react with 
the surface of microfilariae collected from the same patient, in some cases antibodies do 
bind the surface of parasites taken from different individuals. It will be important both 
to test the generality of this finding and to identify the target of these antibodies so that 
potential variant antigen genes can be studied. 
There is increasing evidence that MHC are subject to ongoing selection 
pressures by infectious pathogens, supporting the theory that natural selection by such 
parasites plays the central role in maintaining MHC polymorphism. Studies on 
association of malaria parasite population structure, HLA, and immunological 
antagonism (Gilbert et al., 1998) supports the view that host-parasite coevolution has 
been linked to a molecular arms race, with particular parasite genes evolving to evade 
specific host defenses. Up to now, such interesting theories have not been tested yet in 
filariasis research. 
It is evident that our present knowledge on the genetics of lymphatic filariasis is 
still very meagre: the genetics of human susceptibility to lymphatic filariasis, the genetic 
basis of filarial susceptibility in vector mosquitos, and the genetic constitution of human 
filarial parasites and their mosquito vectors are all which have barely been investigated. 
The need to study various genetic aspects of the disease is highlighted. 
1.7 Immunity, T cell antigens and vaccination 
Although complete immunity to any helminth parasite is rarely been 
demonstrated, there is increasing evidence for a degree of acquired immunity to filarial 
parasites, which builds up over many years of exposure in human populations (Day et 
al., 1991). Epidemiological studies generally show that the prevalence and intensity of 
filarial infection tapers off after the age of 20-30, but controversy reigns over whether 
this is due to acquired immunity, to parasite dynamics, or to non-immune age-
dependent effects. In seminal work in Papua New Guinea, it was shown that children 
continued to accumulate adult worms, while adults bore a stable worm burden (Day et 
al., 1991). This appears to constitute a state of concomitant immunity, directed at 
restricting incoming larval parasites but ineffective against the established population. 
Studies on animal models have given clearer evidence that there is immunity 
against filarial parasites. Protection against filarial infection, defined as a percentage 
reduction in the 'take' of infective larvae, can be generated in three ways. First, 
repeated infection of cats with viable B.pahangi L3 does, in some animals, result in a 
state of refractoriness to further infection (Denham et al., 1983; Denham et al., 1992); 
this is the most likely analogue of immunity in naturally-exposed humans. Second, 
drug-mediated clearance of Dirofilaria immitis infections in dogs renders animals 
resistant to challenge (Grieve et al., 1988). Finally, and most familiarly, immunisation 
with irradiated infective larvae from various filarial species does elicit relatively high 
levels (>90%) of protective immunity (Maizels et al., 1999). These model systems 
have been studied with respect to the critical immune system components for the 
induction and effector mechanisms of protective immunity. For many years our view of 
how the immune system can kill filarial parasites are based on two indirect sources: in 
vitro culture and assay systems, and on statistical association in human studies. More 
recently, some gene-knockout (cytokine genes and other immune cell related genes) 
mouse models have been used to attempt to identify specific cytokines and/or individual 
cell types which generate immunity against helminth parasites. These studies give some 
indications, but the conclusions are far from compelling. 
During the past few years it has become generally accepted that T cell-mediated 
immune responses are key determinants to the natural course of infections caused by 
both intracellular and extracellular parasites. Thus T cell-activating proteins of parasites 
continue to generate active interest, particularly in view of their importance in the 
development of newer and more effective diagnostic tests and vaccines. Although 
parasite-specific T cells have been implicated in mediating both pathogenic and 
protective immune responses in a number of filarial infections, the nature of the 
antigens inducing such responses remains poorly studied. The apparent lack of 
knowledge about these antigens may be partly attributed to the limited availability of 
crude parasite antigens. Selection of candidate antigens for vaccines against human 
lymphatic filariasis is further complicated by the large number of stage-specific and 
sheared antigens in its developmental stages. 
At the moment there are major difficulties in identifying CD4 T cell-stimulating 
antigens (Shastri, 1996; Walden, 1996). Multiple approaches have been used to attempt 
to identify T cell antigens from parasites. (1) Antibody screening of cDNA libraries. 
The use of antibodies present in "immune" serum has so far been the major tool for 
identifying T cell antigens, based on the premise that B cell antigens may contain T cell 
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epitopes as well. The presence of serum antibodies against parasite antigens is certainly 
proof that the antigens are "seen" by the host's immune system during natural infection, 
a prerequisite for a natural antigen based vaccine. However, the complexity of the 
serum response is such that it is generally impossible to select any particular antigen 
among the vast array of antigens recognised and that highest antibodies are often to 
abundant structural proteins. It is quite likely that many predominant T cell antigens 
have been missed by antibody screening. (2) Biochemical purification of proteins. 
Many biochemical approaches, such as fast protein liquid chromatography (FPLC) and 
T cell blotting have been used to try to isolate individual fractions which stimulate T 
cells, in order to define a single protein molecule which acts as a T cell antigen. 
However, the structural and biochemical complexity of parasites and the limited 
availability of crude parasite antigens make it very difficult to purify individual T cell 
antigens by conventional biochemistry. (3) MHC il-peptide elution. The generation of 
peptide-MHC ligands on the APC surface via the exogenous or the endogenous 
pathway is the crucial event in T cell recognition. Individual peptides (8-10 mers) 
associated with MHC I elute as homogenous peaks when cell extracts are fractionated 
by high-performance liquid chromatography (HPLC), share well defined consensus 
motifs, and are active in exogenous T cell stimulation assays at picomolar 
concentrations (Jardetzky et al., 1991; Rotzschke et al., 1990; Van Bleek and 
Nathenson, 1990). In contrast, the antigenic peptides presented by MHC II are 
heterogeneous in size (13-25 mers), and usually require one to three magnitudes higher 
concentrations in exogenous T cell stimulation assays (Chicz et al., 1992; Hunt et al., 
1992; Rudensky et al., 1991). Thus, it has proved easier to purify MHC I-bound 
peptides by HPLC and to identify their sequences by conventional Edman degradation 
or by mass spectroscopy techniques. Consequently, with notable exceptions (Monach 
et al., 1995; van Noort et al., 1995), peptides presented by MHC class II have been 
difficult to identify by biochemical techniques. Up to date, only one parasite T cell 
antigen has been defined by MHC il-peptide elution: Ldp23 from Leishmania donovani 
(Campos-Neto et al., 1995). Interestingly, Ldp23 is the first identification of an 
unknown CD4 T cell stimulating antigen by MHC 11-peptide elution, partially due to 
the fact that Leishmania donovani infects macrophages exclusively and resides inside 
the phagosome vesicles that comprise the cellular compartment where most of the 
association between foreign peptides and MI-IC class H molecules takes place. (4) 
Expression cloning. A parasite T cell antigen, LACK (Leishmania homolog of receptors 
for activated C kinase), has also been found by this approach from Leishmania major 
(Mougneau et al., 1995). An epitope-tagged expression library allowed recombinant 
proteins made in bacteria to be purified and the purified recombinant proteins then were 
captured by macrophages, through tag-bound antibody, for presentation to T cell 
clones. However, the fact that a huge percentage of recombinant proteins made in 
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bacteria are highly insoluble makes this approach more problematic for identification of 
T cell antigens. I believe that there is a urgent need to develop a novel system to directly 
identify CD4 T cell antigens from parasites. 
There is enormous scope for anti-helminth vaccines (Maizels et al., 1999), for 
in the vast majority of helminth infections chemotherapy provides only temporary 
respite from infection. For lymphatic filariasis, researchers have been seeking for a 
vaccine for many years, spurred on by the established efficacy of vaccination with 
radiation attenuated infective larvae in permissive animal models (Oothuman et al., 
1979), and the establishment of protective immunity through 'trickle' infection with 
infective larvae (Denham et al., 1992). As yet, no suitably effective vaccine has 
emerged from such studies. During recent years, some novel approaches have been 
adapted for helminth vaccination and these are discussed below. 
Anti-pathology vaccines. In many helminth infections, diseases are partly or 
even mostly the results of immunological reactions. There is therefore due concern that 
injudicious amplification of responses may exacerbate rather than alleviate disease. This 
issue is reversed by recent thinking on developing vaccines with an objective purely of 
blocking parasite-induced pathology and not attacking the parasite themselves. One 
example of anti-pathology vaccine has been pioneered in schistosomiasis, in which co-
administation of IL-12 with S.mansoni eggs reduces the granulomatous liver reactions 
to those eggs (Wynn et al., 1995). 
Live attenuated bacteria vaccine. The development of multivalent vaccines 
for human and veterinary use based on the expression of heterologous antigens in live 
attenuated bacteria such as Salmonella spp has received considerable attention in the 
last decade. Attenuated bacteria carrying precise deletions in their genome for reducing 
virulence, modified to carry genes coding for protective antigens from other pathogens 
can be delivered orally to restablish a self-limiting infection persisting in the tissues for 
a few weeks before being cleared. During that time, they can evoke a broad spectrum of 
immune responses against their own antigens as well as recombinant heterologous 
antigens. A few helminth parasite antigens, from Schistosoma mansoni (Khan et al., 
1994; Kremer et al., 1996; Mielcarek et al., 1998; Renauld-Mongenie et al., 1996), 
Echinococcus granulosus (Chabalgoity et al., 1997) and Brugia malayi (Chacon et 
al., 1996) have been tested by such attenuated bacteria vaccines in animal models, 
generally inducing strong immune responses, but no vaccines have been tested yet so 
far. One advantage of orally delivered live attenuated bacteria vaccine is they induce 
stronger and longer-lasting mucosal immunity, which could be ideal for vaccines 
against intestinal helminths. As an alternative to oral delivery, used in most live 
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attenuated bacteria vaccines so far, a new route explored recently has been to a single 
intranasal administration of attenuated Bordetella pertussis carrying Schistosoma 
mansoni glutathione S-transferase (Sm28GST) gene vacciated animals had a significant 
(56%) reduction of worm burden and an equivalent (60%) decrease in egg counts in the 
liver after the parasite challenge compared with nonimmunized mice (Mielcarek et al., 
1998). 
DNA vaccines. Perhaps the most exciting development in vaccine 
technology in recent years has been the development of naked DNA gene transfection 
techniques (DNA vaccines). DNA vaccines are particularly interesting for several 
reasons: they are relatively simple; antigen is produced in a mammalian system with 
corresponding post transitional modification and conformation; DNA itself can act as an 
adjuvant (Roman et al., 1997). Since the initial development of DNA vaccines more 
than 6 years ago, DNA vaccines have been shown to be effective at generating 
protective immune responses against a wide variety of diseases (Donnelly et al., 1997). 
However, much less is known about the potential of DNA vaccination to induce 
protective immune responses against multicellular parasites. Some helminth parasites 
antigen genes (such as glutathione S-transferase (Kayes et al., 1998), paramyosin 
(Yang et al., 1995), Si22 (Waine et al., 1999) from Schistosoma mansoni and 
Schistosoma japonicum , and 45W (Rothel et al., 1997) fromTaenia ovis) have been 
found to induce significant humoral immune responses in mice and sheep by DNA 
immunization. Interestingly, DNA vaccination using a gene encoding a proline-rich 
protective peptide from Taenia crassiceps showed 58.6% protection similar to the 
protective level induced by purified protein (Rosas et al., 1998), demonstrating that 
DNA vaccination is a simple approach to induce a protective immune response against 
multicellular parasites if a definitive protective antigen gene is used. Recently, the use of 
molecular adjuvants to drive responses induced by DNA vaccines has been reported in a 
number of experimental systems. It is possible to codeliver DNA expression constructs 
encoding antigen with the gene plasmids encoding the Th2-type cytokines to drive 
antigen-specific Th2 immunity, which may be desirable effective immunity against 
gastrointestinal tract-dwelling nematodes (Maizels and Holland, 1998). Thus a Th2 
response could be performed although DNA immunization tends to develop down Thi 
pathway. New techniques applied in DNA vaccination, such as site-directed and 
multivalent epitopes immunogenesis (Boyle et al., 1998), have shown promise for 
vaccine development against helminth parasites. 
Targetting APCs for vaccine induction. A striking feature of some helminth 
infections is the induction of antigen specific hypo-responsiveness in patients, and in 
animal models, similar to some tumour immune responses. One exciting development 
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in tumour vaccination recently is that tumor lysate- or peptide-dendritic cells induced 
therapeutic anti-melanoma immunity in human in vivo (Nestle et al., 1998). Dendritic 
cells are rare leukocytes and regarded as the most potent of all antigen-presenting cells. 
They may be the only cells which initiate immune response by presenting processed 
peptide antigen to naive T cells. Given this property they have attracted great attention 
as potential cellular adjuvants for vaccines. Based on a breakthrough of recent 
vaccination of melanoma and the parallels between tumor and parasite evasion of 
immune responses, it is well worth pursuing to investigate the effects of dendntic cell-
based vaccine on the helminth parasite diseases. 
(5) From genomics to vaccines. In the past 3 years, the genomic sequences of 
about at least 8 pathogens have been completed (http://www.tigr.org/tdb/mdb/mdb . 
html) and an entire field of functional genomics has developed around the use of these 
sequence data for new drug discovery. However, there has been much less attention to 
the use of these sequence data in vaccine development. At present two helminth parasite 
genome projects are now well under way: Brugia malayi (Blaxter, 1999) and 
Schistosoma mansoni (Johnston et al., 1999) which have already provided an 
extensive body of sequence information. I believe it is time to start exploiting genomic 
information in helminth parasites for new vaccines and a similar view on malaria is 
emerging recently (Hoffman et al., 1998). The simplest approach would be the 
expression library immunization with the entire genome cloned into plasmids, testing 
vaccine efficacy of large pools in animal models and hopefully finally identifying the 
protective genes (Barry et al., 1995). This approach is not an impediment for viruses 
with small numbers of genes and antigens, but may be problematic for parasites with 
much larger genomes. The second approach, I think it is more practical, would be to 
attempt to identify stage-specific genes by analysis of genome information, then to PCR 
amplify all open reading frames of these genes and subclone into DNA vaccine 
plasmids, assess vaccine efficacy in mice and identify the protective genes. Over the 
coming few years, I expect an explosion of using genomic information for vaccines. 
1.8 Aims of the thesis 
T cells recognize antigenic peptide-MHC complexes on the surface of APCs. 
This interaction plays a crucial role in determining outcome of parasitic infection in 
terms of both protective immunity and immunopathology. However, the major T cell 
antigens of filarial species such as B.malayi are still undefined. 
The aim of the work detailed in this thesis was on the identification, gene 
cloning, functional expression and vaccine development of major T cell antigens in 
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B.malayi Mf, by combining multiple approaches including biochemistry, molecular 
biology and genome project analysis. 
The Filarial Genome Project is now well under way and has already provided a 
vast number of sequences. We believe it is time to start exploiting this genomic 
information in immunology. A further aim of this thesis was to find possible immune 
evasion genes, such as homologues of human cytokine genes, from B.malayi by 
analysis of the Filarial Genome Project and other databases. 
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Chapter 2 	Materials and Methods 
2.1 Immunology 
2. 1. 1 Parasite isolation 
B. malayi adults and microfilariae (MO were obtained from infected jirds 
(Meriones unguiculatus) purchased from TRS laboratories (Athens, GA). Adult worms 
were removed from the peritoneal cavity of jirds that had been euthanised by cardiac 
puncture under anaesthesia, and washed in RPIVII 1640 (Gibco-BRL, UK) 
supplemented with 50 jtg/ml gentamcin. MI were isolated from lavage fluid by gentle 
centrifugation ( 1000 rpm for 10 mm) and purified by passage through PD10 
Sephadex® G-25 M columns (Pharmacia Biotech AB, Uppsala, Sweden) (Allen et al., 
1996). Infective larvae (L3) were obtained from Aedes aegypti mosquitoes that had 
been fed on blood containing 1.6 x io MI/ml 12 days previously. After this time, 
mosquitoes were gently crushed between a glass plate and a test tube, following which 
larvae were separated from mosquito debris in a Baennann apparatus with Grace's 
insect tissue culture medium (Gibco-BRL, UK). 
2.1.2 Preparation of parasite antigen 
B. malayi antigen (B mA) was prepared by homogenization of mixed sex adult 
worms or Mf in PBS (lOx stock solution: 80 g NaCl, 2g KC1, 11.5 g Na2HPO4 
7H20, 2 g KH2PO4 to 1 litre) on ice followed by centrifugation at 10,000 x g for 20 
mm (Maizels, 1991). The resultant supernatant was passed through a 0.2 gm filter prior 
to protein concentration determination by the Coomassie Plus protein assay (Pierce, 
Rockford, Illinois). This material was used in T cell assays and for ELISA at the 
concentration indicated in the text. In some experiments, adult or Mf were homogenized 
in PBS, sonicated, irradiated for 30,000 Rad, and then used as antigens. 
2.1.3 Mouse and immunization 
For all experiments, mice used were 6-8 week old females unless otherwise 
stated. Experimental mice were generally purchased from Harlan-UK (Bicester, UK), 
or obtained from source (Ann Walker House, Edinburgh University). PCC TCR 
transgenic mice were kindly privded by Dr. R.Germain, NIH, USA. 
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For immunization, mice were injected (sub-cutaneously, intraperitoneal or 
footpad) with 20-50 tg/50-200 t1/mice of antigen mixed with adjuvants. Tail blood 
was taken for antibody measurement or Mf number counts. 
2. 1 .4 Cultures and cell lines 
Unless otherwise stated, all in vitro cultures were carried out in complete 
medium: RPMI 1640 medium (Gibco-BRL, UK) supplemented with 2 mM glutamine, 
0.25 units/ml penicillin, 100 pjg/mi of streptomycin, 5 PM 2-mercaptoethanol and 10% 
FCS (GibcoBRL, heat-inactivated 1 h at 56°C), at 37°C in 5% CO 2 . The IL-211L-4 
responsive NK cell line [Swain, 1981] was maintained by incubation of cells with 
complete medium for 3 days, after which cells were diluted 1:10 in complete medium 
with 10% (v/v) conditioned medium from a 48 h culture of concanavalin A (Con A)-
stimulated mouse lymphocytes. The COS-7 cell line was also maintained by growth in 
complete medium as well. 
2. 1.5 Proliferation assays 
Popliteal lymphocytes for proliferation assays were cultured in complete 
medium. The number of viable cells were counted by trypan blue exclusion. The 
popliteal lymph nodes cells were incubated at 4 x 105  cells/well in 100 jil triplicate 
cultures with 100 p1 of diluted antigen. After incubation for 48 h at 37°C, 100 p1 of 
supernatant was removed from each well for cytokine analysis; 1 tCi [3H] thymidine in 
10 91 complete medium was then added to each well, and plates were incubated for 16-
18 hr at 37°C prior to harvesting and counting using a Top Count Microplate 
Scintillation Counter (Canberra Packard). 
For analysis of lymphocyte responses in the spleens of animals, splenocytes 
were obtained by teasing spleens apart, then lysing erythrocytes using red blood cell 
lysis buffer (Sigma Chemical Co.). Viable cells were then counted by trypan blue 
exclusion. Whole spleen cells were incubated at 5 x io cells/well with antigens. After 
incubation for 65 h at 37°C, supernatants were taken for subsequent cytokine analysis. 
With purified CD4 T cell populations (see 2.1.10), proliferation assays were 
performed as followed. First, 100 jil PEC at 1x10 6 /ml were adhered to a flat-bottomed 
96 well plate (Nunclon) at 37°C for 2-3 hours, after which non-adherent cells were 
removed by washing with complete medium so that the adherent PEC act as APC. For 
some experiments, irradiated (2,000 Rad) spleen cells can also be APC. 1-5 x 105 
CD4 T cells/well were incubated with antigens and APC. 
2.1.6 Cytokine assays 
For IL-2 and IL-4, the IL-211L-4 responsive NK cell line [Swain, 1981] was 
used to measure cytokine production by primary T cells and spienocytes. Proliferation 
of the NK cells at 10 5irnl, 100 p1/well, was measured in the presence of 10 jil culture 
supernatant, with the addition of anti-IL-2 (S4B 6)(ATCC: Rockville, MD) neutralising 
antibody for IL-4 measurement, and anti-IL-4 (1 1B1 1)(ATCC:Rockville, MD) 
neutralising antibody for IL-2 measurement. S413  and 1 I  11 were obtained from 
ascites for in vitro use, and used at 2.5 p1/ml, the optimal concentration for 
neutralisation as determined by titration. After incubation at 37°C for 24 hours, 1 
jiCi/well of [3H]TdR (Amersham) was added in 10 p1 RPMI complete medium prior to 
incubation for a further 16 to 18 h. Plates were then harvested and counted using a Top 
Count microplate scintillation counter (Packard Instrument Co. Meriden, CT). 
Standard curves using recombinant IL-2 (Sigma Chemical Co.) and I1-4 (Sigma 
Chemical Co.) were performed to determine cytokine levels in supernatants. 
IFN--y was measured by capture ELISA. ELISA Plates (NUNC-Immunoplate 
MaxiSorpTM NUNC, Denmark) were coated with 3 jig/ml with rat-anti-mouse IFN-y 
mAb (R46A2)(ATCC, Rockville, MD), 50 p1 per well, diluted in 0.06 M carbonate 
buffer (pH 9.6). After overnight incubation at 4°C, plates were blocked by addition of 
100 p1 per well 1% BSA or 10% fetal calf serum in carbonate buffer, incubated for one 
hour at 37°C. 25 p1 of sample to be tested, and a recombinant IFN-y (Sigma Chemical 
Co., 1-5517) standard curve, were added to give a final volume of 50 RI/well in TBST 
[50 mM Tris-buffered saline (pH7.6) + 0.05% Tween-20]. Plates were then incubated 
overnight at 4°C. After washing four times with TBST, 50 p1 per well biotinylated rat-
anti-mouse-IFN-y monoclonal Ab (XMG1.2) (Pharmingen, San Diego, CA 18112D) 
was added at 1 jig/ml in TBST, and incubated for 1 hour at 37°C. Plates were again 
washed four times with TBST, followed by addition of 50 pllwell strepavidin-alkaline 
phosphatase (Sigma Chemical Co.) at 1 pg/ml in TBST, which was incubated for 45 
minutes at 37°C. Finally, after washing four times with TBST and rinsing once with 
deionised water, p-nitrophenyl phosphate substrate (Sigma Chemical Co.) was added at 
50 p1/well. The plates were developed in the dark for 30 minutes to several hours, with 
regular checking for colour change. Once a colour change was observed, plates were 
read at 405 nm in an ELISA reader (Anthos Labtec Instruments). Detection limits using 
this protocol were ~!0. 125 Units/ml IFN-y, as determined from the standard curve. 
25 
2.1.7 Antigen-specific IgG isotopes 
ELISA plates (NUNC-Immunoplate MaxiSorpTM NUNC, Denmark) were 
coated with 50 p1/well BmA at 5 .tg/ml, diluted in 0.06M carbonate buffer, and 
incubated overnight at 4°C. They were then blocked for 1 h with 100 jil/ well 5% BSA 
in PBS at 37°C. After washing four times with PBST, serum samples diluted 1:100 in 
PBST were added at 50 jillwell, then incubated for 4 h at 37°C. Plates were washed 
four times with PBST, then 50 j.tllwell horseradish peroxidase-conjugated isotype-
specific mAbs diluted in PBST were added: anti-IgGi (Cat No 1070-05, Southern 
Biotechnology Associates Inc. Birmingham, AL), diluted 1:6000; anti-JgG2a (Cat No 
1080-05, SBA Inc.), diluted 1:4000; anti-IgG2b (Cat No 1090-05, SBA Inc.), diluted 
1:4000; and anti-IgG3 (Cat No 1100-05, SBA Inc.). In the case of C57BL/6 mice an 
alternative anti-IgG2a antibody (R19-15, Pharmingen, San Diego, CA) had to be 
employed, since the IgG2a isotype produced by this strain of mouse differs 
significantly from those produced by other strains [Martin, 1998], and is not recognised 
by the Southern Biotechnology mAb. Following a 1 h incubation at 37°C and four 
washes with PBST, ABTS substrate (KPL Biotechnology, Gaithersburg MD) was 
added at 50 jil/well, and plates read at 405nm on an ELISA reader and comparative 
optical densities (O.D.) plotted. 
2.1.8 Western blotting 
Proteins were mixed with an equal volume of 2x SDS-PAGE (SDS-
polyacrylamide gel electrophoresis) sample buffer [125 MM Tirs (pH 6.8), 4% 10% 
SDS, 20% glycerol, 0.01% Bromophenol blue. For reducing conditions, 5% fresh 2-
ME was added; for nonreducing conditions, 1 mg/mi iodoacetaniide was added] and 
boiling for 5 min prior to loading. Gels were run in an electrode buffer (5x stock 
solution: 144 g glycine, 30 g Tris base, 5 g SDS to 1 litre) at 40 mA. Separated proteins 
were then either stained with Coomassie blue staining solution (50% methanol, 10% 
acetic acid, 0.25% Coomassie Blue R-250) or Gelcode Blue Stain Reagent (Cat No 
24590, PIERCE) or electrophoretically transferred onto a membrane for Western 
blotting. 
Proteins separated by SDS-PAGE were transferred onto PVDF (Sigma) or 
Hybond-C nitrocellulose (Amersham) membrane, which were presoaked in transfer 
buffer (0.5x electrode buffer containing 10% methanol) by the electrophoretic transfer 
method. Transfer was conducted at 140 mA for 1.5 h on LKB NOVABLOT. The 
transferred proteins were also visualised by Ponceau S solution (Cat No P-7170, 
Sigma). 
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The membranes were incubated in blocking solution [5% fat-free dried skimmed 
milk (MARVEL), PBS, pH 7.4] overnight, rinsed once in PBS-TT (0.1% Triton X-
100 and 0.05% Tween-20 in PBS), and then incubated with diluted antibody (usually 
1:1000-2000) in the buffer (5% fat-free dried skimmed milk, 0.1% Triton X-100 and 
0.05% Tween-20, PBS) for 2 h. After washing by PBS-TT, the membranes were 
incubated with peroxidase-conjugated rabbit anti-mouse IgG (Cat No P0260, DAKO, 
Denmark). The bound antibodies were detected by chemiluminescence using ECL+PIus 
Western blotting detection system (Cat No RPN2 131, Amersham Life Science) and 
Hyperfilm ECL (Cat No RPN3 103H, Amersham Life Science) as the following: the 
membrane was incubated with detection solution for 5 min at room temperature and 
then exposed with film for 2-30 sec. 
2. 1.9 Fluorescence activated cell sorter (FACS) analysis 
Cells were washed and adjusted to a concentration of 1x10 7 /ml in FACS PBS 
(PBS containing 1% BSA and 0.1% sodium azide). 2 pA of antibody was then added to 
100 t1 of cell sample (1x10 6 cells) to be stained, either in a 15 nil centrifuge tube or in a 
round bottomed microtitre plate. Samples were incubated at 4°C for 30 minutes, 
washed three times with FACS PBS, then transferred to FACS tubes (Becton 
Dickinson) and either analysed directly, or fixed with a few drops of 10% formalin and 
stored in the dark prior to analysis, using a FACScan with CELLQuest software 
(Becton Dickinson). Antibodies used for flow cytometly were: R-phycoerythrin-
conjugated anti-CD4 (RM2504, Caltag), FITC-conjugated anti-CD8 (RM2201, Caltag), 
FITC-conjugated anti-CD40L (09025B, Pharmingen), FITC-conjugated anti-CD80(B7-
1) (RM6901, Caltag), R-phycoerythrin-conjugated anti CD86(B7-2) (RM7004,Caltag). 
2.1.10 Cell sorting using magnetic beads 
The MACS magnetic cell sorting system (Milteyni Biotec, Germany) was used 
for positive selection. Cells were washed and adjusted to 1x10 7/90 pA of in the buffer 
(PBS pH 7.2 supplemented with 2 mM EDTA and 0.5% bovine serum albumin), and 
were stained with 10 pA of MACS CD4 (L3T4) MicroBeads (Order No 492-01, 
Miltenyi Biotec) for 15 min at 4°C. Cells were washed by 10-20x volume of the buffer 
and centrifuged at 300xg for 10 mm, and resuspended in 500 pA of the buffer per 10 8 
cells. MS+ separation column (Order No 422-01, Milteyni Biotec) was prepared by 
application of 500 jil buffer. Cell samples were then added, and the column was then 
washed with 3 x 500 jil buffer, with the total effluent collected as the depleted fraction. 
Positively selected cells were then obtained after removal of the column from the 
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magnet, by washing of the column with 1 ml of buffer. To avoid binding of adherent 
cells to the column matrix, all buffers were stored at 4°C or on ice, and columns were 
incubated at 4°C prior to use. 
2.1.11 Gene vaccination 
Large scale preparations of plasmid DNA were prepared using QIAGEN 
EndoFree Plasmid Mega Kit and eluted in 0.9% sodium chloride solution (Sigma). 1-3 
mg of plasmid can be got from 1 L of bacterial incubation by this kit. The purity of 
DNA was estimated by measuring its absorbence at 260nm and 280nm in 
spectrophotometer to ensure that the 260:280 ratio is >1.8. 
For DNA immunization, mice should be anaesthetized since awake mice will 
contract their muscles and squeeze the DNA solution out. BALB/c female mice of 6-8 
wk were injected with 20-50 p1 of anaesthetic drug [1 volume of Romoun (Bayer) + 2 
volume of Vetalar V (Pharmacia & Vpjohn Limited)] and the hair on quadriceps 
muscles were removed using IMIvIAC (Reckitt & Colman). 100 jig of each plasmid 
construct in a final volume of 100 p1 0.9% sodium chloride solution was injected into 
the quadriceps muscles. Two weeks later, the mice were boosted in the opposite leg 
with 100 j.tg of plasmid DNA. Tail blood was taken for antibody measurement two 
weeks after booster. 
2.1.12 Immune screen of cDNA libraries 
Titering of cDNA libraries. A single colony of XL1-Blue MRF' was grown 
overnight in 50 ml of LB containing 0.2% (WIV) maltose and 10 MM  MgSO4 without 
antibiotic. 1:100 dilution of overnight culture was incubated for 3 h; 200 jil of bacteria 
was mixed with ljtl of cDNA library [101108  dilutions of the phage in SM buffer 
(5.8g of NaCl, 2g of MgSO4 .7H20, 5 ml of 2% gelatin, 50 ml of 1 M Tris-HC1, pH 
7.5, water up to 1 L] and incubated at 37°C for 15 mm, added 2-3 ml of 0.75% top 
agarose (50°C), 15 p1 of 0.5 M IPTG, and 50 p1 of X-gal [250 mg/ml in 
dimethylformamide], and then immediately onto agar plates. The plates were incubated 
at 37°C overnight and the white and blue plaques were counted. 
Immune sera. Mice were injected sub-cutaneously with antigens in a 1:1 ratio 
with incomplete Freund's adjuvant (IFA), and boosted at four and eight weeks after the 
initial immunization by intraperitoneal injection with antigens in IFA. Sera were 
collected at twelve weeks and tested by Western blotting to check for antibody 
responses. The serum samples were preadsorbed against E.coli lysate. 4 nitrocellulose 
membranes were immersed into 1 mg/ml of E.coli lysate in TBST (0.05% Tween-20, 
150 mM NaCl, 20 mM Tris-HCI, pH 7.5) for 30 min at room temperature. The 
membranes were removed and air dried on whatman paper, washed 3-5 times for 5 mm 
each with 50 ml of TBS, immersed in 50 ml of blocking solution (1% BSA in TBS) 
for at least 30 min and then rinsed 3 times with 50 ml of TB ST. One membrane was 
incubated with the immune sera (diluted 1:5 in TBST) for 10 min at 37°C and then 
removed; The immune sera was repeat incubated using other 3 membranes, filtered 
through 0.2 gm and stored at 4°C. 
Plaque screening. 1 ml of the XL 1-Blue MRF overnight culture was added 
into 100 ml of LB containing maltose and MgSO 4 and incubated overnight. The 
bacteria was centrifugated at 2,000 rpm for 10 min and then resuspend in 6 ml of 10 
MM MgSO4 200 p1 of bacteria was mixed with 1tl of diluted cDNA library at 37°C for 
15 mm, added 2-3 ml of top agarose and poured onto the plates prewarmed at 37°C for 
at least lh. The plates were incubated at 42°C for 3-6 h until small plaques just become 
visible; 30 min prior to use, nitrocellulose membranes (Hybond TM-C extra, Amersham) 
were wetted with 10 mM IPTG and then air dried. The plates were coved by the 
membranes and incubated at 37°C for 3.5 h or overnight. The membranes were 
washed in TBST 3-5 time for 15 min each and then in blocking solution for 1 h, 
transfered into 8mllmembrane of blocking solution containing diluted immune sera for 1 
h and washed in TBST 3-5 time for 5 min each; The membranes were transfered into 
conjugated second Ab, washed and then tested by Th'IB Membrane Peroxidase 
Substrate System (Cat No 50-77-00, Kirkegard & Perry Laboratories Inc). 
Clone excision. The positive plaque from the plate was transfered to tube 
containing 500 p1 of SM buffer and 20 j.il of chlorform. 0.5 ml of overnight culture 
XL 1-Blue MRF and SOLR were added into 50 ml of LB and incubate for 2-3 h. SOLR 
was kept at room temperature while XL 1-Blue was spun and resuspend in 6 ml of 
MgSO4. 200 jil of XL 1-Blue, 250 p1 of phage stock, 1 p1 of the ExAssist help phage 
(Stratagene) were added into 50-ml tube, incubated at 37°C for 15 mm, added 3 ml of 
LB and then incubated for 2 h. The tube was incubated at 70°C for 15 min and spun 
4000 g for 15 mm. The supernatant was transfered into new tube and this stock 
contains the excised pBluescript phagemid packaged as filamentous phage particles. 50 
p1 of the supernatant was mixed with 200 p1 of SOLR cells and incubated 37°C for 15 
mm. 10-50 p1 of incubation was plated on LB-Amp plates and incubated at 37°C 
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overnight. Plasmid DNA was prepared by QlAprep Spin Miniprep Kit (QIAGEN Inc.) 
and sequenced. 
2.2 Molecular biology 
2.2.1 Oligonucleotide primers, plasmides and cDNA libraries 
The oligonucleotide primers used in this study were synthesised by the Oswel 
DNA Service and other companies. The sequence of the primers are given in Table 
2.1. 
Table 2.1 Oligonucleotide primers used in this course of studies 
Name Sequences (5' to 3 1 ) Comments 
CAACAGTACTTTAAAC +strand primer from 87-111 
Serpin-Exp.F CATTGTTCTG of Bm-spn-2 cDNA 
CTAACCTTTGTCTTTT -strand primer from 	1310- 
Serpin-Exp.R TTTCGGTGTTTCC 1283 of Bm-spn-2 cDNA 
CGCGCATATGAACAGT +strand primer from 87-103 
Bm-SPN-2-1F ACTTTAAACCA of Bm-spn-2 cDNA, Nde I 
site 
+strand primer from 528-544 
Bm-SPN-2-2F CGCGCATATGATATTTA of Bm-spn-2 cDNA, Nde I 
TTAAATGGAT site 
+strand primer from 915-931 
Bm-SPN-2-3F CGCGCATATGGTTACA of Bm-spn-2 cDNA, Nde I 
ATTCCAAAATT site 
-strand primer from 557-540 
Bm-spR-2-1R GCATATGTTACATACTT of Bm-spn-2 	cDNA, 	stop 
TTCTTTATCCA codon 
-strand primer from 944-927 
Bm-spR-2-2R GCATATGTTAATTTTCG of Bm-spn-2 	cDNA, 	stop 
TACTTAAATTT codon 
GCATATGTTATTCAACA -strand 	primer from 	1403- 
Bm-spR-2-3R TCATATTT 1386 of Bm-spn-2 cDNA 
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AATATTGGCAATITCGCAA +strand primer from 1-29 of 
Serpin.Gen F TTATCTCATG Bm-spn-2 cDNA 
AAATTAATGCAFITITIA -strand 	primer from 	1418- 
Serpin.Gen R 111'CAACATCA 1391 of Bm-spn-2 cDNA 
ACGGTAGCGACACCGCT -strand primer from 780-761 
BmSerpin.F2 TGC of Bm-spn-2 cDNA 
GGAAGGGATGATT'AGCA -strand primer from 	1176- 
BmSerpin.F 1 CGA 1157 of Bm-spn-2 cDNA 
GCCAGAAGTGAAACTGA +strand primer from 261-280 
BmSerpin RI GCG of Bm-spn-2 cDNA 
GGAGCCCGTAATATCGC +strand primer from 564-584 
BmSerpin.R2 TGGC of Bm-spn-2 cDNA 
GCTATAGGCTACTGATA +strand primer from 309-335 
Serpin.G1 ACTAAGGCGC of Bm-spn-2 gene 
CGGGCTCCATAATT'CATA -strand 	primer 	from 	1124- 
Serpin.G2 C 1108 of Bm-spn-2 gene 
GCAAGCGGTGTCGCTAC +strand primer from 1505- 
Serpin.G3 CG 1523 of Bm-spn-2 gene 
GTGCACTTGACTCATCTC +strand primer from 886-906 
Serpin2-xxz-blood ACG of Bm-spn-2 cDNA 
CGGTAGGCGTGTACGGT +strand primer 779-801 	of 
XXZ-pcDNA3.1 (-)F GGGAGG pcDNA3. 1 (-) 
CAGTGGGAGTGGCACCT -strand primer 1107-1086 of 
XXZ-pcDNA3.1(-) R TCCAGG pcDNA3.1(-) 
CCGGGCCCATTCCCTG subclone E80 into pcDNA3.1 
XXZ-ApaI-Ii8OF CTGCTGCTGC (-) R 
CCGGGCCCCTGCAGCT subclone E80 into pcDNA3. 1 
XXZ-ApaI-Ii80R GCAAGTTTCATGC (-) R 
CGGGCCCGCCACCATG contain Kozak consensus; 
PCDNA-SERPIN GAGCTTTTCGAAGTA subclone Bm-spn-2 into 
pcDNA3.1 (-) R 
pcDNA3. 1 (2R) TGGTGAATTCATAGACA subclone Bm-spn-2 into 
ATTCGCGTGGATA pcDNA3.1 (-) R 
GGAATTCCATATGCCG subclone Bm-MIF-2 into Nde 
XXZ-MIF2-F CTGATAACGCTTGCT I site of pET-29c(+) 
CCGCTCGAGTTTCTTCA subclone Bm-MIF-2 into Xho 
XXZ-MIF2-R TAAGCTCTTTCAT I site of pET-29c(+) 
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subclone mutant Bm-MIIF-2 




MIF2-RT-F GAATTA RT-PCR for Bm-mif-2 
GATACAATGCGCTGG 
MIF2-RT-R ATCG RT-PCR for Bm-mif-2 
CCATATGCCATATTTT subclone Bm-MIF-1 into Nde 
XXZ-MIF1-F ACGATTGATAC I site of pET-29c(+) 
CTCGAGTCCCAAAGTA subclone Bm-MT-1 into Xho 
XXZ-MIF1-R GATCCATTAAAAGC I site of pET-29c(+) 
subclone mutant BM-MIF- 1 
XXZMIF1G2 CCATATGGGATATTTT (P1— 	G) into Nde I site of 
ACGATTGA 
PET-29c(+) 
GGTGACATTGAAAAA subclone PCC into pTrcHlis2 
XXZ-PCC-F GGT TOPO TA-vector 
TTACTTAGCGGTGGC subclone PCC into pTrcHlis2 
XXZ-PCC-R TTG TOPO TA-vector 
Table 2.2 Plasmids used in this course of studies 
Name Company Comments 
for cloning of PCR products; white/blue screen; 
pGEM-T Promega Amp-resistance 
for cloning of PCR products; white/blue screen; 
pMOS Blue-T Amersham Amp-resistance 
for direct cloning and high-level expression of 
PCR products; fusion protein containing 	N- 
pET-29 T-vector Novagen terminal 29 aa S.Tag 	and C-terminal 	8 	aa 
His.Tag; Kan-resistance 
for 	direct 	cloning 	(5 	mm) 	and 	high-level 
pTrcHlis2 TOPO expression of PCR products; fusion 	protein 
TA-vector Invitrogen containing N-terminal 3 aa and C-terminal 29 aa 
myc epitope and His.Tag; Amp-resistance 
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for high-level expression of target gene; fusion 
pET-29c(+) Novagen protein could contain C-terminal 8 aa His.Tag; 
Kan-resistance 
for high-level expression of target gene; fusion 
pET-15b Novagen protein could contain C-terminal 20 aa His.Tag; 
Amp-resistance 
for high-level stable and transient expression of 
pcDNA3.1(-) Invitrogen target gene in mammalian host; Amp- and G418- 
resistance 
B. malayi stage-specific cDNA expression libraries from L3, adult males, adult 
females, Mf and other stages were supplied by the Filarial Genome Project. Further 
details on construction of these libraries and their availability are posted on 
http://helios.bto.ed.ac.uk/mbx/fgn/net/fgpresource.htn -d. 
2.2.2 Bacterial strains, growth and storage 
Bacterial strains used in this study were are given in Table 2.3. 
Table 2.3 Bacterial strains used in this course of studies 
Strain Genotype Comments 
A(mcrA)183 L(mcrCB-hsdSMR- for recombinant DNA 
mrr)1 73 endAl supE44 thi-1 recAl 
manipulation with 
 
XL 1-Blue blue/white screening, 
gyrA96 relAl Lac [F'proAB 
(Stratagene) Tet-resistant 
1acIqlacZAM15TnlO(t etr)] 
supE44 	A1acUl69 	(080 	1acZEM15) for recombinant DNA 
DH5a hsdR17 	recAl 	endAl 	gyrA96 	thi-] manipulation with 
relAl blue/white screening 
e14(McrA) ii(mcrCB-hsdSMR-mrr)1 71 
for plating excised 
sbcC recB recJ uvrC umuC: : Tn5(Kan') 
SOLRTm phagemids, Kan- 
(Stratagene) lac gyrA96 relAl thi-1 endAl 
A!?  [F' resistant 
proAB lacP ZziM]5]Su 
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BL21(DE3) 	F ompT  hsdsfi ( rB-mB-)  gal dcm (DE3) 
(Novagen) 
for 
expression of gene 




A single colony of E.coli was inoculated in 10 ml of LB supplemented with the 
appropriate antibiotic (50 jig/ml ampicillin; 15 Jig/ml tetracyline; or 30 jig/ml 
kanamycin) in a 50 ml polypropylene centrifuge tube, and grown at 37°C with vigorous 
shaking overnight. For cryopreservation, 0.85 ml of culture was mixed with 0.15 ml 
of sterile glycerol and stored at -70°C. For recovery, the bacteria was streaked out from 
frozen culture onto a L-agar plate or LB with antibiotic when required. 
2.2.3 Preparation of competent E.coli cells 
A single colony of E.coli was added into 100 ml of LB broth in a 1 litre flask 
and incubated with shaking for approximately 3-6 h until the cell density was 4-7 X.  10 
viable cells/mi (013600 of 0.4-0.6). The culture was transferred into ice-cold 50 ml 
tubes, chilled on ice for 10 min and then centrifuged at 4000 rpm for 10 min at 4 °C. 
The pellet was then resuspended in the original culture volume of an ice-cold 
CaC12/glycerol solution (60 mIVI CaC12 and 15% glycerol, filter sterilised) incubated on 
ice for 30 mm. The cells were then collected by centrifugation as above, resuspended in 
1/2 of the original culture volume of an ice-cold CaC12/glycerol solution, and incubated 
on ice for 10 mm. The cells were then collected by centrifugation again, resuspended in 
1/30 of the original culture volume of an ice-cold CaC12/glycerol solution, and stored on 
ice overnight. The following morning the cell suspension was dispensed as 50 jil 
aliquots into prechilled eppendorfs and stored at -70°C 
2.2.4 Genomic DNA preparations 
Genomic DNA was isolated from B.malayi parasites. Parasites were lysed by 
immersion in lysis buffer (100 mM NaCl, 50 mM EDTA, 1% SDS, 1% 2ME, 10 
j.tg/ml RNase, 100 jig/nil proteinase K, 100 mM Tris-Cl, pH 8.5) at 65 °C for 30 mm 
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with occasional very slow inversion, and then extracted with 0.5 ml phenol by very 
slow inversion for 5 mm. After spinning 10 min at 12,000 rpm, the upper aqueous 
phase was extracted with 0.5 ml of phenol/chloroform and chloroform. After spinning 
10 min at 12,000 rpm, 0.4 ml of the upper aqueous phase was added to imi of 100% 
ethanol (kept at -20 °C) and then spun 15 min at 12,000 rpm. The DNA pellet was 
washed twice with 70% ethanol and once with 95% ethanol. The DNA pellet was 
briefly air dried and then resuspended in TE buffer (10 mM Tris-HC1 pH 8.0, 1 mM 
EDTA pH 8.0). Genomic DNA preparations were kept at 4 °C. 
2.2.5 Plasmid DNA preparations 
Mini-preparation of plasmid DNA. Plasmid DNA was prepared by QlAprep 
Spin Miniprep Kit (QIAGEN Inc.), according to manufacturer's instructions. Single 
colony or frozen culture bacteria were inoculated into 10 ml of LB broth containing 
antibiotic and grown overnight at 37°C with shaking. The cells were collected by 
centrifugation at 3,000-4,000 rpm for 10 min and resuspended in 250 j.tl of Buffer P1 
(100 tg/ml RNase A, 10 mM EDTA, 50 mM Tris-Ci pH 8.0, pH 8.0). The cells were 
then lysed by the addition of 250 p1 of Buffer P2 (200 mM NaOH, 1% SDS) and 
mixed gently by inversion of the tube several times. This was neutralised with 350 .t1 of 
chilled Buffer P3 (3.0 M potassium acetate pH 5.5), mixed immediately, and then 
centrifuged at 13,000 rpm for 10 mm. The supernatant was transferred to QTAprep spin 
columns and then centrifuged at 13,000 rpm for 1 mm. The columns were washed by 
adding 0.5 nil of buffer PB and centrifuged at 13,000 rpm for 1 mm, adding 0.75 ml of 
buffer PE and centrifuged twice at 13,000 rpm for 1 mm. Finally the column received 
30 p1 of dH20 and was centrifuged at 13,000 rpm for 1 mm. 
Maxi-prep of plasmid DNA. Large scale preparations of Plasmid DNA were 
prepared using QIAGEN EndoFree Plasmid Mega Kit, following the manufacturer's 
instructions. Single colony or frozen culture bacteria were inoculated into 10 ml of LB 
broth containing antibiotic and grown overnight at 37°C with shaking. 4 ml of the 
culture was transferred to 2 litres of selective LB medium and grown 12-16 h at 37°C 
with shaking. The bacteria were harvested by centrifugation at 6,000 x g for 15 min at 
4°C and the pellet resuspended in 50 ml of buffer P1 as above. The cells were lysed by 
adding 50 ml of buffer P2 (200 mM NaOH, 1% SDS). The lysate was mixed gently 
and incubated at room temperature for 5 mm. After the addition of 50 ml of buffer P3 
(3 M potassium acetate pH 5.5) and mixing, the solution was then poured into the 
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QiAfilter Cartridge and incubated at room temperature for 10 mm, pulled through by a 
vacuum. The cartridge was washed by 50 ml of buffer FWB (15% isopropanol, 750 
mM NaCl, 50 mM MOPS, pH 7.0). The filtered lysate was mixed with buffer ER, 
incubated on ice for 30 mm, and then poured into a QIAGEN-tip 2500 equilibrated by 
applying equilibration buffer QBT (750 mM NaCl; 50 mM MOPS, pH 7.0; 15% 
isopropanol; 0.15% Triton X-100). The tip was washed with buffer QC (1.0 M NaCl; 
50 mM MOPS, pH7.0; 15% isopropanol) and DNA was eluted in buffer QN (1.6 M 
NaCl; 50 mM MOPS, pH 7.0; 15% isopropanol). The DNA was then precipitated by 
24.5 ml of isopropanol, and centrifuged immediately at 15,000 x g for 30 min at 4 °C. 
The DNA pellet was washed with 7 ml of 70% ethanol and centrifuged at 15,000 x g 
for 10 mm. The DNA pellet was air-dried and then redissolved in 0.9% endotoxin-free 
sodium chloride solution (Sigma). 
2.2.6 RNA preparations 
Total RNA from L3, adult males, adult females and Mf was isolated using 
RNAzo1 B Isolation of RNA kits (AMS,TX). Parasites were homogenized with 
RNAz01TM B. To 2 ml of homogenate was added 0.2 ml of chloroform (HPLC grade, 
99.9%), shaken vigorously for 15 sec, placed on ice for 5 mm, and then centrifuged at 
12,000g (4°C) for 15 mm. The upper aqueous phase was transferred to the fresh tube, 
mixed with an equal volume of isopropanol (>99%, Sigma), and stored at 4°C for 15 
mm. After centrifugation at 12,000 g (4°C) for 15 mm, the RNA was washed with 1.5 
ml of 75% ethanol by vortexing, and subsequently centrifuged for 8 min at 7,5000 g 
(40C). At the end of the procedure, the RNA pellet was dried completely and then 
dissolved in 1 mM EDTA (pH 7) or water. The preparation should have a 260/280 ratio 
higher then 1.9. 
2.2.7 Quantification of DNA and RNA 
The concentration of DNA and RNA in solution was estimated by measuring 
their absorbances at 260 nm in spectrophotometer. It was assumed that an OD260 of 
1.0 is equivalent to a concentration of 50 j.tg/ml for double stranded DNA, 35 p.g/ml for 
oligonucleotides, and 40 jig/ml of single-stranded RNA. The purity of DNA and RNA 
was estimated by measuring its absorbance at 260nm and 280nm in a 
spectrophotometer. A good DNA preparation should have a 260/280 ratio higher than 
1.8 while a good RNA preparation should have a 260/280 ratio higher than 1.9. 
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2.2.8 Polymerase chain reaction (PCR) 
The PCR is used for enzymatic synthesis of specific DNA sequences (Innis, 
1990). The single or double stranded DNA is first denatured, then annealed with 
specific primers [Tm = 2 0Cx(A+T) + 40Cx(G+C)] corresponding to each end of the 
target sequence, and to extend the sequence. This cycle is repeated 20-40 times and has 
the potential of amplifying the target sequence as much as 10 7-109 times. Due to the 
high temperature required for the denaturation step, the thermostable DNA polymerase, 
so-called Taq DNA polymerase was normally used in the thermal reactions. However, 
the pfu and Deep Vent DNA polymerase could be used instead of Taq to improve the 
PCR accuracy. 
PCR was performed in 0.5 ml Eppendorf tubes. Each reaction (25 tl) contained 
14.75 p1 of dH20, 0.5 p1 of DNA, 2.5 pA of lOxTaq polymerase buffer (500 mlvi 
KC1, 100 mM Tris-HC1 pH 8.3, 0.02% gelatin), 1.5 p1 of 25 mM M902, 2.5 p1 of 
lOx dNTP solution (780 jil of dH20, 4 p1 of each 100 mM dNTP, 8 j.il of 1 M Tris pH 
8.0), 1.5 p1 of each primer at 30 jig/ml or 5 pmol/pJ, 0.25 j.il of AmpliTaq DNA Taq 
polymerase (5U/p1). The reaction mixture was overlaid with mineral oil and PCR was 
performed using HYBAID Omnigene thermal reactor. The reaction temperature may 
vary, depending on the primers and templates and must be determined empirically. 
The products of the PCR reactions were mixed with DNA loading Buffer (lOx 
stock solution: 20 mM EDTA, 60% glycerol, 0.05% bromophenol blue) and analysed 
by electrophoresis in TAE (50x stock solution: 242g Tris base, 37.2 g 
Na2EDTA2H20 or 100 ml of 0.5 M EDTA, 57.1 ml glacial acetic acid, dH20 to 1 
litre) on agarose gels with ethidium bromide staining (stock solution 5mg/mI). 
2.2.9 Reverse transcriptase-PCR (RT-PCR) 
Total RNA was isolated using RNAzoP' B Isolation of RNA kits (AMS,TX). 
Single-stranded cDNA was reverse transcribed from total RNA according to the 
GeneAmp RNA-PCR kit protocol (Perkin Elmer, CA). Each reaction (20 p1) contained 
1 p1(1 jig) of total RNA, 1 p1 of oligo d(T) 16 (2.5 gm) and 18 p1 of master mix (4 p1 of 
25 mM MgCl2, 2 p1 of lOx PCR buffer II, 2 p1 of DEPC treated DI water, 2 p1 of each 
dNTP, 1 p1 of RNase inhibitor, 1 p1 of MuLV reverse transcriptase). All tubes were 
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incubated at room temperature for 10 min to allow for the extension of the oligo d(T) 16 
by reverse transcriptase. The extended primers will then remain annealed to the RNA 
template upon raising the reaction temperature to 42°C. The reaction mixture was 
overlaid with mineral oil and performed: 42°C 15 mm (up to 60 min for synthesis of 
longer RNA transcripts), 99°C 5 mm (to inactivate the reverse transcriptase), 55°C 5 
mm. The tubes were placed on ice for immediate PCR amplification or stored at -70°C 
for later use. The PCR conditions were set up as described above using gene-specific 
primers. The amplified PCR products were analysed by agarose gel electrophoresis and 
ethidium bromide staining. 
2.2.10 5' Rapid amplification of eDNA ends (5' RACE) 
5' RACE is used to amplify DNA sequences from an mRNA template between 
a defined internal site and unknown sequence of 5' end of the mRNA (Frohman, 
1994). 
Reverse transcription. Total RNA was isolated using RNAzol B kits 
(AMS,TX). Reverse transcription was carried out using a gene specific primer 1 (SP I) 
and total RNA according to the 5'/3' RACE kit protocol (Boehringer): 4 p1 of cDNA 
synthesis buffer, 2 p1 of dNTP, 1 p1 of SP1 (12.5 jiM), 2 p1 (2 jig) of total RNA, 1 
p1 of AIvIV reverse transcriptase, water up to 20 p1. The mixture was incubated for 60 
min at 55°C and then 10 mm at 65°C. The cDNA was purified using the High Pure 
PCR Product Purification Kit (Boehringer): 100 p1 of binding buffer was added to 20 
p1 of reverse transcription reaction, pipetted to upper reservoir of filter tube and spun 
for 30 sec at 13,000 g; 500 p1 of wash buffer was added and spun for 30 sec at 13,000 
g; 200 p1 of wash buffer was added and spun again. cDNA was eluted in 50 jil of 10 
mM Tris-HC1 by spinning for 30 sec at 13,000 g. 
Tailing reaction of cDNA. To attach a known sequence to the 3' end of the first-
strand cDNA, a homopolymeric tail was appended using terminal transferase and 
dATP. The reaction mixture (19 p1 of purified cDNA, 2.5 p1 of reaction buffer, 2.5 
p1 of 2 mM dATP) was incubated for 3 min at 94 0C, chilled on ice, spun down. 1 p1 
of terminal transferase was added into the mixture and incubated for 30 min at 37 0C 
and then 700C  for 10 mm, placed on ice. 
PCR amplification of dA-tailed cDNA. PCR was carried out using 5 jil of dA-
tailed cDNA, 1 i1 of oligo dT-anchor primer, 1 j.tl of a gene specific primer 2 (SP2), 1 
pJ of dNTP, 0.5 pi of Taq polymerase, 5 tl of reaction buffer and 36.5 tl of water. 
The reaction temperatures used, which depend on the primers and templates and must 
be determined empirically. The resulting products were purified (Microcon, MA), 
subcloned into pGEM T-vector (Promega, MA) and then sequenced. 
2.2.11 Purification of PCR products/DNA fragments 
Gel extraction. DNA fragments of 70bp- 10kb were purified from agarose gels 
by QlAquick Gel Extraction Kits (QIAGEN Inc.). PCR reaction or enzyme-digested 
DNA products were separated on agarose gel and then the DNA fragments were excised 
from the gel. 3 volumes of Buffer QG was added to 1 volume of gel and incubated at 
50°C for 10 mm. 1 gel volume of isopropanol was added to the sample, pipetted to 
QlAquick spin column and then centrifuged at 13,000 rpm for 1 mm. 0.5 ml of buffer 
QG was added to column and centrifuged again. 0.75 ml of buffer PE was added to 
column and centrifuged twice at 13,000 rpm for 1 mm. 30 jil of water was added to 
column and stand for 1 min and then centrifuged at 13,000 rpm for 1 mm. 
Microconcentrators. PCR products were also purified directly using Microcon 
kit s (Amincon, Inc). Completed PCR reaction contents were pipetted into sample 
reservoir and spun at 2,500 rpm for 3-5 mm (4°C). The sample reservoir was washed 
twice using water (100 tl). 30 tl of water was added into reservoir, placed upside 
down, spun at 3,500 rpm for 3mm. 
2.2.12 T-vector construction 
The pMOSBlue-T vector system from Amersham (UK) and pGEM-T vector 
system from Promega (USA), were routinely used to provide a one-step cloning 
strategy for direct insertion of PCR products into a plasmid vector. For some 
experiments, T vectors were made in the laboratory according to the method (Marchuk 
et al., 1991). Briefly, plasmids were digested with blunt-cutting restriction 
endonucleases (EcoR V. Sma I, Pvu II, Pme I, etc.). Cut plasmids were incubated with 
Taq polymerase (1 unit/Jig plasmidl20 j.il volume) using standard PCR buffer in the 
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presence of 2 mM dTTP for 2 hours at 70°C, re-purified again, and then used for 
cloning. 
2.2.13 Subcloning of PCR products into T vectors 
Ligations into pMOS- or pGEM-T vectors were carried out following the 
manufacturer's instructions. Briefly, for each ligation reaction, 2 p1 of gel-purified 
PCR product were mixed with 1 tl of T-vector, 1 p1 of lOx ligation buffer (0.5 M Tris 
pH 7.4, 0.1 M MgC12, 0.1 M dithiothreitol, 10 mM spermidine, 10 MM ATP, 1 mg/ml 
BSA), 1 p1 of T4 DNA ligase (3 Weiss Units/pI, Promega) and 5 tl of d1120. 
Ligation mixes were incubated at 16°C overnight, and 2 p1 of mixes taken for 
transformation of E.coli. 
2.2.14 Subcloning of DNA fragments into plasmids 
10 p1 of plasmid (3 jig) and 10 j.il of insert DNA (3 jig) were cut with suitable 
restriction enzyme in total volume of 30-50 p1 at 37°C for 4 h or overnight. When 
plasmid was cut with single restriction enzyme, 0.2 units of alkaline phosphatase was 
added into the digestion mix and then incubated at 37°C for 30 mm to prevent the self- 
ligation of compatible ends of digested plasmid. Purified cut plasmid and insert DNA 
were then ligated. Briefly, for each ligation reaction, 2 p1 insert DNA, 1 p1 of vector, 1 
RI of lOx ligation buffer, 1 p1 of T4 DNA ligase (3 Weiss Units/p1 for cohesive ends 
and 20 Weiss Units/p1 for blunt ends ) and 5 p1 of dH20. The ligation mix was 
incubated at 16°C overnight or room temperature for 3 h, and 2 p1 of mix taken for 
transformation of E.coli. 
2.2.15 Transformation of E.coli 
Heat-shock method. Competent cells (50-100 p1) were mixed with either 2 p1 of 
a ligation reaction or 20 ng of uncut plasmid DNA. The cells were then incubated on ice 
for 30 mm, heat-shocked at 42°C for 40 seconds and incubated on ice for 2 minutes. 
To each transformation mixture, 100-200 p1 of room-temperature SOC medium (Cat 
No 15544-042, GIBCOBRL) was added and the mixture was incubated at 37°C, with 
gentle shaking, for 1 h. 50-300 p1 of transformation were plated out on appropriate 
selective LB agarose plates and incubated overnight at 37°C. 
Electroporation method. A single colony of E.coli was inoculated onto 10 ml of 
2X YT media and grown at 37°C overnight with vigorous shaking. The cells were 
chilled on ice for 15- 30 min and pelleted in a cold rotor at 4000g for 15 min at 4°C. 
Then the cells were washed 3 times by resuspending the pellet in 10 ml of cold water 
followed by centrifugation. Finally the cells were resuspended in 150 t1 of water. 1 p1 
of ligated DNA was mixed with 40 p1 of cells in an eppendorf and then transferred to 
the bottom of a electroporation cuvette. The transformation mixture was electroporated 
at 25 pF, 2.5 KV and 200 Q. 1 ml of SOC was immediately added into the cuvette and 
mixed with the cell. The mixture was transferred to a small bottle and grown at 37°C 
for 1 h before plated out on a suitable selected plate. 
2.2.16 Rapid screen of recombinant colony 
Direct PCR. A colony from plate was picked using a 200 jil pipet tip which 
was touched to a plate to keep a copy of the colony. The tip was touched to 50 p1 of 
sterile water in a 1.5 ml tube, stirred gently to mix. The tubes were placed in boiling 
water or a heat block at 90-100°C for 5-10 min to lyse the cells and denature DNases, 
centrifuged at 12,000 g for 1-2 mm. 5 t1 of the supernatant was transferred to a 0.5 
ml tube for PCR. A master reaction mixture was made by combining the following: pre 
reaction containing 13.75 jiF of sterile water, 2.5 il of lOx buffer containing 15 mlvi 
MgCl2, 2.5 p1 lOx dNTP mix, 0.5 p1 each primer 1 and 2 (5 pmollpl or 30 pg/ml), 
0.25 tl AmpliTaq DNA polymerase (5U/p1). 20 p1 of the master mix was added to 
each sample, mixed gently, and added 2 drops of mineral oil. The reactions were placed 
in a thermal cycler with the following program: 35 cycles of: 94°C 1mm, 55°C 1mm 
and 72°C 2 mm; followed by 1 cycle of 72°C 5mm. The PCR reaction products 
were visualised on a 1% agarose containing ethidium bromide. 
Rapid size screen. The equivalent of a 1 mm diameter colony was transferred 
into 70-100 il of pre-warmed lysis buffer (5 mM EDTA, 10% w/v sucrose, 0.25% 
w/v SDS, 100 mlvi NaOH, 60 mM KC1, 0.05% w/v bromophenyl blue) and incubated 
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at 37°C for 5 mm. The mixture was placed on ice for 5 mm, spun for 1 min at 13,000, 
and loaded 20 jtl onto an agarose gel, electrophoresis and ethidium bromide staining. 
The recombinant plasmids containing >1.0-1.5 kb inserts were rapidly screened. 
Blue/white screen. The ligation reaction was transformed into XL- 1 blue cells 
and incubated at 37°C for lh. To each plate was spread 35 tl of X-gal (50mg/mi stock 
solution in dimethyl-formamide) and 20 p1 of 100 mM IPTG, and left to soak for at 
least 30 min prior to plating. XL-1 blue cells were spread on plates and incubated at 
37°C overnight. The white colonies contained recombinant colonies. 
2.2.17 DNA automatic sequencing 
Automated sequencing of plasmid DNA was carried out using dye terminators 
with the PRTSMTM  cycle sequencing kit (Applied Biosystems Inc.) and the 377 
automated sequencer (ABI). Protocols were carried out as described by the 
manufacturer (ABI PRISM dye Terminator protocol, P/N 402078). For each reaction, 
the reagents were aliquoted into a 0.5 ml PCR tube as follows: 4 p1 Terminator Ready 
Reaction Mix, 2 i1 dsDNA Template (0.2 tg/m1), 0.5 p1 sequencing primer (20-30 jig 
/ml), 3.5 j.tl H20 with total volume 10 jil. Cycle sequencing was performed on a 
HYBAID DNA thermal cycler (OmniGene) with the following condition: 25 cycles 
(96°C for 30 sec, 50°C for 20 sec, 60°C for 4 mm, respectively). After completion, 
reaction products were mixed with ijil of 3 M sodium acetate (pH4.6 or 5.2) and 25 p1 
of cold 95% ethanol, and placed on ice for 10 mm. After centrifugation at 13,000 rpm 
for 20 mm, the precipitated pellets were washed again using 125 j.tl of cold 70% ethanol 
and finally resuspended in 3 p1 loading buffer (5 parts of deionized formamide and 1 
part of 50 mg/nil Blue dextran in 25 mM EDTA, pH8.0). Samples were heated at 90°C 
for 3 min and 1.8 p1 of each sample was loaded. 6% Denaturing gels were run at 50 W 
for 7 h. Chromatograms were viewed and data was edited using the SeqedTM program 
(ABI) and using MacVector program version 6.0. (Oxford Molecular Group, UK). 
2.2.18 Southern blotting 
Blotting. DNA was digested with restriction enzymes at 37°C for 24 h and then 
separated on 0.8% agarose gel. Following electrophoresis, agarose gels were soaked 
in 0.25M HCl for 10-20 min to partially depurinate the DNA. The gel was then rinsed 
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in H20 for 5 min before being soaked in 5x gel volume denaturing solution (0.5 M 
NaOH, 1.5 M NaCl) two times for 30 minutes each. The gel was rinsed in H20 for 2 
min before being immersed in 5x gel volume neutralisation solution (0.5 M Tris-HC1, 
pH 6.8, 1.5 M NaCl) for 90 min and then placed onto blotting paper pads. The DNA 
was transferred to Hybond N membrane (Amersham) with 20x SSC (174 g/l NaCl, 
88.2 g/l sodium citrate; pH 7.0). After overnight transfer the membrane was removed, 
rinsed in 2x SSC for 5 mm, air dry and then baked at 800C  for 2 h. 
Radioactive random primed labelling of probe. Several methods are available 
for making probes. End-labelling with polynucleotide kinase is employed with short 
oligonucleotides, whereas longer DNA fragments are generally labelled by random 
priming labelling methods. Random primer labelling method was used in this work. 
The approach utilises the Kienow enzyme which has 5'-3'polymerase activity but lacks 
the 5'-3' exonuclease activity, thus ensuring that incorporated nucleotides are not 
subsequently removed as monophosphates. A mixture of random DNA hexanucleotides 
is used to prime the DNA and synthesise the radiolabelled complementary strand DNA 
from the 3'-OH termini of the primers. In this work, the Random Primed DNA 
Labelling Kit (Boehringer Mannheim), was used to synthesise radioactive probes for 
hybridisation reactions. The DNA template (25-50 ng in TE buffer) was first denatured 
by boiling for 10 minutes and chilled on ice to prevent reannealing. A mixture of 2 jil 
hexanucleotide mixture in lOx reaction buffer [900 mM HEPES, adjusted to pH 6.6 
with 4 N NaOH, 100 MM  MgC121, 1 tl [0.5 mlvi] each of dCTP, dGTP, dTTP, 5 il 
[50 pCi, 1 .85MBq] of [(X-32P]  dATP (Amersham International Plc.), and 1 iJ (2 units) 
of Kienow enzyme were then added to the denatured DNA template and incubated at 
37°C for 30-60 minutes. The reaction was stopped by addition of 0.5mM EDTA. In 
general, the denatured labelled DNA can be used directly as a hybridisation probe 
without stopping the reaction or removing unincorporated label. Removal of 
unincorporated nucleotides was performed by QlAquick PCR purification kit or passing 
the labelling reaction through a Sephadex G-50 column. A 1.5 ml Eppendorf tube was 
punctured by a No.27 needle, plugged by glasswool and then packed with 1 ml 
Sephadex G-50 preparedlTE buffer (10mM Tris-HC1 pH 8.0, 1 mlvi EDTA pH 8.0). 
The column was placed on the top of a new Eppendorf tube and spun at 700x g for 5 
minutes to remove excess TE buffer. After the radiolabelling reaction was completed, 5 
jtl of gel loading buffer was added to the DNA sample. The DNA sample was applied to 
the top of the column. The column was then placed on the top of another new 
Eppendorf tube and spun at 700x g for 5 minutes again to recover radiolabelled 
fractions. 
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Hybridisation. All hybridisations were performed in a Hybridisation oven 
(HybaidTM). Blots were prehybridised at 65°C for 4 h in 3x SSC, 1% SDS and 0.2% 
Blotto and replaced with fresh buffer before adding probes. Just before hybridization 
was carried out, the probes were mixed with 0.1 ml of 5 mg/ml sonicated herring 
sperm DNA and 0.9 ml of H20, and boiled for 10 minutes to denature the DNAs. For 
hybridisation, the prehybridisation buffer was reduced to 50 .il of hybridisation buffer 
per cm2 of membrane. The boiled, denatured probe was then added and hybridisation 
continued overnight at 56-65°C. Non-specifically bound nucleotides were removed by 
washing the membrane with excess 2x SSC and 1% SDS at 65°C for 30 min and 
washed twice at room temperature for 30 min each. Filters were then placed between 
two layers of cling film and autoradiographed. 
Autoradiography. This was performed using X-ray film (Kodak XAR-5 or 
AGFA Curix) for 32P probed filters, in a cassette containing intensifying screens. The 
cassette containing 32P probed filters were stored at -70°C. Film was developed using a 
X-O'GRAPH X  automatic X-ray film processor. 
2.2.19 Recombinant protein expression in E.coli 
pET29-TA vector, pET-29 and pET-15b were used to express polypeptides 
fused with His6-tag in E. coli BL21 (DE3) host. 
2 jil of a ligation reaction containing recombinant plasmids were transformed 
into XL-1 blue cells and then grown on LB-kanlamp agar plates overnight at 37°C. 
Positive clones were identified by direct PCR. Plasmid DNA was prepared with the 
QlAprep Spin Miniprep Kit (QIAGEN Inc.) and sequenced to provide confirmation of 
identify. Positive plasmid DNA with correct sequence was transformed into BL21 
(DE3) cells, and grown on LB-kan/amp agar plates overnight at 37°C. 
Single colonies were picked and put into 10 ml of LB-kanlamp and grown at 
37°C with shaking to an 0D600 of 0.6-0.8 (about 3-6 h). 5 ml of culture was removed 
as a control before induction, and to the remaining culture 1 M IPTG was added to a 
final concentration of 1mM in order to induce fusion protein expression. Cells were 
then grown for a further 3-6 h. Cells were collected by centrifugation at 5,500 rpm 
(Sorvall) for 10 minutes at 4°C. They were then resuspended in 1 ml of ice-cold lx 
PBS. The cells were lysed by sonication on ice and the lysate microcentrifuged. A 
sample of both the supernatant and pellet was analysed by SDS-PAGE and Coomassie 
staining to indicate the expression and solubility of the His-tag fusion protein. 
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2.2.20 Recombinant protein expression in COS-7 cells 
In this thesis, genes for Bm-SNP-2, and murine IL-4, B7.1, B7.2 and CD40L, 
were subcloned into pcDNA3.1(-) (Invitrogen), which is designed for high-level stable 
and transient expression in mammalian host. Recombinant pcDNA3. 1 (+) plasmids 
transformed COS-7 which is an African green monkey kidney fibroblast-like cell line, 
established from CV- 1 cells transformed by an origin-defective mutant of SV40 which 
codes for wild-type T antigen. The recombinant pcDNA3. I(+) plasmid expressing - 
galactosidase was from Invitrogen. 
COS-7 cells were resuspended in RPMI-1640 complete medium at 1 x 105iml, 
disposed at 2 ml per well and incubated at 37 0C for 24 h at which time cells were 50-
80% confluent. For each transfection, solution A [dilute 1-2 ig of DNA into 100 il 
OPTIMEM I (GIBCOBRL)] and solution B [dilute 2-25 lii of LIPOFECTAMThJE TM 
reagent (GIBCOBRL) into 100 jil OPTIMEM I] were mixed gently and incubated at 
room temperature for 15-45 min to allow DNA-liposome complex to form. While 
complex form, cells were rinsed once with 2 ml of OPTIMEM I and then aspirated. 
For each transfection, 0.8 ml of OPTItVIEM I was added to the tube containing 0.2 ml 
of complex, mixed gently and overlaid the solution onto the cells. The cells were 
incubated for 2-24 h, added 1 ml of RPMI1640 medium containing 20% FCS without 
antibiotic, and then incubated for 18-24 h. After aspirating medium, 2 ml of complete 
RPMI1640 medium was added into per well, and then incubated for 24 h. The 
supernatant, cells, or cell extracts were tested for gene activity. 
The supernatant was tested for expression of IL-4 by the NK cell assay while 
transfected cell expression of B7.1, B7.2 and CD40L was tested by FACS. Cell 
extracts were also evaluated for expression of Bm-SPN-2 by Western blotting, and the 
expression of LacZ by a 3-gal assay kit (45-0449, Invitrogen). 
2.3 Biochemical techniques 
2.3.1 Protein determination 
10 jil of sample buffer or protein standard was mixed with 200 j.il of Coomassie 
Plus Protein Assay Reagent (PIERCE) in ELISA plates, incubated at room temperature 
for 5 mm, and then read at 570 or 620 nm by ELISA Reader. Bovine serum albumin 
(50-2000 ig/ml) was used as protein standard. 
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2.3.2 Clotting assays 
Clotting assays were performed with activated partial thromboplastin time 
(APTT) and prothrombin time (PTT) kits to test whether Mf lysates and recombinant 
Bm-SPN-2 protein inhibits the activity of serine proteinases in the human blood 
coagulation pathway. 
For APTT, 0.1 ml of pooled human normal plasma and 0.1 ml of various 
concentrations of proteins or TBS buffer alone were incubated at 37°C for 5 mm 
before adding 0.1 ml of prewarmed ANT reagent. After 3 mm, 0.1 ml of prewarmed 
20 mM calcium chloride solution was added and the clotting time was recorded. 
For PTT, 0.1 ml of pooled normal human plasma and 0.1 ml of TB  buffer or 
Mf extract were incubated for 5 minutes at 37°C. Thereafter, 0.1 ml of prewanned 
Thromboplastin-M reagent was added and the clotting time was measured. 
2.3.3 -GaIactosidase activity assay 
LacZ is a bacterial gene often used as a reporter construct in eukaryotic 
transfection experiments because the gene product, 3-ga1actosidase, is resistant to 
proteolysis in cellular lysates, and its activity is easily assayed using the n-gal assay kit 
(Invitrogen), 3-galactosidase catalyzes the hydrolysis of -galactosides such as ortho-
nitrophenyl--D-galactopyranoside (ONPG). Hydrolysis of ONPG to the ONP anion 
produces a bright yellow colour with a peak absorbance at 420 nm. 
COS-7 cells expressing the LacZ gene were centrifuged at 250 g for 5 mm, 
resuspended in lysis buffer, froze on dry ice and thawed in 37°C water bath, which 
was repeated twice. The mix was spun at 13,000 rpm (4°C) for 5 min and the 
supernatant was transferred to a new tube. 10 tl of the supernatant was mixed with 20 
RI of water, 70 tl of ONPG, 200 p1 of the cleavage buffer, and then incubated at 37°C 
for 30 min and 500 pA of stop buffer was added to the mix. The absorbance at 420 nm 
against blank containing ONPG and cleavage byffer without lysate were read. 
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2.3.4 Affinity purification of recombinant proteins 
Preparing the cell extract. 1 litre of bacteria expression culture was harvested by 
centrifugation at 10,000 - 20,000 x g for 20 mm, resuspended in 20 ml ice-cold 
Binding buffer (8X Binding buffer: 40 mM imidazole, 4 M NaCl, 160 mM Tris-HC1, 
pH 7.9) and sonicated with the sample on ice. The lysate was centrifuged at 10,000 - 
15,000 x g for 15 min and the supernatant was filtered through a 0.45 pm Millex-HY 
Filter Unit (Cat No SLHVR25LS, MILLIPORE) to prevent clogging of the resin 
Preparing the resin. A few ml of deionized water was added to the dry column 
(PIERCE) and the column flowing was started. The bottle containing His-Bind resin 
(Novagen) was gently mixed by inversion and 5 ml of resin was then added into 
column which can be used to purify up to 20 mg of target protein. When the level of 
storage buffer (20% ethanol) drops to the top of the column bed, the column was 
washed with the following sequence: 7.5 ml of deionized water, 12.5 ml of 1X Charge 
buffer (8x Charge buffer: 400 mM NiSO4), 7.5 ml of 1X Binding buffer. 
Performing column chromatography. When the Binding buffer drains to the top 
of the column bed, the column was loaded with the prepared extract, washed with the 
following sequence: 25 ml of 1X Binding buffer, 15 ml of 1X Wash buffer (8X Wash 
buffer: 480 mM imidazole, 4 M NaCl, 160 mM Tris-HC1, adjust final pH to 7.9), 25 
ml of lx TBS (150 mM NaCl, 20 mM Tris-HC1, pH 7.9). Recombinant proteins were 
eluted with 15 ml of TBSE (TBS containing 50 mM EDTA), injected into Dialysis 
cassettes (PIERCE) and then dialysed in TBS for 24 h at 4 0C. 
2.3.5 SDS-PAGE electro-elution 
Parasites were mixed with SDS-PAGE loading buffer containing fresh 2-ME, 
heated at 100°C for 10 mm, and centrifuged at 13,000 rpm for 30 mm. The supernatant 
was loaded onto 15% SDS-PAGE gels. Gels were run in electrophoresis buffer at 35 
mA. After electrophoresis, a slice was taken from either side of the gel and stained with 
Coomassie blue. The rest of the gel was cut into 13 horizontal fractions. Gel slices were 
placed into molecularporous membrane tubing (SPECTRUM) and the proteins were 
eluted from each fraction on an Western blotting transferred apparatus (Hoefer) for 2 h. 
After elution, all tubes were dialyzed against PBS at 4°C for 48 h, precipitated SDS 
and SDS-protein complexes were removed by centrifugation at 13,000 rpm for 30 mm 
at 24 h and then at 48 h, and then passed through a 0.2 im filter (Dimock et al., 
1994). 
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All fractions were visualized by SDS-PAGE and silver stain to determine the 
molecular range of proteins within each fraction The protein concentration in each 
fraction was determined by using the Bradford assay with bovine serum albumin as 
standard. 
2.3.6 Fast protein liquid chromatography (FPLC) 
PBS or Tris buffer-solubilized proteins were dialyzed against the buffer A (20 
mM Tris, pH 8.0) overnight at 40C, passed through a 0.2 gm filter and the protein 
concentrations were then determined by the Bradford assay. 
A FPLC apparatus (Pharmacia Biotech) and an anion exchange column (Mono 
Q HR5/5, Pharmacia Biotech) were used. The buffer A was run first to allow the 
system to reach equilibrium and then a few ml of samples, about 2-10 mg of proteins, 
were loaded onto the mono Q column. The proteins were eluted from the column by 
applying a linear gradient of 0 to 1000 mM NaCl, each fraction containing 0.5 ml. All 
fractions were visualized by SDS-PAGE and silver stain. The protein concentration in 
each fraction was determined by using the Bradford assay with bovine serum albumin 
as standard. 
2.4 Computing analysis and World Wide Web 
Sequence analysis was performed using MacVector program version 6.0. 
(Oxford Molecular Group, UK) or through World Wide Web (WWW) browsers. 
Sequence searching was performed with the BLAST algorithm (Gish and States, 1993) 
using the National Center for Biotechnology Information (NCBI) BLAST server ( 
http://www.ncbi.nlm. nih.gov/cgi-binJBLAST/nph-blast),  parasite genome blast server 
(http://www.ebi.ac. uk/parasites/parasite_blast_server.html)  and other servers in NCBI 
(http://www.ncbi. nlm.nih.gov/).  
The GCG program PILEUP (Genetics Computer Group, University of 
Wisconsin), MacVector program version 6.0, and BOXSHADE (http://www.isrec.isb-
sib.chl software/BOX_form.html ) were used to carry out multiple alignments. The tree 
reflecting evolutionary relationships was constructed by PAUP 3. 1.1 (Swofford, 199 1) 
using maximum parsimony, excluding constant, and uninformative sites. Some 
molecular research tools on www were used in this studies (http://www.fmi.chl  
biology/research_tools.html; http://www-biol.univ-mrs.fr/englishllogligne . html). The 
restriction mapping nucleotide sequences were searched by Webcutter (http://www. 
medkem.gu.se/cutter/)  and MacVector program version 6.0. 
Motif searching was done by some servers on www (http://www.isrec.isb-
sib.chl softwarefPFSCAN_form.html; http://www.motif.genome.ad.jp/;  http://dna. 
Stanford.EDU/emotif/;  http://www.expasy.chlsprot/scnpsite.html;  http://www.expasy. 
chlsprot /scnpsitl .html). 
Various databases, The GenBank (http://www.ncbi.nlm.nih.gov/Web/Search/  
index.html), The Genome Database (http://gdbwww.gdb.org/ ), Protein Data Bank 
(http://www.pdb.bnl.gov/ ), Protein family resources (http://www.blocks.fhcrc.org  
/-steveh/protein.html), ExPASy ( http://expasy.hcuge.chl ), Subject-specific databases 
(http://bioinformatics.weizmann.ac.illmb/db/subject_specific_databases.html#inmriunol  
ogy), were searched in studies. 
2.5 Other experiments 
2.5.1 Inhibitory activity against mammalian serine proteinases. 
These assays were done by Dr. Haobo Jiang in Dr. Michael R. Kanost's laboratory, 
Department of Biochemistry, Kansas State university, USA, to investigate the 
inhibitory activities of Bm-SPN-2 on a panel of mammalian serine proteinases. 
2.5.2 D-dopachrome 	tautomerase activity. The dopachrome 
tautomerase activity of Bm-MTF-2 was measured by Dr. David Meyer's lab, 
Department of Infectious and Tropical Diseases, London School of Hygiene and 
tropical Medicine, UK. 
2.5.3 Processing and presentation of CD4 T cell eptiopes. Assays 
of macrophage antigen processing and presentation were performed, by Dr. Alexei A. 
Delvig in Dr. John H. Robinson's laboratory, Department of Immunology, Newcastle 
University, UK, to investigate whether Bm-SPN-2 inhibits the activity of serine 
proteinases involved in the MHC class II pathway within macrophages. 
2.5.4 High-performance liquid chromatography (HPLC). HPLC 
analysis of MIF-2 protein was done by Dr. Lu Jiang in the Center for Protein 
Technology, University of Edinburgh, UK. 
2.5.5 Protein sequencing. The N-terminal sequence of purified 
recombinant Bm-MIF-2 was done by Dr. Andrew Cronshaw's lab in the Structural 
Biochemistry Group, Department of Biochemistry, University of Edinburgh, UK. 
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Chapter 3 
In vivo induction of Thi and Th2 immune responses against 
B.malayi antigens by different adjuvants 
3.1 Introduction 
CD4 T helper cells (Th) play a central role in most immune reactions and are 
required for induction of cytotoxic T cell and most B cell responses (Abbas et al., 1996; 
Allen and Maizels, 1997; Carter and Dutton, 1996; Mosmann and Sad, 1996; Murray, 
1998). Based on the cytokines they secrete, Th cells have been classified as belonging 
to three distinctive subsets: ThO, Thi and Th2. ThO cells are considered to be the 
precursors, and they mainly secrete IL-2. Following antigenic stimulation, ThO cells 
differentiate down two pathways such that cells with one of two possible cytokine 
profiles emerge. The Thi subset, which secretes IL-2, TNF-13 and the signature type 1 
cytokine IFN-y, preferentially promotes cell-mediated immunity and IgG2a production 
by B cells; while the Th2 subset, which secretes IL-5, IL-b, IL-13 and the signature 
type 2 cytokine IL-4, induces humoral immunity and IgGl and IgE isotypes 
production. Moreover, CD4 T cells producing high amounts of TGF-13 have been 
termed TO (Chen et al., 1994) although this has not been accepted widely. The 
characteristic cytokine products of Thi and Th2 cells are mutually inhibitory for the 
differentiation and effector functions of the reciprocal phenotype (Morel and Oriss, 
1998). Thus, IFN-y selectively inhibits proliferation of Th2 cells, and IL-10 inhibits 
cytokine synthesis by Thi cells. 
An important aspect of the Thl/Th2 dichotomy is the insight this concept 
provides into immunological determinants of diseases (Abbas et al., 1996; Allen and 
Maizels, 1997; Mosmann and Sad, 1996). The outcomes of a wide range of 
pathological processes, including infectious, allergic and autoimmune disorders, as well 
as tumours, have been linked to Thi or Th2 cytokine expression patterns, and, by 
inference, to the particular T cell subset induced. It has been accepted that the balance 
between Thi and Th2 responses to an infectious agent can influence both pathogen 
growth and immunopathology. Human filarial infection is associated with an immune 
response that is skewed toward a Th2 response, with infected individuals producing 
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high levels of TL-4, IgE and IgG4, and showing marked eosinophilis (Maizels et al., 
1995; Ottesen, 1992). Although characteristic of helminth infection, the benefits 
conferred on host or parasite by the emergence of an immune response dominated by 
Th2 antibody and cytokine production are still poorly understood. For example, it has 
been suggested that Th2 responses are protective against B.malayi (Mosmann and Sad, 
1996) because survival of the non-infective larval stage (MO is negatively associated 
with the presence of eosinophils and IgE (Pearlman et al., 1993). By contrast, 
knockout of the gene encoding IL-4 had no effect on the survival of any life cycle stage 
(Lawrence et al., 1995). Moreover, human filariasis studies have shown that the most 
heavy and chronic infections are in patients with the strongest Th2 responses (Maizels 
et al., 1993). Thi, but not Th2 responses, are associated with low infection levels, and 
elevated Thi responses in antigen- and microfilaria-negative individuals are thought to 
contribute to protection in putatively immune individuals (Dimock et al., 1996; Elson et 
al., 1995). It is often generally, and perhaps mistakenly, stated that Th2 responses are 
'protective responses' in helminth infections. Although this is apparently the case with 
gastrointestinal nematodes (Else et al., 1994; Maizels and Holland, 1998), the degree of 
protection conferred by a Th2 response on individuals infected with helminths 
inhabiting extra-intestinal locations is certainly not as clearly defined (Allen and 
Maizels, 1997). 
The question of whether Th 1 or Th2 cells are protective against infection 
filariasis is still far from resolved (Allen and Maizels, 1997). In a mouse model, 
Lawrence et al previously demonstrated that contrasting cytokine profiles are induced 
in mice by different life cycle stages of B. malayi, with intra-peritoneal implantation of 
adult or L3 parasites inducing high levels of IL-4 with a matching 'Th2' antibody 
isotype profile, while microfilariae induce IFN-y and a 'Thi' antibody profile 
(Lawrence et al., 1995; Lawrence et al., 1994). However, it is unclear if different 
B.malayi antigens induce different Th responses. Therefore we think, for identification 
of T cell antigen from B. malayi, the T cells which are use to primary screen B. malayi 
antigens should contain both Thi and Th2 cells. In the present study, it is shown that, 
by choosing the appropriate adjuvant, different types of immune responses can be 
induced, and mixed Thl/Th2 responses against MI also are induced. Thus, the T cells 
from desired immune response profile (mixed Thl/Th2) against Mf proteins could be 
used for screening Mf T cell antigens in next step (see chapter 4). Clearly, the 
possibility to induce different types of immune responses in vivo against antigens, as 
shown in this chapter, could be a useful model system for studying the mechanisms 
involved in immune polarization in vivo using mice of the same genetic background. 






3.2.1 CD4 T lymphocytes are predominant population in the popliteal 
lymph nodes 
To investigate the characteristics of popliteal lymph node cells, recruited by 
B.malayi MI antigens in adjuvants, female (8-week-old) BALB/c mice were injected 
with 20 jig of Mf proteins mixed 1:1 with Incomplete Freund's Adjuvant (WA) or 
Complete Freund's Adjuvant (CFA) containing Mycobacterium tuberculosis H37Ra ( 
Sigma Chemical Co.). 50 jil were injected into each footpad, a total volume of 100 jil 
per mouse. Mice were killed 12 days post-immunisation and popliteal lymph node cells 
removed for fluorescence activated cell sorter (FACS) analysis using antibodies against 
mouse CD4 and CD8 molecules. 
The results show in Fig 3-1 that two adjuvants induced comparable T cell 
levels. About 60% of total popliteal cells are T cells, of which about 75% are CD4 T 
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Figure 3-1. Percentage of T cells isolated from popliteal lymph nodes of BALB/c 
mice immunized with Mf proteins in either CFA or IFA. The percentages of T cells 
were determined by FACS analysis and data is shown as mean ± SD of four individual 
mice separately analysed. 
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3.2.2 Different adjuvants induce Thi- or Th2-dominated responses 
against B.malayi antigens during prime immune response 
Popliteal lymph node cells from mice primed with 20 pg of Mf antigen with 
CFA or WA were also used in T cell proliferation assay and cytokine production 
assays. As shown in Fig 3-2, vigorous antigen-specific T cell proliferative responses 
were observed with both adjuvants. 
The effect of each adjuvant on Thi cell priming was assessed by measuring I1L-
2 and IFN-y production by stimulated primed T cells. As shown in Fig 3-2, both WA 
and CFA were able to prime cells capable of inducing comparable amounts of IL-2 in 
response to Mf antigen stimulation in vitro. However, when restimulated with specific 
antigen, cells derived from CFA-primed mice produced considerable amounts of IFN-y 
while cells derived from WA-primed mice produced much less (p<O.Ol). These data 
indicate that in terms of cytokine profiles, immunization with CFA favoured the Thi 
pathway in response to Mf proteins. 
Priming of Th2 cells was measured by assessing 11L-4 production. In contrast 
to IFN-y, measurable amounts of 11L-4 were secreted only by cells derived from IFA- 
primed mice with little or no cytokine detectable from cells derived from CFA-primed 
mice (p< 0.01). These data indicate that immunization with WA induces a Th2-biased 
response to Mf proteins. 
3.2.3 Antibody responses to Mf antigens do not always correlate 
with cytokine production patterns from helper T cell subsets 
Sera were taken from mice 19 days post-immunization with 20 pg of MI 
antigens in either CFA or WA. The Mf antigen-specific antibody isotypes, IgGi, 
IgG2a, IgG2b, IgG3 and 1gM, were measured by ELISA assays from each of the 
individual mice. 
The results of these assays of antibody are shown in Fig 3-3. Priming with Mf 
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Figure 3-2. Proliferation and cytokine levels secreted by T cells in popliteal cells 
from BALB/c mice, immunized with MI proteins in association with CFA or IFA, 
stimulated with antigens. Proliferation was measured by tritiated thymidine uptake at 72 
h in culture and results are shown as stimulation indices = proliferation with specific 
antigen/medium proliferation. Supernatants were taken after 60 h in culture and 
cytokines were measured by bioassay (IL-2 and IL-4) or ELISA (IFN-y). Data shown 
are the means ± SD of four individual mice in each group 
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Figure 3-3. Antibody isotype levels specific for Mf antigens in two groups of 
BALB/c mice, one group immunized with Mf antigens with CFA and other group 
immunized with Mf antigen with IFA. Antibody levels were measured by ELISA. Fig 











in CPA resulted in significant level of antibody. The response was generally dominated 
by IgG 1 and no IgG3 could be detected. A very similar isotype pattern was seen upon 
priming with Mf in IFA. Moreover, on average the two adjuvants also induced 
comparable antibody levels. 
3.2.4 Sequential immunization with Mf antigen in CFA and IFA 
induces both Thi and Th2 responses 
Having established that Mf antigen in CFA and lEA stimulated differential 
primary Thi and Th2 responses, the secondary response was then examined. BALB/c 
mice (four mice per group) were primed S.0 with 20 pg of Mf antigen in association 
with CFA and then injected antigens in WA into footpad after five weeks. T cell 
proliferation and cytokine production were measured from each of the individual mice. 
As shown in Fig.3-4, a vigorous antigen-specific T cells proliferative and sufficient 
amounts of IL-4 and IFN-y secreted by cells induced by specific antigens were 
observed. These data indicate that immunization with antigens in CFA and then in WA 
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Figure 3-4. Proliferation and cytokine levels secreted by T cells in popliteal cells 
from BALB/c mice, immunized sequentially with Mf proteins in association with CFA 
and IFA, stimulated with antigens. Proliferation was measured by tritiated thymidine 
uptake at 72 h in culture and results are shown as stimulation indices = proliferation 
with specific antigen/medium proliferation. Supernatants were taken after 60 h in 
culture and cytokines were measured by bioassay (IL-4) or ELISA (IFN-'y). Data 













This chapter describes a system in which the immunization regimen dramatically 
affected the T cell response but had no detectable effect on the B cell response. Two 
different adjuvants, CFA and WA, were compared for their abilities to induce murine 
helper T cell responses and antibody production. Significant differences were found in 
the ability of these adjuvants to induce T cells to produce cytokines although no 
differences were found on antigen-induced T cell proliferation. The cytokine pattern in 
particular suggested that CFA might preferentially prime IFN-y producing Thl cells 
while WA might preferentially prime IL-4-producing Th2 cells. Interestingly, we found 
that immunization with antigens in CFA and then in WA can induce both Mf-specific 
Thi and Th2 responses. Thus, the T cells from desired immune response profile 
(mixed Th 1/Th2) against Mf proteins could be used for screening Mf T cell antigens in 
next step. 
We examined then whether different adjuvants would influence isotypic 
responses against Mf antigens. However, when antibody were examined, CFA and 
WA consistently generated similar isotype patterns and comparable antibody levels. The 
isotype and level of antibody did not correlate with differences in the relative amounts 
of IL-2, IL-4 and WN-y produced by T cells primed by either set of adjuvant. CFA and 
WA were both potent adjuvants for the antibody response to Mf antigens. In both cases 
the antibody response appeared to be dominated by IgGi. 
Our data are in agreement with the observation by Forsthuber et a!, who 
reported that mice immunized with HEL in CFA produced IFN-y but virtually no IL-5, 
consistent with the induction of a Thl response, while mice immunized with HEL in 
WA produced IL-5 but virtually no IFN-y, consistent with the induction of a Th2 
response (Forsthuber et al., 1996). Mauri et al also found a dramatic shift from a Thl 
response in mice given type II collagen in CFA to a Th2 response in mice given type II 
collagen in WA as reflected by reduced IFN-y production and increased IL-4 and IL- 10 
production (Mauri et al., 1996). In mice, susceptibility to collagen-induced arthritis has 
been shown to require the administration of type II collagen in CFA while only very 
small minority of mice immunized with type II collagen in WA develop signs of 
arthritis, Mauri et al believed that the role of CFA in the arthritogenic response is to 
promote the development of Thi response (Mauri et al., 1996). 
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It is also interesting to note that our data conflict with Fox et al, who report that 
priming with pigeon cytochrome c peptide antigen 81-104 with CFA or WA induced a 
comparable levels of IL-2, IL-4 and IFN-y from T cells, frequencies of antigen-specific 
cells, and dominantly IgGi antibody (Fox, 1992). It is possible that the contradictory 
nature of the results is due to the fact: 1) our results were obtained from BALB/c mice 
while Fox et al looked at B 10.A mice. MHC genotype may predetermine Th 
phenotype based on the selection of the TCR-peptide-MHC interaction. For example, 
BALB/c mice is easier to produce a Th2 response while B 10. PL is easier to produce 
Thi response. MHC control of ThliTh2 selection in human is suggested by some 
reports linking specific MHC genotypes to Thi-like or Th2-like response against 
defined antigens in insulin-dependent diabetes mellitus, malaria and leprosy (Mutis et 
al., 1994; Roep et al., 1996; Stephens et al., 1995). The most striking example of 
genetic control of Th l/Th2 development is the resistance or susceptibility of inbred mice 
to infection with Leishmania major, which correlates with specific Thi or Th2 
responses, respectively (Reiner and Locksley, 1995). In vitro studies indicate that CD4 
T cells from two mouse strains that are resistant and susceptible to Leishmania major, 
B 10.D2 and BALB/c, respectively, differ in their intrinsic tendency to develop towards 
Thi or Th2 cells in response to antigens. This difference is attributable to greater initial 
IL-4 production by BALB/c T cells and more prolonged maintenance of IL- 12 
responsiveness in B 10.D2 cells (Guler et al., 1996) (Hsieh et al., 1995). The molecular 
basis of these effect is not yet defined. However, recent work suggest that differential 
expression of MHC II gene on murine macrophages is associated with T cell cytokine 
profile [B aumgart, 1998]. 2) the dose and the form of antigens are different between 
ours and Fox's. The effects of adjuvants are known to be dependent on the antigen 
system used. We used MI somatic extracts as antigens, which is very complex and 
contains many antigens, whereas Fox et al used a simple peptide as the antigen. Some 
reports suggest that the structural characteristic of an antigen may be important for the 
induction of different Th responses. For example, large polymers of ovalbumin elicit 
Thi response whereas ovalbumin in the nonpolymerized form leads to Th2 responses 
(Yang et al., 1993). One possible explanation is that macrophages are better able to 
process and present polymerized ovalbumin (and send a Thi signal) than B cells. B 
cells, on the other hand, may process the smaller forms of ovalbumin, and either deliver 
Th2-promoting signals as they present to T cells or down-regulate Thi cells by 
secreting IL-b. Moreover, we also note that the dose of antigens in our study was 20 
jig of Mf somatic extracts while in Fox's study 10 nmol of antigen was used. Some 
reports suggest dose of antigen may also direct T cell response. Low antigen 
concentrations or low-dose infections tend preferentially to induce Thi response 
whereas high doses induce Th2 development (Bretscher et al., 1992; Hosken et al., 
1995). The mechanisms underlying these effects of antigen dose are not well 
understood. It has been proposed that quantitative differences in TCR occupancy by the 
MHC-antigen complex may led to qualitative differences in signal transduction during 
activation, therefore ultimately resulting in one phenotype rather than the other. It is 
also possible that high concentrations of antigen lead to repeated T cell stimulation, 
thus increasing IL-4 production and Th2 development, or induce a state of 
immunological tolerance, which often preferentially shuts off Thi cells (Burstein and 
Abbas, 1993; De Wit et al., 1992). This may be one reason, we think, helminth 
parasites, which produce lot of excretory/secretory products in vivo, usually induce 
Th2 response. Although this is an interesting hypothesis, so far there is no formal 
evidence to support it. 
Although B cell production of IgGi is thought to be largely driven by IL-4, one 
of interesting findings in this chapter is Mf antigens induced dominantly IgGi antibody 
even in CFA immunization group in which IL-4 was very low or undetectable. Brewer 
et al also found that ovalbumin-specific IgGi production was still readily detectable in 
IL-4 gene-disrupted mice immunized with ovalbumin in CFA or alum, although 
significantly reduced compared with wildtype mice (Brewer et al., 1996). Recently, 
Urban et al found that IL-4Ra-mediated signalling is able to stimulate IgGi production 
through a Stat6-independent mechanism (Urban et al., 1998). Because IL-13, like IL-4, 
is a ligand for a receptor that contain IL-4Ra (Hilton et al., 1996; Zurawski et al., 
1995) , it will be interesting to see if IL-13 regulates IgGi production. The important 
role of EL-13 in Th2 cell mediated immune responses has been recognized recently. 
Previous studies have demonstrated that Thi clones could induce IgGi synthesis by B 
cells via an IL-4 and IL-5-independent pathway which had an absolute requirement for 
Thi-drived IL-2 production (DeKruyff et al., 1990). Our results suggest that IgGi 
production, in this instance, may via an IL-4-independent pathway and IgGi 
production does not necessary mean that a Th2 response has been induced. However, 
another possibility, which our results could not rule out, is that Th responses in 
popliteal cells may be different from those of the spleen. Our previous study showed 
serum antibodies mainly from spleen during the primary immune response (Zang et al., 
1990), so it is possible that spleenic Th cells have more effect than popliteal Th cells on 
antibody production from spleen. 
Although CFA has been employed as a vaccine adjuvant for approximately 50 
years and has become the "gold standard" adjuvant used in most system, at present little 
is understood about how these adjuvants work. Therefore, it is not surprising that CFA 
and IFA, which induce Thl and Th2 responses respectively in our system and other 
systems, have not been more widely exploited in studies of the factors which control 
the differential expansion of these T helper phenotypes. Studies using normal T cells 
stimulated with polyclonal activators and naive T cells from transgenic mice expressing 
TCR of known specificities have established the key concept that Thl and Th2 are 
developed from the same T cell precursor, whose differentiation is influenced by the 
manner and environment in which the precursors are stimulated, and that Thl and Th2 
populations are irreversibly committed. There is a possibility that CFA and WA may 
recruit different types of inflammatory cells, that induce characteristic early cytokine 
environments, necessary for Th polarization. In that regard, some findings showing 
that mast cells, basophils and eosinophils are capable of producing immunoregulatory 
cytokines such as IL-4, IL-S, EL-10, IL-13 and IFN-y are of interest (Tom et al., 1998) 
(Frandji et al., 1998) (Desreumaux et al., 1998) (Seder et al., 1991). It is also possible 
that CFA and WA may recruite different types of APCs and/or regulate costimulatory 
molecules. Stimulation of these cells and molecules by adjuvants would influence the 
nature of the immune response. For example, influenza virus envelope protein-pulsed 
various types of APC, encompassing peritoneal cell, unfractionated splenocytes, 
spleenic dendritic cells, and B cells, stimulated primed T cells to produce differently 
cytokines in vitro (Villacres-Eriksson, 1995). In vivo experiments had suggested a 
direct linkage between costimulation by B7-1 versus B7-2 and the development of Thi 
versus Th2 immune response (Kuchroo et al., 1995). 
The innate immune system has long been thought of as an evolutionary 
rudiment whose only function is to contain the infection until the adaptive immune 
response can be induced. Accumulating evidence suggests that the innate immune 
system is also essential for the activation of the adaptive immune response and its 
direction into a particular effector type. Recently Janeway and colleague hypothesize 
that adjuvants could induce the innate immune system to produce the signals that are 
required for activation of an adaptive immune response (Medzhitov and Janeway, 
1997). This interesting hypothesis, which so far has no formal evidence to support it, 
can be tested in our system. 
Detailed studies of adjuvants and the Th subsets that they induce have not yet 
been performed. The properties of CFA and WA that are important in this differential 
Th effect remain to be determined. However, accumulating evidence in recently years 
suggests that bacterial DNA have the capacity to cause polyclonal activation of B cells 
and stimulation of APCs and other cells (Stacey et al., 1996; Sun et al., 1997; 
Yamamoto et al., 1992). Such activities of bacterial DNA is due to CpG motifs. CpG 
DNA activates B cells, macrophages and dendritic cells to secrete IL-6, TNF-ct, GM- 
61 
CSF, chemokines, and most importantly IL-12 and IFN-y which could drive Thi 
responses (Chu et al., 1997; Klinman et al., 1996; Krieg et al., 1995; McCluskie and 
Davis, 1998; Roman et al., 1997). Thus, it is interesting to speculate that Thi-biased 
activity of CFA may be due, at least in part, to the presence of dead bacteria, a source of 
immunostimulation. We also found that at present there seems no any reports to 
determine if DNA from nematode parasites do something on immune system. 
Adjuvants are potent immunostimulators, most of them cannot be used in the clinic 
because of unwanted side effects. CFA and IFA could induce differential Th responses 
in our system and others, which provides a chance for identification of the active 
components of the adjuvants and their subsequent modification to minimize side effects. 
Such knowledge may allow more rational design of novel adjuvants and therapeutic 
strategies. It is now accepted that the orientation of the immune response to a Th 1 or 
Th2 profile may greatly influence disease outcome in several infectious and allergic 
conditions. Therefore, an understanding of the mechanisms involved in immune 
response polarization induced by some adjuvants would greatly improve 
immunotherapy and vaccination protocols to achieve maximum protection. 
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Chapter 4 
FPLC and SDS-PAGE electro-elution showed a restricted 
number of major T cell antigens among Mf 
4.1 Introduction 
T cell-mediated immune responses are key determinants of the natural course of 
infections caused by intracellular and extracellular parasites. Thus T cell-activating 
proteins of these parasites continue to generate active interest, both to gain 
understanding of the basic immunology of infection, and to the further design and 
development of newer and more effective diagnostic tests and vaccines. These questions 
are prominent issues in filariasis, in which a wide variety of cellular and humoral 
immune reactions have been reported, ranging from an apparent lack of lymphocyte 
responsiveness (Ottesen et al., 1977; Piessens et al., 1980; Piessens et al., 1982; 
Sartono et al., 1995) to T cell mitogenic activation (Lal et al., 1987; Wadee and 
Piessens, 1986) and a heightened degree of serum antibodies (Ottesen et al., 1982). The 
nature or manner by which filarial antigens elicit these responses, however, is not well 
understood. 
The understanding of parasite-specific immune responses and the development 
of vaccines demands identification and characterization of the parasite antigens 
recognized at the T cell level. Although parasite-specific T cells have been implicated in 
mediating both pathogenic and protective immune responses in a number of filarial 
infections, the nature of the antigens inducing such responses remains poorly 
characterised. Identification of T cell antigens in filariasis is a difficult problem for both 
practical and theoretical reasons as outlined in Chapter 1, because of limited availability 
of crude parasite antigens and the complexity of a pathogen with multiple sets of stage-
specific and shared products through the developmental cycle. 
Across the spectrum of micro-organisms and eukaryotic parasites, an 
impressive array of T cell antigens has been identified and characterized. Nonetheless, 
since these proteins were mostly pre-selected by antibody screening of recombinant 
DNA libraries, it is likely that many predominantly T cell-activating molecules have 
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been missed. This realization has led to a series of attempts towards developing the 
technology for a comprehensive search for T cell-stimulating molecules. 
Fast protein liquid chromatography (FPLC), using a linear gradient for elution 
with improved ion exchange resins, is an efficient means of separating small amounts 
of proteins while maintaining their biologic activity. Lal et al used this system to 
fractionate the complex mixture of solubilized adult B.malayi antigens, and tested their 
ability to induce patient's lymphocytes to proliferate (Lal et al., 1987). However, one 
disadvantage of FPLC is that only soluble materials can be resoled in this system. An 
alternative simple approach to antigen fractionation is SDS-polyacrylamide gel 
electrophoresis (SDS -PAGE) elution, in which proteins are fractionated by 
continuously decreasing molecular weight. This method can accommodate poorly-
soluble or membrane proteins due to the presence of SDS. SDS also destroy most 
biological activity, but does not compromise T cell recognition which is based on 
denatured peptide presentation. Luder et al have used the SDS-PAGE electro-elution to 
fractionate Onchocerca volvulus (O.volvulus ) antigens, and were able to show that 
0. volvulus antigen fraction of 11-15 kDa induced strong proliferation of endemic 
normal peripheral blood mononuclear cells (PBMC) and substantial production of IL-2 
and IFN-y but not in those from onchocerciasis patients (Luder et al., 1996). To 
characterize filarial antigens that may be associated with the development of chronic 
lymphatic dysfunction in persons with lymphatic filariasis, Dimock et al have also used 
the SDS-PAGE electro-elution to fractionate B.pahangi antigens, and found that 
antigen fractions that stimulated the highest proliferative responses (in the 25-49 kDa 
range) in filarial patients and IL- 10 production were not identical (Dimock et al., 1994). 
In Chapter 3 it was shown that, by choosing the appropriate adjuvant, different 
types of immune response can be induced, and mixed Thl/Th2 responses against MI 
also be induced. In this chapter, such T cells against Mf proteins are used for screening 
Mf T cell antigens. Firstly, phosphate-buffered saline (PBS)-solubilized Mf proteins 
were separated into 32 fractions by FPLC and each fraction measured for T cell 
antigenicity. Secondly, 13 fractions of SDS-solubilized MI proteins prepared by SDS-
PAGE electro-elution were similarly tested for stimulation of primed T cells. 
4.2 Results 
4.2.1 FPLC fractionation of Mf proteins 
Somatic extracts of Mf were prepared in phosphate-buffered saline (PBS). Mf 
were obtained from B. malayi infected jirds and separated from host cells over 
lymphocyte separation media and then passed through a Sephadex G-25 column. 
Fractions containing Mf without host cells were pooled. Mf were disrupted in a ground-
glass homogeniser and then sonicated for 3 min on ice in PBS. Suspensions were 
extracted on ice for 60 min with occasional agitation and then centrifuged at 10,000 g 
for 30 min at 40C, passed through a 0.2 gm filter, and then the protein concentration 
determined by using the Bradford assay (Pierce, USA), with bovine serum albumin 
(BSA, Sigma, USA) as standard. The suspensions were aliquotted for storage at - 
700C. 
For FPLC, total of 5 mg of crude PBS-soluble Mf extract was dialyzed against 
buffer A (20 mM Tris, pH 8.0) overnight at 4 °C, passed through a 0.2 jim filter and 
then fractionated on an anion exchange column (Mono Q HR5/5, Pharmacia Biotech). 
An FPLC apparatus was used and 7 ml (about 5 mg) sample of crude extract of Mf was 
loaded onto the mono Q column. The proteins were eluted from the column by applying 
a linear gradient of 0 to 1000 mM NaCl and the protein concentration in each fraction 
was determined by using the Bradford assay (Pierce, USA), with BSA as standard. As 
shown in Fig 4-1, 9 protein peaks in total 32 fractions (0.5 mI/fraction) were eluted 
from the column by FPLC. 
4.2.2 T cell antigenicity of proteins fractionated by FPLC 
BALB/c mice (four mice per group) were primed sub-cutaneously with 20 jig of 
PBS-soluble Mf antigen emulsified CFA and 5 weeks later boosted with Mf antigen in 
IFA into the footpads. The popliteal lymph node cells were removed from individual 
mice for use in T cell proliferation and cytokine production at 10 days after challenge. 
Each fraction from FPLC was measured for T cells antigenicity, namely proliferation, 
IFN-y and IL-4. 
As shown in Fig 4-2, the strongest T cell antigenicity located in protein peak 5 
and 6, eluting 587 to 692 mM NaCl (fraction 18-22), while the dominant protein peak 
were peak 3 and 4. Interestingly, fraction 9-16 did not induce cell proliferation and IL- 
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Figure 4-1. Mf Protein fractionated by FPLC. 5 mg of crude extract of Mf in 7 ml of 
buffer (20 mM Tris, pH 8.0) was loaded into an anion exchange mono Q column and 
eluted with a linear gradient of 0 to 1000 mM NaCl. The protein concentration in each 
fraction was determined using the Bradford assay and the protein peaks were indicated 
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Figure 4-2. T cell stimulation by Mf proteins fractionated by FPLC. Proliferation 
and cytokine responses of T cells from popliteal lymph node cells from BALBIc mice, 
immunized sequentially with Mf proteins in association with CFA and IFA, were 
stimulated with each of 30 fractions from FPLC. Proliferation was measured by tritiated 
thymidine uptake at 72 h in culture and results are shown as stimulation index. 
Supernatants were taken after 60 h in culture and cytokines were measured by bioassay 
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Figure 4-3. SDS-PAGE and silver stain analysis of Mf proteins fractionated by 
FPLC. Fractions 18-22, eluted at 587 to 692 mM NaCl, were found to contain strong 
T cell stimulating activity measured by antigen-specific T cell proliferation, IFN-i and 
IL-4 production. The major band in these fractions is indicated with solid arrowheads. 
MW, molecular weight standards are molecular sizes in kDa shown on the left. 
Individual FPLC fractions, 17 to 24, were next characterized by SDS-PAGE 
and silver staining as shown in Fig 4-3. Fractions 18-22 which have the strongest T cell 
stimulating activity contain a major 58 kDa protein and several less prominent bands. 
Although it would have been desirable to reproduce this experiment, sufficient material 
was only available for s single experiment. Unfortunately, therefore, there was 
insufficient proteins in fractions 18-22 for protein sequencing. 
4.2.3 Mf Protein fractionated by SDS-PAGE electro-elution 
As an alternative approach to identify T cell antigens, SDS-PAGE fractionation 
followed by electro-elution (Dimock et al., 1994; Mehrotra et al., 1997) was used to 
separate T cell antigens from Mf. MI were mixed with SDS-PAGE loading buffer, 
heated at 100°C for 10 ruin, and centrfuged at 13,000 rpm for 30 mm. The supernatant 
was recovered and loaded onto a 15% SDS-PAGE gel. After electrophoresis, a slice 
was taken from either side of the gel and stained with Coomassie blue. The rest of the 
gel was cut into 13 horizontal fractions. Gel slices were placed into molecularporous 
membrane tubing and the proteins were eluted from each fraction by Western blotting 
transferred apparatus. After elution, all 13 tubes were dialyzed against PBS at 4°C for 
48 h (change of buffer for 3 times). SDS was removed by the method by Dimock et al 
(Dimock et al., 1994) and then passed through a 0.2 .Lm filter. 
The protein concentration in each fraction was determined by using the Bradford 
assay with bovine serum albumin as standard (Fig 4-4). All 13 fractions were 
visualized by SDS-PAGE and silver stain to determine the molecular range of proteins 
within each fraction (Fig 4-5). 
4.2.4 T cell antigenicity of proteins fractionated by SDS-PAGE 
electro-elution 
BALB/c mice (four mice per group) were immunized with Mf and adjuvant (see 
section 4.2.2). The popliteal cells removed from individual mice for use in T cell 
proliferation and cytokines production. Each fraction from SDS-PAGE electro-elution 
was measured for T cells antigenicity, namely proliferation, INF-y and IL-4. 
As shown in Fig 4-6, a few fractions of T cell stimulating activity were 
detected. Fractions 1 and 2 (molecular mass region of 130 to 220 kDa), fractions 8 and 
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9 (35 to 55 kDa) induced exceedingly potent T cell proliferation, IL-2, IL-4 and IFN-y 
production. T cells proliferated and produced moderate amounts of EL-2, I1L-4 and IFN-
y when stimulated with fraction 6 (50 to 65 kDa). 
Interestingly, fractions 11 and 13 seem to inhibit T cell proliferation and 
production of IL-2 and IL-4, but not IFN-y. 
In comparing the results from FPLC fractions results and SDS-PAGE electro-
eluted fractions, it was found that at least four fractions with different molecular mass 
from electro-elution are T cell antigens while only one peak from FPLC were T cell 
antigens. These results suggest that some proteins which are not readily soluble in PBS 
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Figure 4-4. Mf proteins fractionated by SDS-PAGE electro-elution. SDS-soluble 
crude extract of Mf was separated by SDS-PAGE and then eluted by electro-elution. 
The protein concentration in each fraction was determined using the Bradford assay. 
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Figure 4-5. SDS-PAGE and silver stain analysis of Mf proteins fractionated by 
SDS-PAGE electro-elution. SDS-soluble crude extract of Mf was separated by SDS-
PAGE and then eluted by electro-elution. Each of 13 electro eluted fractions were 
analysed to determine the molecular range of proteins within each fraction. The 












1 	2 	3 	4 	5 	6 	7 	8 	9 	101112 1 







1 2 3 4 5 6 7 8 910111213 








1 2 3 4 5 6 7 8 9 10111213 




1 2 3 4 5 6 7 8 910111213 
iVif: SDS-PAF fraction 
Figure 4-6. T cell antigenicity of proteins fractionated by SDS-PAGE electro-
elution. SDS-soluble crude extract of Mf was separated by SDS-PAGE and then eluted 
by electro-elution. A total of 13 fractions were used to determine T cells antigenicity. 
Proliferation and cytokine levels secreted by T cells in popliteal cells from BALBIc 
mice, immunized sequentially with Mf proteins in association with CFA and IFA, 
stimulated with 13 protein fractions. Proliferation was measured by tritiated thymidine 
uptake at 72 h in culture and results are shown as stimulation index. Supernatants were 
taken after 60 h in culture and cytokines were measured by bioassay (IL-4) or ELISA 
(IFN-'y). Data shown are the means ± SD of four individual mice. 
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4.3 Discussion 
As it is becoming more obvious that T cell-mediated immunity plays a major 
role in the development of protection against many infectious agents, including parasites 
(Allen and Maizels, 1997; Bona et al., 1998; Maizels et al., 1993), identification of 
those determinants immunogenic for T cells becomes all the more important. In the 
past, crude filarial parasite extracts have been used widely to test and characterize both 
cellular and humoral responses in filarial infection. The specific T cell antigens 
contained in these complex parasite preparations have not been fully characterized in 
any sense. The present study was designed to identify those specific T-cell antigens 
which induce B.malayi Mf-specific T cellular responsiveness in vitro. Two 
biochemical approaches, FPLC fractionation and SDS-PAGE electro-elution, were used 
to fractionate MI antigens. Both techniques indicated major MI T-cell-stimulating 
antigen of 35-60 kDa. 
In this chapter PBS-solubilized MI proteins were fractionated by FPLC and 
strong T cell antigenicity located in protein peaks 5 and 6, which contained a major 58 
kDa protein and several less prominent proteins. In a previous study using FPLC 
fractionation of solubilized adult B.malayi antigens, Lal et al found that three 
fractions, fraction A (22-62 kDa), fraction B (a major protein band of 67-72 kDa with 
several less prominent bands), and fraction C (high molecular mass proteins, 90-180 
kDa), were each capable of inducing patient's peripheral blood mononuclear cells 
(PBMC) to proliferate (Lal et al., 1987). It is interesting to compare our FPLC results 
with the results from Lal et al. Molecular weight of proteins in fraction 18-22 in our 
system are close to fraction A in Lal et al system. In fact, we once found that there 
was strongly T cell cross-reactivity between Mf and adult antigens in mice model. 
Interestingly, more PBS-solublie B.malayi adult antigens were found in Lal et at 
system than ours. Therefore, whether B.malayi adults contain more T cell antigens 
than Mf remains an interesting possibility. 
A second biochemical approach for fractionating T cell antigens is SDS-PAGE 
electro-elution. Using this technique, Luder et al separted 0. volvulus adult proteins 
into 22 fractions by molecular weight and found that vigorous Thi-type responsiveness 
in endemic normals was restricted to low molecular weight of antigens (11-15 kDa), 
while such reactivity was absent in microfilaridermia-positive individuals (Luder et al., 
1996). The similar approach, high performance electrophoretic chromatography, was 
once used by Mountford et al to fractionate antigens from adult Schistosoma mansoni 
worms on the basis of molecular weight and fractions were used directly to stimulate 
cultures of lymphocytes taken from the lymph nodes of infected or vaccinated mice 
(Mountford and Wilson, 1993). In this chapter, whole MI proteins were fractionated 
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into 13 fractions which were tested for T cell antigenicity. Fractions 1 and 2 (130-220 
kDa), fraction 6 (50-65 kDa), fractions 8 and 9 (35-55 kDa) potent induced cell 
proliferation and cytokine production. Interestingly, fractions 11 and 13 seem to inhibit 
T cell proliferation and production of IL-2 and 11L-4, but not IFN-y. There are a few 
reports that B.inalayi directly inhibit host cell proliferation, for example, Wadee et al 
found that B.malyai Mf extracts showed inhibition of Concanavalin A (Con A)-
induced lymphocyte proliferation (Wadee et al., 1987); Rao et al found that B.malayi 
adult female suppressed the growth and proliferation of human endothelial cells in vitro 
(Rao et al., 1996) while Lal et al reported that phosphocholine from B.malayi 
suppressed phytohemagglutinin (PHA)-driven T cell proliferation in patients with 
filariasis and control individuals as well (Lal et al., 1990). However, the B.malayi 
molecules and mechanisms for such direct suppression on host cells have not been 
studied in detail. 
Comparing the results obtained from FPLC and SDS-PAGE electro-elution it is 
interesting to find that more T cell antigens were found by SDS-PAGE electro-elution 
although this is a less refined system than FPLC. One explanation for this difference is 
that SDS-denatured proteins may be more readily processed and presented to T cells by 
antigen presenting cells. Neophytou et al also found that preparation of recombinant 
antigens by SDS-PAGE electro-elution appeared to facilitate their presentation to T cells 
compared to soluble protein and enhanced the sensitivity of T cell proliferation assays 
by a factor of 50 or more (Neophytou et al., 1996). In addition, it is likely that some 
Mf proteins insoluble in PBS but soluble in SDS-buffer may be important T cell 
antigens. Therefore, B.malayi homogenates, which contain all B.malayi components, 
and can be sterilised by irradiation, may be better antigen than the PBS-solubled 
B.malayi protein fractions used in the most studies to date. 
Taken together, analysis of T cell responsiveness to B.malayi Mf antigens, 
using the biochemical and immunochemical techniques described in this chapter, shows 
a restricted number of major T cell antigens from the Mf stage. Further analysis of these 
antigens should help to elucidate the mechanism of host-parasite interaction at both the 
cellular and molecular levels. 
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Chapter 5 
Cloning and characterization of a novel serpin gene 
(Bm-spn-2 ) from B.malayi microfilariae 
(published in part in the BLOOD) 
5.1 Introduction 
The studies described in previous chapters have established that Mf proteins 
induce strong T cell responses (cell proliferation and cytokine production), and that 
these responses can be used for identification of Mf fractions separated by FPLC and 
SDS-PAGE electro-elution. Because there is insufficient Mf protein available to 
separate and further purify individual candidate antigen proteins for protein sequencing, 
an immunochemical approach was adapted, as described in this chapter, to find 
candidate genes for T cell antigens. Mouse antisera was raised against fractional 
proteins of the molecular weight range 35-55 kDa, showen to be potent at inducing 
antigen-specific T cell proliferation and cytokine production. We postulated that such 
antisera would contain antibodies against the major T cell antigens and therefore could 
be used to isolate T cell antigen genes from a cDNA expression library. By this 
approach, a novel serpin (serine proteinase inhibitor) gene was found from the Mf stage 
of B.malayi. This chapter describes the isolation and characterization of this new gene, 
Bm-spn-2. In a comparable experiment, antisera from mice immunized with whole 
lysate of Mf were used for screening antigen genes from the cDNA expression library, 
five positive clones were found and all were paramyosin. 
Serpin genes comprise a large gene family (Potempa et al., 1994) and their 
protein products regulate a wide variety of proteinase-dependent physiological functions 
such as blood coagulation (Carrell et al., 1991), fibrinolysis (Cohen and Lijnen, 1991), 
activation of complement and the inflammatory response (Travis and Salvesen, 1983). 
In addition to these fluid-phase reactions, serpins have critical roles in cell interactions 
and mobility: for example maspin suppresses invasion and motility of mammary tumor 
cells (Zou et al., 1994); plasminogen activator inhibitor 1 (PAl- 1) blocks migration of 
smooth muscle cells (Stefansson and Lawrence, 1996), while PAI-2 can prevent 
apoptosis in cells exposed to tumor necrosis factor-(x (TNF-(x) (Dickinson et al., 
1995). In view of the potency of serpin regulation of biological processes, it seems 
likely that pathogens may themselves encode serpins and use them to block host 
defence functions. For example, virus-encoded serpins prevent the proteolytic 
activation of interleukin-1f3 (Kettle et al., 1997; Petit et al., 1996; Ray et al., 1992), 
block granzyme activity (Quan et al., 1995) and protect infected cells from Fas- and 
TNF-induced apoptosis (Kettle et al., 1997; Smith et al., 1996). However, less is 
known of serpins from parasitic agents. A novel serpin was found from B.malayi Mf 
stage in this chapter, which raises the possibility that Mf may produce serpin(s) to act as 
a functional interaction between parasites and host defence system. 
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5.2 Results 
5.2.1 Antibody screened cDNA library: paramyosin 
Eight-week old female BALB/c mice were injected with 50 pg whole Mf lysate 
in complete Freund's adjuvant (CFA) and boosted four weeks later with 50 tg whole 
Mf lysate in incomplete Freund's adjuvant (IFA). Mice were killed at six weeks and 
antisera collected. Antibodies, preabsorbed against E.coli lysate, were used to screen a 
B. malayi Mf cDNA expression library, supplied by the Filarial Genome Project 
(Williams et al, unpublished; Scott et a!, unpublished;(Blaxter et al., 1996)), to identify 
the principal antigenic proteins. The immunoreactive plaques, detected using 
peroxidase-conjugated rabbit anti-mouse IgG (DAKO, Denmark) and the TMB 
membrane peroxidase substrate system (KPL, MD), were purified to homogeneity by 
two subsequent rounds of screening. Bluescript phagemids were then excised from 
positive clones using the manufacturer's protocols and sequenced. Five positive clones 
were isolated and sequenced. Sequence results showed all of the five positive clones 
were paramyosin. 
5.2.2 Isolation and characterization of a cDNA for Bin-spn-2 
Following the studies of Mf proteins described in Chapter 4, the fraction from 
Mf containing proteins of 35-55 kDa, was found to be one of most potent at inducing 
antigen-specific T cell proliferation and cytokine production. Eight-week old female 
BALB/c mice were then injected with 50 pg of the 35-55 kDa fraction in CFA, boosted 
at 4 weeks with 50 .tg of the 35-55 kDa fraction in IFA, and antisera collected at 6 
weeks. Antibodies, preadsorbed against E.coli lysate, were used to screen a B. malayi 
Mf cDNA expression library. Three positive clones were isolated, one of which was 
found to be a novel cDNA insert and was analysed as described below. 
The sequence of the full length eDNA was determined and is shown in Figure 
5.1. The cDNA insert contained 1438 bp and a single open reading frame (ORF) 
starting at nt 27 and ending at nt 1311 which was followed by two more stop codons 
and a potential polyadenylation signal sequence (AATAAA, nt 1398-1404) 15-20 nt 
upstream from a poly A tail. Like most B. malayi cDNAs, the GC content was low 
(35.1%). The ORF encoded a 428 amino acid protein with 2 potential N -glycosylation 
sites at asparagines 21 and 360 of the deduced amino acid sequence. 
(A) 
	
M K L F E V I F I V V A V L 	14 
AATATTGGCAATTCGCAATTATCCATGAAGCTTTTCGAAGTAATATTTATTGTGGTGGCAGTACTC 68 
Serpin.Gen F 
G S S R A 0 S T L N H C S E N N D D S N K L 	37 
GGTGGTAGTTCCCGTGCTATCAGTACTTTAAACCATTGTTCTGAAAACAATGATGATTCAAACAAGCT 136 
L I T K A Q M N F A L E L L R Y S S Q A D E 	59 
ACTGATAACTAAGGCGCAAATGAATTTCGCATTGGAACTATTGCGCTATTCTTCGCAAGCTGATGAAA 204 
S L L S P F A I A S V M S L L Y E G A R G E 	82 
CCTCGCTATTATCGCCATTTGCAATCGCTTCCGTAATGTCATTATTATATGAAGGAGCCAGAGGTGAA 272 
T E R E N G R V L S A D Q P K N A F G A Y I E 	105 
CTGAGCGTGAGATGGGGAGGGTGCTTTCAGCAGATCAACCAAAAAATGCATTTGGAGCTTACATAGA 340 
BmSerpin Ri 
C A I K N I H K Q S K R N D Y S L Y Y L T K 	127 
GTGCGCTATCAAAAATATTCACAAGCAATCAAAGCGAAATGATTATTCTTTGTACTATTTAACCAAAT 408 
F F V Q Q N S L K S D F K D I T R R R Y P Y E 	150 
TTTTTGTGCAACAAAATTCTTTGAAGTCTCATTTTAAAGATATTACTCGTCGACGATATCCTTATGAG 476 
L T Q I N F A S P L Q V K S I R E I F I K W I 	173 
TTGACACAAATCAATTTCGCTTCACCTCTGCAAGTGAAGAGTATAAGAGAAATATTTATTAAATGGAT 544 
K K S M N Y G A R N I A S I T S T Q S L N L 	195 
AAAGAAAAGTATGAATTATGGAGCCCGTAATATCGCTAGCATCACTTCCACTCAGTCATTAAACTTAT 612 
10 BmSerpin.R2 
F N G I H F T D D W M Y E F L P L N H I L P F 	218 
TTAATGGAATACATTTCACTGATGATTGGATGTACGAATTTCTTCCGCTCAATCACATATTACCGTTC 680 
Y S P R L R V T D M P M M E R T A K F P Y Y E 	241 
TATTCACCACGGCTACGTGTAACTGATATGCCAATGATGGAAAGAACGGCCAAATCCTTACTATGA 748 
N Q H M Q A V S L P F K D S E M Q M L I I L 	263 
AAACCAACACATGCAAGCGGTGTCGCTACCGTTCAAAGATTCCGAAATGCAAATGTrAATTATTTTGC 816 
BmSerpin F2 
P K K T F D L A K F E D K L T G E E L F S Y I 	286 
CCAAAAAAACCTTTGATCTAGCAAAGTTTGAAGATAAACTTACGGGAGAGGAACTATTCACTTATATT 884 
S A L D S S H E I T V T I P K F K Y E N Q I C 	309 
AGTGCACTTGACTCATCTCACGAAATTACCGTTACAATTCCAAAATTTAAGTACGAAAATCAAATATG 952 
L L N G L K R M G V Q S M F H E S N D F S G 	331 
TTTGTTAAATGGATTGAAGAGGATGGGAGTGCAATCAATGTTCCACGAATCGAATGATTTTTCCGGCA 1020 
I F E Q R L F TM D D I RN HAY I K I DIE-RI 	354 
TTTTTGAGCAGCGGTTATTTACAATGATGATATCAGAAATCATCCTTATATCAAAATTGATGAGAAA 18 
IG I NH E®S S M P V R N D M V M D K G E AEB 377 
GGAATCAATAACGAAAATTCAAGTATGCCAGTAAGAAATGATATGGTAATGGATAAAGGAGAAGCATT 1156 
R A N H P F L Y A iii D N H G TV L W I G R 	399 
CGTGCTTCATCCCTTCCTTTACAATCATTGATAACCACGGGACTGTACTAGATTGGTCGTT 1224 
BmSerpin Fl 
T G K N R E T I V E N S D D S M Q C E E T P 	422 
CACCGGAAAAAACAGAGAAACAATTGTCGAAAACTCGGATGACTCTATGCAATG3AGGAAACACCG 1292 
K K R Q R L * 	 428 
1AAAAAGACAAAGGTTATAACAGATACGAATGTTTGAGGAACGATTGAACAATATATCATTTGATTA 	1360 
ATCCACGCGAATTGTCTATTTTTGAAATATGATGTTGAATAAAAAATGCATTAATTTAAAAAAAAAA 1428 
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Figure 5-1. 	A: nucleotide and deduced amino acid sequences of the Bm-spn-2 
cDNA. Inferred amino acid numbering is in bold face. The putative hydrophobic 
signal peptide (amino acids 1-20) is underlined and two potential N -glycosylation sites 
(amino acids 21 and 360) are circled. The serpin motif (amino acids 353-357) and 
serpin signature (amino acids 377-387) are boxed. The position of a potential 
polyadenylation signal (nucleotide 1398-1404) is in bold face. Primers used in PCRs 
or sequenceing are indicated with solid arrow: Serpin.Gen F (bp 1-29), BmSerpin Ri 
(bp 261-280), BmSerpin.R2 (bp 564-584), BmSerpin F2 (bp 780-761), BmSerpin Fl 
(bp 1176-1157), and Serpin.Gen R (bp 1418-1391). The nucleotide sequence has been 
deposited in GenBank with the accession numbers AF009825. B: Hydrophilicity plot 
of the deduced protein sequence of Bm-spn-2. 
Residues 1 through 20 formed a very strong hydrophobic region consistent with a 
signal peptide function. The predicted mature protein, without this signal sequence, 
would have a molecular mass of 47.5 kDa and an isoelectric point of 6.9. 
In GenBank searches for similar amino acid sequences, 85 significant matches 
were found by the BLAST algorithm (Gish and States, 1993) using the NCBI BLAST 
server, all of which belonged to the serine proteinase inhibitor, or serpin, superfamily. 
One member of this superfamily from B. malayi, previously described by Yenbutr and 
Scott (Yenbutr and Scott, 1995), encodes a distantly related gene we now designated 
as Bm-spn-1. In light of this similarity, the novel protein was designated Bm-SPN-2, 
and its gene Bm-spn-2. 
5.2.3 Isolation and characterization of the Bm-spn-2 gene 
The Bm-spn-2 cDNA clone contained 26 bp 5'-untranslated region. (UTR) and 
105 bp 3'-UTR, which allowed the isolating of the genomic copy of Bm-spn-2 by 
PCR. 
MI were lysed and digested in lysis buffer and then extracted with phenol, 
phenol/chloroform, and chloroform. The DNA was precipitated and washed with 
ethanol, and then resuspended in TE buffer. Genomic DNA (100 jig/mi) was heated at 
100°C for 10 mm, put on ice for 10 min and then used as template for PCR 
amplification using the following primers: Serpin.Gen F (AATATTGGCAATTCGCA 
ATTATCCTC, nt 1-26 of Bm-spn-2 cDNA) and BmSerpin F2 (ACGGTAGCGACA 
CCGCTTGC, nt 780-761); or BmSerpin.R2 (GGAGCCCGTAATATCGCTGGC, nt 
564-584) and Serpin.Gen R (AAATTAATGCATIITIIATTCAACATCA, nt 1418- 
1391). The PCR reactions were 94 °C for 5 mm, and 30 cycles of 94 °C for 40 sec, 
55°C for 40 see, 65 °C for 2 mm; with a final 10-min extension period at 65 °C. The 
resulting products (Serpin.Gen FlBmSerpin F2, 1 524-bp; B mSerpin.R2/Serpin. Gen 
R, 1456-bp) were purified and subcloned into pMOSBlue T-vector. At least four 
independent clones of each target fragment were picked and sequenced. Introns and 
exons were identified by comparing genomic sequence and eDNA sequence. 
The Bm-spn-2 gene spanned 2572 bp (Fig. 5.2), and on comparison to the 
eDNA sequence, was found to consist of 7 exons and 6 introns with the intronlexon 
boundaries conforming to the normal pattern (exon/GT ...AG/exon) of splice acceptor 
and splice donor sites. Intron lengths were remarkably uniform, varying from 182 to 
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Figure 5-2. 	Sequence (A) and schematic (B) of the gene structure of Bm-spn-2. 
The gene spans 2.7 kb, and is split into 7 exons and 6 introns (lowercase and italic) as 
depicted. The nucleotide sequence has been deposited in GenBank with the accession 
number AF009826. Primers used in PCRs or sequenceing are indicated with solid 
arrow: Serpin.Gen F (bp 1-26), Serpin.G1 (bp 309-335), Serpin.G2 (bp 1124-1106), 
Serpin G3 (bp 1505-1523), and Serpin.Gen R (bp 2572-2545). 
A comparison was made between Bm-spn-2 and the 12 genes (macrophage 
migration inhibitor factor, microfilarial sheath protein 2 and 3, heat shock protein 70, 
GP29, glia maturation factor, myosin heavy chain, a2 (IV) basement membrane 
collagen, y-glutamyltransferase, 63 kDa antigen, actin) from B. inalayi for which full 
genomic sequence information is available in GenBank. These contained a total of 99 
exons and 86 introns, with each gene containing between 2 and 27 exons. The majority 
of both exons and introns range from 60 bp to 240 bp, with only 3/86 introns being 
smaller than 60 bp (Fig. 5-4). In this respect, Bm-spn-2 appears to be a typical B. 
malayi gene, in marked contrast to C.elegans in which more than half of introns are 
shorter than 60 bp (Blumenthal, 1997). Although other lower eukaryotes show a 
marked shift towards AT abundance in intronic sequences (Csank et al., 1990), the AT-
richness of exons in the 13 known B. malayi genes attenuates this effect. B. malayi 
exons and introns are 62% and 69% AT respectively, while the corresponding figures 
for C.elegans are 54% and 70% (Blumenthal, 1997). Although B. malayi introns 
conform to the GT-AG rule, in rare instances, GC or TT are used as 5' splice sites and 
AC used as 3' splice site (Table 1). B. malayi introns have an extended and conserved 
3' splice site consensus sequence, TTTCAG, in which the -5 position is T in 93% of 
cases (Table 1). 
5.2.4 Bm-spn-2 is a single copy gene. 
Genomic southern blottingwas done to determine the copy number of the Bm-
spn-2 gene in the genome. Amplification of a B. malayi genomic fragment was 
performed by PCR using genomic DNA and gene-specific primers BmSerpin.R2 and 
BmSerpin F2. A 408 bp PCR product, spanning exon 4, intron 4 and exon 5, was 
32P-labelled by random hexanucleotide priming and then used as a probe. 5 j.tg of B. 
malayi genomic DNA was digested with BamH I, EcoRI, Xba I, and Xho I. 
Digested DNA was fractionated on a 0.8% agarose gel, transferred to nylon 
membranes, hybridized with 32P-labelled probe, and then autoradiographed at -70 °C. 
B. malayi genomic DNA digested with each of these restriction yielded single bands 
that hybridized with the 32P-labelled probe (Fig. 5-3), suggesting that Bm-spn-2 is a 
single copy gene. 
M. 
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Figure 5-3. Southern blot analysis of B. malayi genomic DNA. B. 
malayi genomic DNA (5 jig) was digested with the indicated restriction endonuclease 
for 24 h, electrophoresed, blotted and probed with a 32P-labelled probe. The 408 bp 
proble was a PCR product using genomic DNA and gene-specific primers 
BmSerpin.R2 and BrnSerpin F2, spanning exon 4, intron 4 and exon 5. Lane 1, 
BamH I; lane 2, EcoR I; lane 3, Xba I; lane 4 Xho I. Molecular sizes in kb shown 
on the left. 
IMMKI  
Intron/exon boundaries of 13 B. malayi genes so far characterized. The 
survey included 99 exons and 86 introns. Splicing occurs at the vertical lines. Positions 
are numbered with respect to the splice sites, and figures represent the percentage of 
each nucleotide at each position. 
5' splice site 
Base -3 -2 -1 +1 +2 +3 +4 +5 +6 
G 23 7 62 99 0 13 6 50 7 
A 41 65 15 0 0 58 53 14 14 
T 7 10 17 1 98 26 29 27 70 
C 29 18 6 0 2 3 12 9 9 
3' splice site 
Base -6 -5 -4 -3 -2 -1 +1 +2 +3 
G 2 1 12 1 0 99 57 23 21 
A 7 3 23 6 100 0 24 26 30 
T 82 93 52 38 0 0 10 25 32 
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Figure 5-4. Length distribution of exons and introns of all 13 B. malayi genes so 
far characterized for which full genomic sequence information is available in GenBank. 
The survey included 99 exons and 86 introns. Each bar represents the number of exons 
and introns in each size class. The majority of both exons and introns range from 60 bp 
to 240 bp. 
KC 
5.2.5 Mf-specific abundant transcription of Bm-spn-2 gene 
The stage-specificity of Bm-spn-2 expression was first investigated by PCR 
from a range of B.malayi cDNA Libraries. Two Bm-spn-2 gene-specific primers, 
BmSerpin Ri (GCCAGAAGTGAAACTGAGCG, nt 261-280 in Fig 5-1) in exon 2 
and BmSerpin F2 in exon 5, were designed to amplify a 520 bp region of cDNA. PCRs 
were carried out on 1 p1 aliquots of each cDNA library from B. malayi L3, adult 
males, adult females and Mf, with two primers. 40 cycles of amplification were 
performed under the following cycling conditions: 94 °C for 1 mm, 50°C for 1 min and 
72°C for 50 sec. Transcription of Bm-spn-2 was found to be restricted to the MI stage 
(Fig. 5-5). The identity of a 520 bp PCR product from the Mf cDNA library was 
confirmed by sequencing. 
RT-PCR was then done. Total RNA from L3, adult males, adult females and 
Mf was isolated and reverse transcription was carried out using oligo(dT) as the first 
primer with 1 ig of total RNA according to the GeneAmp RT-PCR kit protocol. 
Amplification of Bm-spn-2 cDNA was performed using 1 p1 of first strand cDNA, 
with the gene-specific primers BmSerpin Ri and BmSerpin Fl. This generated a 
product of the expected length (916 bp) only in Mf-stage (Fig 5-6). 
Parallel PCRs were carried out with primers specific for another B.malayi 
gene, tumour protein homologul-1 (tph-1), which is known to be expressed in all 
stages (Gregory et al., 1997). Primers for the tph-1 used published sequence : 5'-
AATGTTGATCTTCAAGGGATGCATTCAC-3' and 5-TTTGTTTTTCTTCAATGA 
GTGCCTCCTT-3'. A tph-1-specific 575 bp band was found in all four cDNA 
expression libraries, and in all RNA preparations from the four stages. 
The absence of a Bm-spn-2 product in the adult female implies that embryonic 
Mf within the uterus do not transcribe this gene. In this respect, Bm-spn-2 differs quite 
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Figure 5-5. 	Transcription of Bin-spn-2 at different development stages of B. 
na1ayi tested by library PCRs. Four stage-specific cDNA expression libraries from L3, 
Mf, adult males (lane M) and adult females (lane F) were used as templates to amplify a 
520 bp fragment from Bni-spn-2 or a 575 bp fragment from B. inalayi tph-1. 
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Figure 5-6. Transcription of Bin-spn-2 at different development stages of B. maiayi 
tested by RT-PCR. RNAs isolated from L3, Mf, adult males (lane M) and adult females 
(lane F) were processed to obtain double-stranded cDNA. The cDNAs were then used 
as templates to amplify a 916 bp fragment from Bm-spn-2 or a 575 bp fragment from 
B. inalayi tph-1. 
To date, the Filarial Genome Project has sequenced a total of approximately 
14,351 expressed sequence tags (ESTs), including 2,334 ESTs from Mf. Of these, 49 
ESTs corresponded to Bm-spn-2 , all of which were isolated from the MI cDNA 
library. This suggests an abundance level of 2.1% of Mf mRNAs. These data are 
consistent with our PCR results and confirm that Bm-spn-2 is an unusually highly 
expressed transcript in the Mf stage. 
A trans-spliced leader (SL) primer and a reverse primer in exon 5 were designed 
for PCR using the Mf cDNA library or first-strand cDNA from MI as templates. Even 
after 40 rounds of amplification, no band was detected in ethidium-stained gels (data 
not shown), suggesting that Bm-spn-2 mRNA is not trans-spliced. This forms another 
contrast to Bm-spn-1, which is known to contain the spliced leader sequence in its 
mRNA (Yenbutr and Scott, 1995). 
5.2.6 Homology with other serpins 
The GCG program PILEUP and BOXSHADE were used to carry out multiple 
alignments of Bm-SPN2 and other serpins. The amino acid sequence of Bm-SPN-2 
shows a low level of overall identity with the other identified serpins, at the level of 20-
26%. However, certain characteristic features of serpins are evident, and of the 51 
residues identified as highly conserved within the serpin superfamily (Huber and 
Carrell, 1989), 33 are identical in Bm-SPN-2 and several more show conservative 
substitutions (Fig. 5-7). Figure 5-7 compares Bm-SPN-2 with 5 known serpins, 
namely human al-antitrypsin ((Xl-AT) (Huber and Carrell, 1989), human squamous 
cell carcinoma antigen 1 (SCCA1) (Schneider et al., 1995), C.elegans serpin (Ce-spn) 
(Wilson et al., 1994), chicken ovalbumin-like gene Y protein (Gene Y) (Heilig et al., 
1982), and mouse proteinase inhibitor 3 (SPI3) (Sun et al., 1995). 
The 'serpin signature' of FRANHPFLYAI (aa 377-387, Fig. 5-7) corresponds 
well to that, for example, of chicken gene Y, FRADHPFLFFI. The 'serpin motif' or 
hinge is less well conserved, with only E353 and G355 conforming to the consensus. 
Between these two motifs is the reactive site loop of serpins, a stretch of approximately 
14 amino acids containing the cleavable bait attacked by proteases. Serpin sequences 
here show extensive variation (Loebermann et al., 1984; Sun et al., 1997), and Bm-
SPN-2 is dissimilar to any known serpin in this region. Other novel structural features 
of Bm-SPN-2 include the absence of a highly conserved dipeptide Ile-Asn from within 
helix F, and the proximity of a potential N -glycosylation site between the serpin motif 
and the reactive loop. Most interestingly, of all 93 serpin sequences deposited in public 
databases, Bm-SPN-2 is one of the largest and has longest C-terminus of any other 
than antiplasmin (Huber and Carrel!, 1989). All of these features would be more clearly 
understood in the light of a structure for the protein. The three dimensional structures 
of serpins such as al-AT (Mottonen et al., 1992), PM-i (Carrell et al., 1994) and 
antithrombin ifi (Goodall and Filipowicz, 1989) have been solved and these provide a 
useful framework for analysing other members of the superfamily. 
At the level of gene structure, Bm-spn-2, which contains 6 introns, also made 
an interesting comparison with five other serpin genes (Fig. 5-8). Introns E and F of 
Bin-spn-2 are positioned exactly as introns C and D in Ce-spn, supporting a close 
relationship between the nematode genes, but no vertebrate serpins contained introns at 
the same point. The genes for chicken Gene Y protein, murine SPI3 and human 
SCCA1 had 5 identical intron positions, but these were not found either in the 
mammalian a 1-AT gene or in either of the nematode sequences. 
5.2.7 Phylogenetic analysis 
A comprehensive search of GenBank, Protein Identification Resource and 
SWISS-PROT databases, identified a total of 93 members of serpin superfamily. Of 
these, 62 are vertebrate (mainly mammalian), and 11 are from invertebrates including 
insects, crayfish, horseshoe crabs, and nematodes. 5 are from plants and 15 from 
viruses. 
A phylogenetic comparison of all invertebrate serpins was carried out using 
PAUP, using maximum parsimony, excluding constant, and uninformative sites, to 
indicate the likely evolutionary relationship of Bm-spn-2 to known genes (Fig. 5-9). 
This analysis divides invertebrate serpins into two groups (91% bootstrap confidence): 
group I comprising serpins from Tachypleus tridentatus (horseshoe crab); and group II 
containing serpins from B.malayi, C.elegans, Bombyx mon (Silkworm), Manduca 
sexta (tobacco hornworm), and Pacfastacus leniusculus (signal crayfish). Within the 
latter group, Bm-spn-1 and Ce-spn form a subgroup which is quite distant from Bm-
spn-2. 
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Figure 54. Amino acid sequences comparison of Bm-SPN-2 with other serpins: 
Human al-antitrypsin (al-AT), C.elegans serpin (Ce-spn), chicken gene Y protein 
(Gene Y), mouse proteinase inhibitor 3 (SPI3), human squamous cell carcinoma 
antigen 1 (SCCA1). The alignment of amino acid sequences using PILEUP and 
BOXSHADE programs was based on the al-AT crystal structure and manually 
adjusted to give the best fit. Gaps were introduced in sequences for optimal alignment. 
The 	al-AT 	sequence 	is 	given 	without 	the 	signal 	sequence 
(MPSSVSWGILLLAGLCCLVPVSLA). Identical residues are highlighted in black 
and similar residues in gray shading. The 51 star bars indicated residues categorized as 
conserved in the larger serpin superfamily. The scissile bond is marked with an arrow. 
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Figure 5-8. Intron/exon positions comparison of Bm-SPN-2 with other serpins: 
Human oti-antitrypsin (al-AT), C.elegans serpin (Ce-spn), chicken gene Y protein 
(Gene Y), mouse proteinase inhibitor 3 (SPI3), human squamous cell carcinoma 
antigen 1 (SCCA1). Thick lines indicate coding regions; thin lines indicate 
untranslated regions; and gaps have been introduced to optimise alignment; arrows 
marked by uppercase letters indicate positions of introns. Sequences were aligned on 
the basis of amino acid similarity with the scale showing amino acid positions 
beginning with the first methionine of Bm-SPN-2. Introns are shaded according to 
their phase: open (phase 0), shaded (phase 1); solid (phase 2). Vertical lines connect 
introns considered to be in identical positions. 
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Figure 5-9. 	Phylogenetic trees showing the relationship between the predicted 
protein encoded by Bm-spn-2 and other all recorded invertebrate serpins. Numbers 
above branches show the percentage bootstrap support for each dade. GenBank, 
Protein Identification Resource and SWISS-PROT accession numbers of the sequences 
used were as follows: T. tridentatus intracellular coagulation inhibitor 2, A55533; 
T.tridentatus intracellular coagulation inhibitor, TATLICI; Bm-spn-1 (Bm-SERPIN), 
BMU04206; Ce-spn (C.elegans serpin), U50301; B. mori antitrypsin, BMOSWAT; B. 
mori antichymotrypsin II, P80034; M. sexta serpin-1, MSU58361; M. sexta serpin-2, 
MSU79 184; B. mori antichymotrypsin, BMOANTICT; P. leniusculus proteinase 
inhibitor II, PLPAPI2; Bm-spn-2, AF009825. 
5.3 DISCUSSION 
Most serpin family members so far characterized are from mammals, insects and 
viruses. Although a few serpin cDNA sequences have been reported from helminth 
parasites (Blanton et al., 1994; Yenbutr and Scott, 1995), only in the free-living 
nematode C. elegans has the genomic sequence of a serpin been determined (Wilson et 
al., 1994). This chapter describes the isolation and characterization of a new serpin 
gene, Bm-spn-2 , from the human lymphatic filarial nematode B. malayi. The Bm-spn-2 
gene, which appears to be a single copy in the genome and consists of seven exons, 
was found to be highly and specifically expressed by the Mf stage. 
The two serpins that have been found in B. malayi, Bm-spn-1 and Bm-spn-2, 
are quite different. They share low homology, and are not closely related as shown by 
phylogenetic analysis. Bm-spn-1 is expressed in most life stages whereas Bm-spn-2 is 
expressed only in the Mf stage. Most nematode mRNAs have at their 5' end a short 
sequence which is not contiguously encoded in the genome. This leader sequence is 
trans-spliced on to the 5' end of primary transcripts during the maturation of the .pre-
mRNA (Blaxter and Liu, 1996). However, Bm-spn-2 mRNA does not contain SL 
although Bm-spn-1 does contain SL. At present, the gene structure of Bm-spn-1 is not 
available. It will be of interest to compare the gene structure, chromosome position and 
physiological roles of these two serpins. Genes that are expressed in a stage-specific 
manner have important functional roles in the parasite life cycle, and thus may provide 
targets for the development for novel immuno- or chemoprophylactic agents. It is 
significant that Bm-spn-2 is an abundant transcript restricted to the Mf stage, and the 
presence of a putative signal peptide (amino acids 1-20) indicates that the mature 
protein could be released as a secretory product to perform some function in parasite 
survival. In several systems, serpins from infectious organisms have been identified as 
factors which help infectious organisms to evade the host defence system (Kettle et al., 
1997; Leid et al., 1986; Ray et al., 1992; Stassens et al., 1996). In Chapter 7 further 
data presented which show that Bm-SPN-2 inhibits two human neutrophil-derived 
serine proteinases, cathepsin G and elastase, thus indicating a fascinating link between 
host enzyme and parasite inhibitor. 
Recent studies on human serpins shown that some serpin genes were clustered 
on chromosomes. For example, proteinase inhibitor 5 (P15, maspin), squamous cell 
carcinoma antigen 1 (SCCA1), squamous cell carcinoma antigen 2 (SCCA2), 
plasminogen activator inhibitor type 2 (PAI2), proteinase inhibitor 10 (bone marrow-
associated serpin) (P110, bomapin) and proteinase inhibitor 8 (cytoplasmic 
antiproteinase 2) (P18) are grouped in a 500 kb cluster region within 18q21.3 on 
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human chromosome 18 (Bartuski et al., 1997; Silverman et al., 1998), while proteinase 
inhibitor 2 (P12), proteinase inhibitor 6 (P16) and proteinase inhibitor 9 (cytoplasmic 
antiproteinase 3) (P19) are clustered within 6p25 on human chromosome 6 (Bartuski et 
al., 1997; Eyre et al., 1996). Thus, it would be interesting to see if Bm-spn-] and Bm-
spn-2 are also clustered on the same B.malayi chromosome. 
The serpin gene family predates the common ancestor of nematodes, arthropods 
and chordates, and may consequently be over 1200 million years old (Wray, 1996). 
Based on vertebrate serpin gene organization, it has been proposed that the ancestral 
gene would have had a large number of introns, and that modern serpin genes derived 
from this by duplication have undergone varied intron deletion (Strandberg et al., 
1988). This model, consistent with the general "introns-early" hypothesis (Gilbert et 
al., 1997) contrasts with a gain-and-loss explanation, which would envisage an 
ancestral serpin gene with between zero and three introns. A comparison of the 
intron/exon structure of Bm-spn-2 with five other serpins, shows sets of introns 
found only in nematode genes and others present only in vertebrate genes. Several 
serpin genes also possessed unique introns. Under the 'introns early' mechanism, the 
ancestral serpin gene would have needed nearly 20 introns to account for the pattern 
observed in just 7 extant genes. It seems therefore that intron gain-and-loss is a more 
likely explanation of serpin gene evolution, as postulated for other gene families 
(Stoltzfus et al., 1994). We hope that, as more genes encoding serpin become available, 
the serpin family can be divided into subgroup on the basis of gene organization and 
position, and this may provide alternate way to advance our fundamental knowledge of 
evolutionary relatedness. 
The serpins are a family of proteins widely distributed throughout the animal 
and plant kingdom and possessing a diverse range of functions. Despite the 
evolutionary distances among serpins and their different functions, the overall serpins 
structure appears highly conserved. The serpin superfamily has been constructed on the 
basis of sequence similarities at the protein level (Marshall, 1993). All members of the 
serpin superfamily are thought to share a common highly ordered tertiary structure, 
defined by X-ray diffraction for the prototype molecule al-AT (Huber and Carrell, 
1989; Loebermann et al., 1984), which consists of nine (X-helices and three n-sheets. 
Although the predicted amino acid sequence of Bm-SPN-2 has a low overall homology 
to the sequences of serpins from other species, its sequence is identical or conserved at 
most of the characteristic amino acid positions. The 'serpin signature' which includes 
the hinge distal to the reactive loop is, for example, well conserved. However, analysis 
of the 'serpin motif' (in the proximal hinge) is ambiguous. Two residues in Bm-SPN-2 
(E353 and G355) are those found in 100% of functional serpins (Hopkins and 
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Whisstock, 1994). Few of the other residues in Bm-SPN-2 follow the consensus for 
small nonpolar sidechains, thought to be necessary to allow the conformational change 
associated with inhibitory function (Hopkins and Whisstock, 1994; Stein and Carrell, 
1995). Further work will establish whether the consensus sequence requires re-
definition in the light of phylogenetically removed genes such as those from nematodes 
and trematodes (Blanton et al., 1994). 
Analysis of the 13 B. malayi genes including a total of 99 exons and 86 introns 
for which complete sequence is available in GenBank, showed the Bm-spn-2 was 
typical of this set. Compared with the nematode model C.elegans (Blumenthal, 1997) 
B. malayi genes have relatively large introns with majority from 60 bp to 220 bp and 
from 300 bp to 340 bp. The reason for this uneven distribution is unknown, but it may 
reflect some constraint imposed by splicesome formation. In fact, in C. elegans, it is 
suggested that recognition of short and long introns may not be identical processes. 
Furthermore, an analysis of information content of short and long introns of C.elegans 
showed that they were significantly different at both splice boundaries. It is also worth 
noting that B.malayi genes have relatively large introns compared with some other 
organisms, for example, Schizosaccharomyces pombe introns have a median length of 
63 bp; introns in the flatworm, Schistosoma mansoni, are 31-42 bp long; Paramecium 
introns all seem to be between 20 and 30 bp in length; and Drosophila introns show a 
sharp distribution around a medial length of 63 bp. Like C.elegans, the introns in 
B.malayi are markedly AT-rich. This is a property shared with introns of other 
invertebrates and plants (Csank et al., 1990; Goodall and Filipowicz, 1989) but not 
mammals, possibly related to effective recognition and splicing of introns (Goodall and 
Filipowicz, 1989). In plants, AT-richness has been demonstrated to represent an 
important aspect of intron recognition: insertion of an AT-rich sequence without splice 
sites into an exon has been shown to result in splicing of the inserted sequence utilizing 
fortuitous matches to the splice site consensus sequences present in the surrounding 
exon. In C.elegans, AT-richness has also been shown to be an important feature of 3' 
splice site recognition. It is interesting to note that B. malayi introns have an extended 
and conserved 3' splice site in which T at -5 position is very highly conserved, a feature 
noted previously only in C.elegans (Blumenthal, 1997). In contrast, introns from most 
other organism have only a combination of an upstream polypyrimidine tract and a 
YAG consensus at their 3' boundaries. This suggests that the 3' intron boundary may 
be a more important element in B. malayi intron recognition than in most other 
organisms. B.malayi exons are most frequently about 60-240 bp in length, similar to 
C.elegans exons and vertebrate exons. However, some of B.malayi exons can be 
much longer. Unusually, the exon sequences in these 13 B. malayi genes are also AT-
rich, much more so than C.elegans exons, and no explanation is yet available for this 
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finding. We hope that, as more genomic sequences become available from the filarial 
genome project, we will know more B.malayi gene organizations and positions to 
advance our fundamental knowledge of evolutionary relatedness. 
One of the remarkable features of the Mf stage of B.malayi is its longevity (>1 
year in the bloodstream), testimony to the effectiveness of immune evasion by this 
parasite. The survival of Mf provides a reservoir of infection in an endemic 
community, but also a clear target for intervention. Bm-SPN-2 seems an important 
component of parasite survival strategies, so it may prove to be an equally appropriate 
target for vaccination or pharmaceutical attack in order to clear infection both from 
afflicted individuals and endemic communities. 
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Chapter 6 
Overexpression and purification of Bm-SPN-2 and its three 
fragments from E.coli and identification of native Bm-SPN- 
2 from B.malayi microfilariae 
6.1 Introduction 
The serpins are a large family of single chain molecules with a wide distribution 
in taxa as diverse as vertebrates, insects, plants, viruses and nematodes (Marshall, 
1993; Potempa et al., 1994). They participate in the regulation of proteinase-activated 
physiological and pathological processes. Some serpin-related proteins have lost 
detectable inhibitory activity but have evolved other novel functions (Bajou et al., 1998; 
Stefansson and Lawrence, 1996). However, to date, no function of any serpin gene 
from nematodes has been reported although identification of homologues in the free-
living model C. elegans makes direct functional analysis more possible (Wilson et al., 
1994). 
Genes that are expressed in a stage-specific manner have important functional 
roles in the parasite life cycle. In Chapter 5 we showed that the Bm-spn-2 gene is 
abundantly transcribed (2.1% of Mf mRNAs) and restricted to the Mf stage, indicating 
that the Bm-SPN-2 protein could perform a key function in parasite survival. To 
further explore possible biological functions and immunological properties of Bm-SPN-
2, the work described in this Chapter aimed to express and purify sufficient quantities 
of soluble native form Bm-SPN-2. 
A number of systems for expressing functional serpins from different species 
have been developed over the past few years: 1) The E.coli expression system. This 
system has been used for expressing functional serpins such as human squamous cell 
carcinoma antigen 2 (SCCA 2) which inhibits cathepsin G and mast cell chymase 
(Schick et al., 1997), insect tobacco hornworm serpins which inhibit some mammalian 
serine proteinases (Jiang and Kanost, 1997), and plant serpins which show inhibitory 
activity against trypsin and chymotrypsin (Dahl et al., 1996); 3) The baculovirus 
expression system, in which baculovirus infects and multiplies in cultured insect cells. 
For example, a factor Xa-directed anticoagulant from the Yellow fever mosquito was 
expressed in Hi-5 cells by the baculovirus expression system, and the purified 
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recombinant protein showed anticoagulant activity against factor Xa (Stark and James, 
1998); 3) An in vitro coupled transcription/translation system. For example, mouse 
serpin proteinase inhibitor 6 (SPI6) protein was produced in a coupled TNT m Wheat 
Germ Extract system and found to be a granzyme B inhibitor (Sun et al., 1997). 
The E.coli system was selected to first test expression of Bm-SPN-2 and, as 
described in this chapter, this proved successful. This relatively simple technique has a 
number of advantages including cost and time efficiency, allowing the production of 
relatively large quantities of recombinant proteins. More importantly, a number of 
biologically active serpins, from divergent species, have been produced using this 
system (Dahl et al., 1996; Jiang and Kanost, 1997; Schick et al., 1997). The pET 
system, one of the most powerful systems developed for the cloning and expression of 
recombinant proteins in E.coli, was used to express the Bm-SPN-2 fusion protein. The 
Bm-SPN-2 fusion protein was constructed to contain a 6xHis affinity tag, which is 
small and poorly immunogenic, and which facilitates binding to Ni 2 -NTA. In most 
other proteins studied the 6xHis tag does not interfere with the structure or function of 
the purified protein, including a wide variety of enzymes, transcription factors, and 
vaccines. Although the overexpressed Bm-SPN-2 was only partially soluble, sufficient 
soluble protein was produced for the studies described in this thesis. 
In Chapter 5 we showed, by RT-PCR, that the transcription of Bm-spn-2 gene 
was seen only in Mf stage. In this chapter, murine antisera against recombinant Bm-
SPN-2 were raised and Western blotting performed to analyse Bm-SPN-2 expression at 
the protein level in each stage of the life cycle. 
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6.2 Results 
6.2.1 Construction of Bm-spn-2/pET-29 expression vector 
The prokaryotic expression vector pET-29 T was employed to express the Bm-
spn-2 ORF as a translational fusion in E.coli. The pET-29 T vector is designed for 
inducible, high level intracellular expression of genes as fusions with N-terminal STag 
and C-terminal His -Tag. The fusion protein containing a six histidine tag allows 
efficient, one step purification of fusion protein on a Ni 2 -NTA affinity resin column 
under both native and denaturing conditions. The pET-29 T vector contains a single 3'-
T overhang on both ends at the insertion site which greatly improves the efficiency of 
PCR product ligation into the plasmid. Ligation takes advantage of the template-
independent addition of a single A to the 3'-end of PCR products by Taq polymerase. 
Primers Serpin-Exp.F (CAACAGTAC1TITAAACCATT'GTTCTG) and 
Serpin-Exp.R (CTAACCTTTGTCTTFTTTT'CGGTGTTTCC) were designed for 
amplification and sub-cloning of the Bm-SPN-2 mature protein. Primer Serpin-Exp.F 
corresponds to bases 87-111 of the Bm-spn-2 cDNA and primer Serpin-Exp.R is 
complemention to bases 1283-1310. Both primers contain an additional 5' nucleotide 
for insertion and in frame expression with the pET-29 T-vector. Primers Serpin-Exp.F 
and Serpin-Exp.R were employed in the PCR reaction using the MI cDNA library as 
template. The resulting PCR product of 1.2-1.3 Kb was gel purified and then ligated 
into pET-29 T-vector in the presence of T4 DNA ligase overnight at 16°C. Competent 
E. co/i XL- 1-Blue cells were then transformed and allowed to grow overnight on Amp-
Kan plates. Colonies containing the Bm-spn-2 sequence were selected by PCR 
screening. DNA from positive colonies were prepared by miniprep and then examined 
by DNA sequencing to confirm that the cloned DNA was correct. Fig 6-1 shows the 
protein sequence and schematic. 
6.2.2 Expression of Bm-SPN-2 protein in E.coli 
The positive Bm-spn-2/pET-29 construct was transformed into the E.coli strain 
BL2 1 (DE3). 10 ml of LB containing kanamycin was innoculated with a single 
transformed colony and grown overnight at 37°C. The following day these cultules 
were diluted 200-fold in LB containing kanamycin and incubated at 37°C for 60-180 
mm. Cultures were then induced with 1 mM IPTG for 5 h at 37°C . Protein expression 
was analysed by SDS-PAGE. 
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AGGCGCAAATGAATTTCGCATTGGAACTATTGCGCTATTCTTCGCAACCTGATG.CC 
L 	L 	S 	P 	F 	A 	I 	A 	S 	V 	N 	S 	L 	L 	Y 	S 	G 	A 	R 80 
CGCTATTATCGCCATTTGCAATCGCTTCCGTAATGTCATTATTATATGA.GGAGCCAGA 
S 	T 	E 	R 	E 	N 	G 	R 	V 	L 	S 	A 	D 	Q 	P 	K 	N 	A 	F 100 
GTGAAACTGAGCGTGAGATGGGGAGGGTGCTTTCAGCAGATCAACCAAkTGCATTT 
A 	Y 	I 	E 	C 	A 	I 	K 	N 	I 	H 	K 	Q 	S 	K 	R 	N 	D 	Y 120 
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CCCGTAATATCGCTAGCATCACTTCCACTCAGTCATTAAACTTATTTAATGGAATACAT 
T 	D 	D 	W 	N 	Y 	S 	F 	L 	P 	L 	N 	H 	I 	L 	P 	F 	Y 	S 220 
TCACTGATGATTGGATGTACGAATTTCTTCCGCTCAATCACATATTACCGTTCTATTCA 
R 	L 	R 	V 	T 	D 	N 	P 	M 	M 	E 	R 	T 	A 	K 	F 	P 	Y 	Y 240 
CACGGCTACGTGTAACTGATATGCCAATGATGGAAAGAACGGCCAAATTTCCTTACTAT 
N 	Q 	H 	N 	Q 	A 	V 	S 	L 	P 	F 	K 	D 	S 	E 	M 	Q 	N 	L 260 
AAAACCAACACATGCAAGCGGTGTCGCTACCGTTCAAAGATTCCGAAATGCAAATGTTA 
I 	L 	P 	K 	K 	T 	F 	D 	L 	A 	K 	F 	E 	D 	K 	L 	T 	G 	5 280 
TTATTTTGCCCAAAAAAACCTTTGATCTAGCAAAGTTTGAAGATAAACTTACGGGAGAG 
L 	F 	S 	Y 	I 	S 	A 	L 	D 	S 	S 	H 	E 	I 	T 	V 	T 	I 	P 300 
AACTATTCAGTTATATTAGTGCACTTGACTCATCTCACGAAATTACCGTTACAATTCCA 
F 	K 	Y 	E 	N 	Q 	I 	C 	L 	L 	N 	G 	L 	K 	R 	M 	G 	V 	Q 320 
ATTTAAGTACGAAAATCAAATATGTTTGTTAAATGGATTGAAGAGGATGGGAGTGCAA 
- 	Bm-SPN-2-3F 
B rn-s pR- 2-2 R 
N 	F 	H 	E 	S 	N 	D 	F 	S 	G 	I 	F 	E 	Q 	R 	L 	F 	T 	N 340 
AATGTTCCACGAATCGAATGATTTTTCCGGCATTTTTGAGCAGCGGTTATTTACAATG 
D 	I 	R 	N 	H 	A 	Y 	I 	K 	I 	D 	E 	K 	G 	I 	N 	N 	S 	N 360 
TGATATCAGAAATCATGCTTATATCAAAATTGATGAGAAAGGAATCAATAACGAAAAT 
S 	M 	P 	V 	R 	N 	D 	M 	V 	M 	D 	K 	G 	E 	A 	F 	R 	A 	N 380 
AAGTATGCCAGTAAGAAATGATATGGTAATGGATAAAGGAGAAGCATTTCGTGCTAAT 
P 	F 	L 	Y 	A 	I 	I 	D 	N 	I-i 	G 	T 	V 	L 	W 	I 	G 	R 	F 400 
TCCCTTCCTTTATGCAATCATTGATAACCACGGGACTGTACTATGGATTGGTCGTTTC 
G 	K 	N 	R 	E 	T 	I 	V 	E 	N 	S 	D 	D 	S 	M 	Q 	C 	E 	E 420 
CGGAAAAAACAGAGAAACAATTGTCGAAAACTCGGATGACTCTATGCAATGTGAGGAA 
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Figure 6-1. 	The sequence (A) and schematic (B) of Bm-SPN-2 protein and its 
three fragments used to construct fusion proteins. Primers Serpin-Exp.F and Serpin-
Exp.R were used to PCR amplify the open read frame of Bm-pn-2 and subcloned into 
pET-29 T-vector. Three overlap fragments F1/Bm-SPN-2 (aa 21-177), F2/Bm-SPN-2 
(aa 167-306), F3IBm-SPN-3 (aa 296-428), were also PCR amplified using primers 
Bm-SPN-2-1F and Bm-spR-2-1R, Bm-SPN-2-2F and Bm-spR-2-2R, Bm-SPN-2-3F 
and Bm-spR-2-3R, respectively, and then subcloned into pET-15b vector. 
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In order to increase the proportion of soluble protein available for use in 
biological function studies, several variables which might effect the solubility of the 
protein were considered. The effects of temperature, IPTG concentration, detergent and 
length of induction time on the Bm-SPN-2 solubility were each investigated. The cells 
produced more soluble protein when expression was induced at 25-30°C than 37°C; 
changing the IPTG concentration from 0.5 mM to 2.0 mM or adding 1% Triton-100 
into the cell lysate had little effect on the amount of soluble protein. Increasing induction 
time from 3 h to 5 h, resulted in a small decrease in soluble protein obtained from the 
same amount of cells, however, the total yield of soluble protein per unit volume of 
culture increased due to the increased cell density. Fig 6-2 shows that a significant 
minority of the recombinant Bm-SPN-2 soluble while the remainder was insoluble. 
6.2.3 Purification of Bm-SPN-2 protein 
Purification of Bm-SPN-2 protein was first performed according to the 
Novagen pET System Manual. Pellets from 1000 ml cultures of expressed protein were 
lysed by sonication in binding buffer. Following centrifugation, the cell-free extract 
containing soluble protein was applied to a Ni 2 -NTA affinity resin column which was 
then washed with binding buffer and wash buffer. The bound Bm-SPN-2 protein was 
eluted with elution buffer and then dialysed against PBS or water overnight at 4°C to 
remove the imidazole. Unfortunately, almost all Bm-SPN-2 protein precipitated under 
these conditions, rendering the standard purification protocol unsuitable for purifying 
Bm-SPN-2. 
A new protocol was therefore developed as described in detail in chapter 2, 
modified from Holzinger's protocol (Holzinger et al., 1996), to purify soluble Bm-
SPN-2. The cell-free extract containing soluble protein was applied to a Ni 2 -NTA 
affinity resin column, and the column then washed with binding buffer, wash buffer, 
and Tris-buffered saline (TBS, 150 mM NaCl; 20 mM Tris-HC1, pH 7.9). The bound 
Bm-SPN-2 protein was eluted with TBS containing 50 mM EDTA (TBSE) and then 
dialysed against TBS for 24-48 h at 4°C to remove the EDTA. Fig 6-3 depicts the 
different stages of protein purification, as visualised on a SDS-PAGE gel. 
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Figure 6-2. 	Soluble and insoluble Bm-SPN-2 recombinant protein expressed in 
E.coli. E.coli cells containing Bm-SPN-2/pET-29 were induced with 1 mM IPTG for 
5 h and lysed by sonicating in binding buffer. Following centrifugation, the cell-free 
extract containing soluble proteins (lane A) and insoluble pellet (lane B) were analysed 
by SDS-PAGE. The arrow marks the soluble Bm-SPN-2 recombinant protein band in 
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Figure 6-3. 	Purification of the Bm-SPN-2-His6-tag fusion protein from E.coii 
BL2 1 (DE3) cells with Ni 2 -NTA affinity chromatography. Coomassie blue-stained 
SDS-PAGE of BL21 (DE3) cells containing the Bm-SPN-2/pET-29 plasmid prior to 
(lane 1) and following (lane 2) IPTG induction. Purified Bm-SPN-2 protein is shown 
in lane 3. Lane M contained molecular mass standards as indicated on the left. 
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6.2.4 Expression of three fragments of Bm-SPN-2/pET-15 
The prokaryotic expression vector pET-15(b) vector was employed to express 
three overlapping fragments of the Bm-SPN-2 ORF as a translational fusion in E.coli. 
Like pET-29, the pET-15(b) vector is designed for inducible intracellular expression of 
fusion proteins containing a N-terminal His -Tag for one step purification on a Ni 2 - 
NTA affinity resin. A map of the 3 Bm-spn-2 constructs is shown in Fig 6-1. 
For in-frame cloning into the pET-15(b) vector, primers were synthesised as the 
following: forward primer Bm-SPN-2-1F (CGCGCATATGAACAGTACIII'AAA 
CCA) homologous to bp 87-103 of Bm-spn-2 cDNA, Bm-SPN-2-2F (CGCG 
CATATGATA1TFA1TAAATGGAT) homologous to bp 528-544, Bm-SPN-2-3F 
(CGCGCATATGG1TACAATTCCAAAATT) homologous to bp 915-931; reverse 
primer Bm-spR-2-1R (GCATATGYT'CATACITITClTFATCCA) homologous to bp 
557-540 of Bm-spn-2 cDNA, Bm-spR-2-2R (GCATATGTFAA1ThFTCGTACT 
TAAATFT) homologous to bp 944-927, Bm-spR-2-3R (GCATATGTTATFCAAC 
ATCATA1TI7) homologous to bp 1403-1386. All primers contains Nde I site 
(underlined) and Bm-spR-2- 1R and Bm-spR-2-2R contain stop codons. The DNA 
produced by PCR using primers Bm-SPN-2-1F and Bm-spR-2-1R was subcloned into 
the Nde I site of pET-15(b) to express fragment 1 of the Bm-SPN-2 (F1/Bm-SPN-2). 
Likewise, the Bm-SPN-2-2F/Bm-spR-2-2R product encoded fragment 2 of the Bm-
SPN-2 (F2/Bm-SPN-2), Bm-SPN-2-3FJBm-spR-2-3R encoded fragment 3 of the 
Bm-SPN-2 (F3/Bm-SPN-2). The fragments overlap by 10 amino acids: Fl 
corresponding to aa 21-177, F2 corresponding to aa 167-306, F corresponding to aa 
296-428. 
The positive constructs were examined by DNA sequence to confirm that the 
cloned DNAs were error-free, and then transformed into E.coli strain BL21 (DE3). 10 
ml of LB containing kanamycin was inoculated with a single transformed colony and 
grown overnight at 37°C. The following day samples were diluted 200-fold into LB 
containing kanamycin and grown at 37°C for 60-120 mm. Cultures were then induced 
with 1 mM IPTG for 3- 5 h. Protein expression was analysed by SDS-PAGE. As 
shown in Fig 6-4, F1/Bm-SPN-2, F2IBm-SPN-2 and F3IBm-SPN-2 recombinant 
proteins expressed very well in E.coli after IPTG induction although most of them 
remained in insoluble pellets even after urea buffer extraction. The three fragments of 
Bm-SPN-2 could be used for T cell epitope mapping in the furture. 
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Figure 6-4. 	Expression and solubility of three fragments of Bm-SPN-2 in E.coli. Three overlap fragments, F1IBm- 
SPN-2 (aa 21-177), F2/Bm-SPN-2 (aa 167-306) and F3/Bm-SPN-2 (aa 296-428) were subeloned into pET-15b and 
expressed induced by IPTG. Lanes 1, 6 and 11 show total cell extracts after induction and that expression was successful. 
Lanes 2, 7 and 12 show no fragment soluble in binding buffer; lanes 3, 8 and 13 indicate all in insoluble pellets. Lanes 4, 9 
and 14 show that only F3/Bm-SPN-2 is partly soluble in urea buffer; lanes 5, 10 and 15 indicate all F1/Bm-SPN-2, all 
F2/Bm-SPN-2 and most of F3/Bm-SPN-2 remain in insoluble pellets even after urea buffer extraction. Recombinant 
protein bands are arrowed. 
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6.2.5 Preparation of antibodies against Bm-SPN-2 fusion protein 
Recombinant Bm-SPN-2 protein was prepared for use as an antigen to raise 
antibodies. Six BALB/c mice were injected sub-cutaneously with 100 tg of purified 
recombinant protein, in a 1:1 ratio with incomplete Freunds adjuvant (IFA), while three 
BALB/c mice were injected sub-cutaneously with PBS and IFA (1:1) as a control. 
These mice were boosted at four and then at eight weeks after the initial immunization 
by intraperitoneal injection. The sera were collected at twelve weeks and tested by 
Western blotting to check for antibody responses. Blood samples were allowed to clot, 
centrifuged and the supernatant removed and frozen in aliquots at -70°C. 
BL21(DE3) E.coli cells containing the pET-291Bm-spn-2 plasmid after 3 h 
IPTG induction were prepared by resuspending pellets in denaturing SDS-PAGE 
sample buffer and boiling for 10 mm. Insoluble cellular debris was removed by brief 
centrifugation, and SDS-soluble proteins were separated by SDS-PAGE and transferred 
to nitrocellulose membranes. Blot strips were incubated with mouse antisera to 
recombinant Bm-SPN-2 protein, diluted 1/4000, and then with peroxidase-conjugated 
rabbit anti-mouse IgG. The bound antibodies were detected by chemiluminescence on 
addition of the luminol-based ECL substrate. 
Western blot analysis of anti-Bm-SPN-2 antisera showed that specific 
antibodies, had been raised in all six mice immunized with recombinant Bm-SPN-2. 
These sera bound the recombinant Bm-SPN-2 protein (Fig 6-5, lane 1-6); no reactivity 
was seen with three control mouse sera (Fig 6-5, lane 7-9). 
6.2.6 Identification of native Bm-SPN-2 protein 
Antibodies raised against purified recombinant Bm-SPN-2 showed high titres 
and good specificity as described in 6.2.5,and were further used to identify native Bm-
SPN-2 protein in B.malayi. 
Lysates of L3, adult males, adult females, Mf and BL21(DE3) cells containing 
the pET-29/Bm-spn-2 plasmid after IPTG induction were prepared by resuspending 
pellets in denaturing SDS-PAGE sample buffer and boiling for 10 mm. Insoluble 
cellular debris was removed by brief centrifugation, and SDS-soluble proteins were 
separated by SDS-PAGE and transferred to nitrocellulose membranes. Blot strips were 
incubated with mouse antisera to recombinant Bm-SPN-2 protein, diluted 1/4000, and 
then with peroxidase-conjugated rabbit anti-mouse IgG. The bound antibodies were 
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Figure 6-5. Western blotting analysis of mice sera against recombinant Bm-SPN-2 
protein. A group of six mice were each immunized with purified recombinant Bm-SPN-
2 in IFA and a group of three mice immunized with PBSIIFA as control. Sera were bled 
from individual mice after three immunizations and tested by Western blotting against 
lysate from E.coii expressing recombinant Bm-SPN-2 protein. Lane 1-6 shows that 
sera from immunized mice recognised Bm-SPN-2 protein (arrowed) while no reactivity 
was seen with three control mouse sera (lane 7-9). 
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detected by chemilurninescence on addition of the luminol-based ECL substrate 
(Ameshan). As shown previously, the Western blot showed that sera from mice 
immunized with recombinant Bm-SPN-2, bound the recombinant Bm-SPN-2 protein. 
These antisera also recognized a single endogenous Bm-SPN-2 protein from Mf 
proteins as antigens (Fig. 6.6, lane 2); no reactivity was seen with normal mouse sera. 
The native Bm-SPN-2 had an apparent molecular mass of 47.5 kDa. This result 
comfirrned the predicted molecular weight of the mature protein encoded by the Bin - 
spn-2 ORF. Western blot analyses were also performed with proteins from L3, adult 
males, adult females, but no reactivity was found (Fig. 5.6, lane 3-5). These data 
confirm that Brn-SPN-2 is expressed only in the Mf stage, which was in good 
agreement with the RT-PCR results described in 5.2.3. showing that the transcription 
of Bin-spn-2 gene is only found in Mf stage. 
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Figure 6-6. 	Native Brn-SPN-2 protein. Western blot of lysates of BL21(DE3) 
cells containing the pET-29/Brn-spn-2 plasmid after IPTG induction (lane 1), and 
extracts of Mf (lane 2), L3 (lane 3), adult males (lane 4), and adult females (lane 5) 
probed with mouse anti-recombinant Bm-SPN-2. Recognition of a 52 kDa band in lane 
1 and a 47.5 kDa band in lane 2 are arrowed. 
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6.3 Discussion 
Expression and purification of recombinant proteins is a standard technique in 
molecular biology, it facilitates production of proteins and allows detailed 
characterisation of virtually any protein. Recombinant DNA techniques permit the 
construction of fusion proteins in which specific affinity tags are added to the protein 
sequence of interest; the use of these affinity tags simplifies the purification of the 
recombinant fusion proteins by employing affinity chromatography methods. One of 
most effective expression and purification system is 6xHis tag expression, allowing the 
purification of proteins from less than 1% of the total protein preparation to more than 
95% homogeneity in just a single step (Janknecht et al., 1991). In this chapter Bm-
SPN2 was expressed and purified using a 6xHis tag system in the pET-29 vector, and 
three fragments, F1IBm-SPN-2, F2IBm-SPN-2 and F3/Bm-SPN-2, were also 
expressed using a similar system in pET-15b vector. 
Although a wide variety of heterologous expression systems, prokaryotic as 
well as eukaryotic, have been developed, the purification of the proteins obtained can 
still be problematic. Recombinant proteins expressed intracellularly in E.coli can be 
produced in soluble form, but in many cases, especially at high expression levels, are 
frequently aggregated and sequestered into insoluble inclusion bodies. It was found that 
Bm-SPN-2 was partly soluble in native conditions. Moreover, among the three 
fragments of Bm-SPN-2, only F3IBm-SPN-2 was partly soluble in denaturing 
conditions while the other two fragments were total insoluble even in 8 M urea buffer. 
It is believed that the intermolecular association of hydrophobic domains during folding 
plays a role in the formation of inclusion bodies. For proteins with cysteine residues, 
improper formation of disulphide bonds in the reducing environment of the E.coli 
cytoplasm may also contribute to incorrect folding and formation of inclusion bodies. 
At the moment, it is not clear why Bm-SPN-2 is partly soluble while all three 
overlapping fragments are totally insoluble under native conditions. 
Several factors, such as incubation temperature, expression level, IPTG 
concentrations, the genotype of E.coli strains and the carrier protein, are thought to 
affect the solubility of expressed fusion proteins. For the Bm-SPN-2 fusion protein, 
decreasing the induction temperature from 37°C to 25-30°C increased the amount of 
soluble protein recovered. Different concentrations of IPTG were used, but no obvious 
effect was observed. Another way to alter the solubility of expressed protein is by 
addition of mild detergent after cell lysis. The detergent is thought to decrease the 
interaction of expressed protein with E. coli proteins and prevent its precipitation with 
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insoluble constituents. 1% Triton-100 was tried but the solubility of Bm-SPN-2 fusion 
protein did not obviously increase. Only longer induction times improved soluble 
protein recovery from per unit volume of culture increased due to the increased cell 
density. It is also interesting that incubation of bacterial cultures at 4°C overnight after 
5 h IPTG induction at 37°C showed increased Bm-SPN-2 solubility on some occasion. 
The 6xHis tag protein purification system has been widely adapted due to its 
ease of use in rapidly preparing large amounts of purified protein. The 6xHis tag 
system takes advantage of the affinity of histidine residues for metal cations, usually 
divalent cations such as Zn 2 , Cu2 , or Ni2 (Yip and Hutchens, 1994). A crude cell 
extract is then applied to the column and only proteins with a high affinity for the 
divalent cation will bind to the column. After washing to remove other proteins, the 
bound protein is eluted from the column. Most commercial systems use imidazole as the 
elution buffer to recover bound proteins. However, this method posed major problems 
for Bm-SPN-2 purification. Although bound Bm-SPN-2 protein was eluted efficiently 
with imidazole elution buffer, it nearly all precipitated during dialysis against PBS or 
water overnight at 4°C to remove the imidazole. Similar observations have been 
reported for His-tag human pre-B-cell leukemia transcription factor 1 (Sprules et al., 
1998), His-tag yeast citrate synthase, and Drosophila transposase (Zhang, L, 
personal communication). Recent reports suggest that higher concentrations of glycerol 
may prevent recombinant proteins precipitating during dialysis (Shimamoto et al., 
1998) or that using L-histidine as the eluent may protect the activity of recombinant 
proteins (Gort and Maloy, 1998). To purify soluble Bm-SPN-2, a new protocol was 
developed, modified from Holzinger's protocol (Holzinger et al., 1996) which was 
initially used for refolding poorly soluble 6xHis tagged proteins. In this way sufficient 
amounts of purified Bm-SPN-2 soluble in TBS were obtained. It is possible that the 
TBS washes imidazole from the column, and that protein refolds within the column. 
Although the biological activity of refolded, recombinant proteins was not assessed in 
Holzinger's report (Holzinger et al., 1996), proteins purified from our protocol retained 
their biological activities. For example, Bm-SPN-2 was found to specifically inhibit 
enzymatic activities of human neutrophil cathepsin G and human neutrophil elastase. 
Drosophila transposase Mos 1 (aa 1-150), purified according to our protocol, specifically 
recognized a 28 bp invert repeated sequence of transposable element (Zhang, L, 
personal communication). 
In Chapter 5 we showed by RT-PCR that the transcription of the Bm-spn-2 
gene was seen only in Mf stage. In this chapter, we further show at the protein level 
that Bm-SPN-2 is expressed only in the Mf stage. Genes that are expressed in a stage- 
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specific manner are likely to have important functional roles in the parasite life cycle, 
and thus may provide targets for the development for novel immuno- or 
chemoprophylactic agents. Although there is as yet little information available on 
B.malayi stage-specific genes, it is remarkable that Bm-spn-2 is an abundant transcript 
(2.1% of Mf mRNAs) and restricted to the Mf stage. This indicates that the Bm-SPN-
2 protein could perform some function in parasite survival in a manner similar to viral 
serpins which help infectious organisms to evade the host defence system (Kettle et al., 
1997; Ray et al., 1992). 
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Chapter 7 
Biological functions of Bm-SPN-2 
(published in part in BLOOD) 
7.1 Introduction 
The serine proteinase inhibitor (serpin) family has evolved over a long period 
of evolutionary time, and now comprises a large gene family and are found in species 
as diverse as vertebrates, insects, plants, viruses and nematodes. Serpins are key 
regulatory proteins and regulate a wide variety of important proteinase-dependent 
physiological functions such as activation of complement and the inflammatory 
response [Cl esterase inhibitor (C1NH)] (Potempa et al., 1994; Travis and Salvesen, 
1983), fibrinolysis [plasminogen activator inhibitor types 1 and 2 (PAIl and PAI2), x2 
antiplasmin (PL)] (Collen and Lijnen, 1991), and blood coagulation [antithrombin III 
(AT3)] (Carrell et al., 1991). In addition to these fluid-phase reactions, serpins have 
critical roles in cell interactions and mobility: for example maspin (P15, PAI2) 
suppresses invasion and motility of mammary tumour cells (Zou et al., 1994); PAIl 
blocks migration of smooth muscle cells (Stefansson and Lawrence, 1996) and 
prevents cancer invasion and vascularization (Bajou et al., 1998); while PAI-2 can 
prevent apoptosis in cells exposed to TNF-a (Dickinson et al., 1995) and protects cells 
from the rapid cytopathic effects of viral infection (Antalis et al., 1998). However, 
several serpins such as angiotensinogen (AGT) and corticosteroid-binding globulin 
(CBG) have lost detectable inhibitory activity but have evolved into blood pressure 
regulatory proteins (Kageyama et al., 1984) and hormone-binding proteins (Hammond 
et al., 1991), respectively. 
In humans, serpins are found both intracellularly and extracellularly and 
represent 10% of the plasma proteins. The biologic importance of serpins in humans is 
underscored by several naturally occurring mutations. For example, individuals 
homozygous for the Z mutation (Glu 342—Lys ) of the alproteinase inhibitor gene 
develop pulmonary emphysema and cirrhosis. Homozygous mutations in the C 1NH, 
AT3, and PL1 genes can result in hereditary angioneurotic edema, thromboembolic 
disorders, and bleeding diseases, respectively (Carrell et al., 1989). 
Infectious organisms have evolved an array of specific adaptations to evade the 
host defence system (Gooding, 1992; Maizels et al., 1993). In view of the potency of 
serpin regulation of biological processes, it seems likely that pathogens may themselves 
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encode serpins and use them to block host defence functions. For example, cowpox 
virus-encoded serpin [cytokine response modifier element (crmA), P17)] blocks 
apoptosis by inhibition of interleukin-1-converting enzyme (ICE) (Ray et al., 1992); 
it also blocks granzyme B activity (Quan et al., 1995) and other related caspases (Zhou 
et al., 1997). CrmA expression in T cells of transgenic mice inhibits CD95 (Fas/APO-
1)-transduced apoptosis. The vaccinia virus-encoded serpin, B 13 (SPI-2), is also an 
inhibitor of ICE, and protects infected cells from Fas- and TNF-induced apoptosis 
(Kettle et al., 1997). Less is known of serpins from parasitic agents, but protease 
inhibitors have been described which inhibit a diverse range of host functions such as 
neutrophil chemotaxis (Leid et al., 1986), blood coagulation (Cappello et al., 1996; 
Cappello et al., 1995; Stassens et al., 1996), and antigen processing (Bennett et al., 
1992). It is interesting that Bm-spn-2 is an abundant transcript of microfilariae, 2.1% of 
total mRNA, which is expressed in only in the microfilarial stage. The presence of a 
putative signal peptide (amino acids 1-20) indicates that the mature Bm-SPN-2 protein 
could be released as a secretory product to perform some important function in parasite 
survival. This chapter describes attempts to elucidate the possible biological function of 
Bm-SPN-2. 
The first question studied was whether Bm-SPN-2 can inhibit human blood 
coagulation. The blood coagulation and fibrinolytic system plays a critical role in both 
haemostasis and host defence against a variety of infectious agents. Infection with many 
bacteria, viruses, and protozoan parasites such as malaria may be complicated by 
disseminated intravascular coagulation or thrombocytopaenia. These complications do 
not occur in patients with filariasis despite the finding that thousands of Mf may be 
present in a single millilitre of blood. It is not understood why exposure to circulating 
Mf, which collectively represent one large "foreign surface", does not result in 
activation of the clotting pathways or induce thrombosis or disseminated intravascular 
coagulation. One experiment described a few years ago suggested that Mf might 
contain inhibitors of the intrinsic coagulation cascade which interfere with the activation 
or activity of the Hageman factor (factor XII) (Foster et al., 1991), a serine proteinase 
and a key regulator of the intrinsic coagulation pathway. An initial experiment therefore 
was to investigate whether Bm-SPN-2 is an inhibitor of the Hageman factor (see Figure 
7-1). 
Secondly, it is possible that Bm-SPN-2 interferes with the ability of 
macrophages to process and present antigens to T cells. Within the last few years, 
considerable progress has been made in understanding intracellular antigen processing 
and the presentation of peptide epitopes to T cell antigens. MIHC class II molecules are 
assembled with the assistance of invariant chain (li) in the endoplasmic reticulum and 
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transported to an endocytic compartment where li undergoes rapid degradation by 
lysosomal proteinases (Wolf and Ploegh, 1995). This allows peptides derived from the 
proteolytic degradation of foreign and self proteins (Engelhard, 1994) to then bind class 
II molecules and appear on the cell surface. Although it is not known which proteinases 
are required for antigen processing, at least two out of four classes of intracellular 
endopeptidases, namely aspartic and cysteine proteinases, have been shown to be 
directly involved in endosomal proteolysis of model antigens (Bevec et al., 1996; 
Fineschi et al., 1996; Manoury et al., 1998; Manoury-Schwartz et al., 1997) as well as 
in enzymatic processing of Ii chain (Nakagawa et al., 1998; Riese et al., 1996). One of 
the immunological observations characteristic of lymphatic filariasis caused by B.malayi 
is the marked absence of T cell proliferation in vitro; interestingly, T cell proliferation is 
recovered following chemotherapy with diethylcarbamazine (DEC) which kills 
microfilariae of B. inalayi (Lammie et al., 1992) (Mistry and Subrahmanyam, 1986). 
This raises the possibility that microfilariae, which reside in the human blood stream for 
long periods, may interferie with the activity of serine proteinases associated with 
antigen processing through Bm-SPN-2. Recent work demonstrated that antigen 
processing of two CD4 T cell epitopes, an 17-31 and an 308-319 of the MS protein 
from Streptococcus pyo genes, occurs in different endosomal compartments by different 
classes of intracellular proteinases (Delvig and Robinson, 1998; Delvig and Robinson, 
1998); processing of aa 17-31 is mediated by serine proteinases whereas processing of 
aa 308-319 is mediated by serine, cysteine, and aspartic proteinases. This is therefore a 
good model system to test whether Bm-SPN-2, a natural serpin from parasite, can 
block antigen processing. 
Finally, a panel of mammalian serine proteinases were screened to see if Bm-
SPN-2 protein can specifically inhibit enzymatic activity. Recent research provides 
evidence that serine proteinases expressed by blood cells are involved in immune 
regulation. For example, human neutrophil-derived cathepsin G, a serine proteinase, 
was recently shown to be a potent chemoattractant for neutrophils and a chemokinetic 
stimulant for T cells (Chertov et al., 1997). In addition, human neutrophil-derived 
elastase was found to cleave intercellular adhesion molecule-i (ICAM- 1) which plays a 
key role during the recruitment and activation of leukocytes at inflammed sites 
(Champagne et al., 1998). Adult B.malayi worms produce millions of Mf which 
migrate into the bloodstream where they can reside for long periods ( ~!1 year). The 
mechanisms by which circulating Mf avoid host immune defences are poorly 
understood, and it is possible that Bm-SPN-2 modulates immune processes by host 
cells in the vascular environment. 
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7.2 RESULTS 
7.2.1 Effect of Mf on human blood coagulation pathway 
It was reported that a crude extract and excretory-secretory product of Mf can 
inhibit blood clotting specifically by interfering with the activation or activity of the 
Hageman factor (factor XII) (Foster et al., 1991), a serine proteinase and a key 
regulator of the intrinsic coagulation pathway. This raises the possibility that Mf may 
produce serpin(s) to inhibit activation of hemostatic mechanisms. Clotting assays were 
therefore performed with an activated partial thromboplastin time (APTT) and 
prothrombin time (PTT) kit, to test whether Mf lysates and recombinant Bm-SPN-2 
protein inhibits the activity of serine proteinases in the human coagulation pathway. 
Mf extract was tested first. Pooled normal plasma and various concentrations 
of Mf extract or TBS buffer alone were incubated at 37°C and then prewarmed APT!' 
reagent was added. After 3 mm, prewarmed calcium chloride solution was added and 
the clotting time was recorded. Fig 7-2 shows that the addition of MI extract to pooled 
normal human plasma resulted in a dose-dependent prolongation of the APTT. For 
example, at 200 jig/ml, the APT!' was 63.7, whereas the APT!' in the presence of 
buffer (TBS) alone was 32.5 seconds (P <0.001). 
Mf extract was found to prolong the APT!' in a dose-dependent way, so the 
PTT assay was then tested. Pooled normal plasma and various concentrations of MI 
extract or TBS buffer alone were incubated at 37°C. Thereafter, prewarmed 
Thromboplastin-M reagent was added and the clotting time was recorded. Fig 7-3 
shows that the addition of Mf extract to pooled normal human plasma did not prolong 
the prothrombin time at concentrations of up to 200 .ig/ml. 
The APT assay is a general screening procedure for the detection of 
coagulation abnormalities in the intrinsic pathway and is sensitive to deficiencies of 
factors II, V, VIII, IX, X, XI, XII, and prekallikrein, high molecular weight 
kininogen, fibrinogen (see Fig 7-1). The PTT assay measures prothrombin activity at 
constant lipoprotein and calcium concentrations and is influenced by various 
components in the sample such as factor V (proaccelerin), factor VH (stable factor) and 
factor X (Stuart factor) (see Fig 7-1). Mf extract inhibited the activated partial 
thromboplastin time but not the prothrombin time. These data suggest that the inhibitory 





















Figure 7-1. The blood coagulation cascade (after Furie et al, 1988). Glycoprotein 
components of the intrinsic pathway include factors XII, IX, IX, VIII, X and V, 
prothrombin, and fibringon. Glycoprotein components of the extrinsic pathway include 
factors VII, X, and V, prothrombin and fibringon. Where indicated, reactions are 
dependent. Proenzymes are drawn as dimonds, enzymes as circles. Other 
abbreviations: HWMK, high molecular weight kininogen; TF, tissue factor; PT, 
prothrombin (factor II); T, thrombin; FG, fibrinogen; F, fibrin. Factors XII, XI, IX, 
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Figure 7-2. 	Inhibition of the activated partial thromboplastin time (APTF) by 
various concentrations of Mf extract. 0.1 ml of pooled normal human plasma and 0.1 
ml of TB  buffer or Mf extract were incubated for 5 minutes at 37°C. Thereafter, 0.1 
ml of prewarmed APTT reagent was added. After 3 more minutes, 0.1 ml of 0.02 5 












Figure 7-3. Effect of Mf extract on prothrombin time (PTT). 0.1 ml of pooled 
normal human plasma and 0.1 ml of TB  buffer or MI extract were incubated for 5 
minutes at 37°C. Thereafter, 0.1 ml of prewarmed Thromboplastin-M reagent was 
added and the PTT was measured 
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before the participation of Stuart factor (factor X). Our data are therefore in agreement 
with the observation of Foster et al (Foster et al., 1991). 
7.2.2 Effect of Bm-SPN-2 on human blood coagulation pathway 
Since it has been shown that Mf extract can prolong the APTT of human blood 
coagulation and that Bm-SPN-2 is a Mf-stage specific serpin, the next step was to see if 
Bm-SPN-2 is the component from Mf extract responsible for inhibiting the intrinsic 
coagulation cascade. Therefore, pooled normal plasma and various concentrations of 
purified Bm-SPN-2 recombinant protein were incubated in the condition described 
above, to measure APTI' and PTT. Fig 7-4 shows that no prolongation of either the 
APTT and PTT was observed with Bm-SPN-2 protein at concentrations of up to 200 
pg/ml. These data suggest that Bm- SPN-2 does not inhibit the serine proteinases of 
the clotting pathway such as factor X and Hageman factor. 
7.2.3 Mf produces three different serpins: Bm-SPN-1, Bm-SPN-2 and 
Bm-SPN-3 
Although inhibition of the serine proteinase Hageman factor of the intrinsic 
coagulation pathway by Mf extract was confirmed, the identify of the inhibition has not 
been established. As this activity is consistent with a serpin, the amino acid sequences 
of Bm-SPN- 1 and Bm-SPN-2 were used to search the B.malayi EST database and 
three EST clones encoding a novel serpin were found. These B.malayi EST clones, 
SWMFCA034 (H48987), BSBmMFSZ02G1O (AA990949) and BSBmMFSZ11G12 
(A1133763), were AssemblyLIGN analysed and shown to be the same gene belonging 
to serpin superfamily, which we termed as Bm-spn-3 and its protein product Bm-SPN-
3. The consensus sequence of the three clones is shown in Fig 7-5. These EST 
sequences did not contain the whole open reading frame, but residues 3 through 26 
formed a very strong hydrophobic region consistent with a signal peptide function. All 
three EST clones came from Mf cDNA libraries, which suggest that Bm-spn-3 
(B.malayi serine proteinase inhibitor 3) might be a Mf-stage specific gene like Bm-spn-
2. Comparsion of protein sequence from three serpins showed Bm-SPN-3 is more 
similar to Bm-SPN-1 than Bm-SPN-2. Future work will established whether Bm-SPN-
3 is the active inhibitor of Hageman factor. 
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Figure 7-4. Bm-SPN-2 has no effect on human blood coagulation pathway. A: the 
activated partial thromboplastin time (APTT). 0.1 ml of pooled normal human plasma 
and 0.1 ml of purified recombinant Bm-SPN-2 or TBS buffer alone were incubated for 
5 minutes at 37°C. Thereafter, 0.1 ml of prewarmed APTI' reagent was added. After 3 
more minutes, 0.1 ml of 0.025 mol/L warm CaC12 was added and then the clotting time 
was recorded. B: the prothrombin time (PTT). 0.1 ml of pooled normal human plasma 
and 0.1 ml of purified recombinant Bm-SPN-2 or TBS buffer alone were incubated for 
5 minutes at 37°C. Thereafter, 0.1 ml of prewarmed Thromboplastin-M reagent was 
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Figure 7-5. B.malayi serine proteinase inhibitor 3 (Bm-spn-3). (A) Nucleotide and 
deduced amino acid sequence of the Bm-spn-3 ESTs. Inferred amino acid numbering 
is in bold face. (B) Hydrophilicity plot of the deduced protein sequence of Bm-spn3. 
The residues 3 through 26 formed a very strong hydrophobic region consistent with a 
signal peptide function. (C) Comparsion of Bm-SPN-3 with Bm-SPN- 1 (aa 1-137) and 
Bm-SPN-2 (aa 1-148). Note, the EST sequences presented here do not contain the 
whole open reading frame. 
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7.2.4 Effect of Bm-SPN-2 on epitopes processing and presentation 
Recently Drs. Delvig and Robinson (Newcastle University) established a model 
to study multiple pathway for antigen processing of CD4 T cell epitopes from the 
surface M protein of viable group A streptococcus pyo genes (Delvig and Robinson, 
1998; Delvig and Robinson, 1998). They found processing of a protruding amino-
terminal epitope 17-3 l/Ed  occurred in early endosomes via the recycling MHC-11 
pathway independent of microtubules, mobilisation of extracellular Ca 2' and newly-
synthesised MHC-ll molecules. In contrast, processing of a cell-wall associated epitope 
308-319/A d  occurred in late endosomes via the classical MHC-II pathway which was 
dependent on microtubles, mobilisation of extracellular Ca 2' and newly-synthesised 
MHC-TT molecules. Thus two T cell epitopes of a single bacterial protein are routed to 
distinct MHC-II processing pathways. Very interestingly, however, both MHC-II 
pathways required processing by serine proteinases, whereas only the classical MHC-IT 
pathway utilised aspartic and cysteine proteinases. This system could be used for 
testing different proteinases inhibitors, drugs etc for their modulatory effect on antigen 
processing of viable S.pyo genes for presentation of two specific T cell epitopes of the 
M5 protein in mouse macrophages. Therefore, purified recombinant Bm-SPN-2 was 
sent to Dr. John H. Robinson's laboratory, Department of Immunology, Newcastle 
University, UK, to see if it could interfere with the processing and presentation 
pathway of two T cell epitopes 17-31/E d  and 308-319/A' of the M5 protein from 
S.pyo genes by inhibiting the activities of serine proteinases in antigen presenting cells. 
These experiments were done by Dr. Alexei A. Delvig in Dr. Robinson's laboratory. 
The murine macrophage cell line J774A. 1 was treated with Bm-SPN-2 and then 
viable S.pyo genes or synthetic peptides corresponding to an 17-31 or aa 308-319 of 
M5 protein were added and incubated. After the bacteria were killed, the macrophages 
were fixed and T cell hybridoma cells, HX17 (recognizing peptide 17-31) and HY2 
(recognizing peptide 308-319), were added and incubated for 24 h. The culture 
supernatants were collected for an IL-2 assay. The I1L-2 activity would be expected to 
decrease if Bm-SPN-2 inhibits the processing and presentation of CD4 T cell 
epitopes. The first experiment showed Bm-SPN-2 significantly inhibited antigen 
processing and presentation (Fig 7-6A). However, this result could not be repeated in 
three further experiments, one which is shown in Fig 7-6B. So there are no effect of 
Bm-SPN-2 on two CD4 T cell epitopes processing and presentation pathway. 
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7.2.5 Inhibitory activity of Bm-SPN-2 on human neutrophil cathepsin 
G and human neutrophil elastase 
To screen for potential inhibitory function of Bm-SPN-2, purified recombinant 
Bm-SPN-2 was tested by Dr. Michael R. Kanost's laboratory, Department of 
Biochemistry, Kansas State university, USA, for its ability to inhibit a panel of 
mammalian serine proteinases with different substrate specificities. These experiments 
were done by Dr. Haobo Jiang in Dr. Kanost's laboratory. 
Individual serine proteinases were incubated with purified recombinant Bm-
SPN-2 protein in TBS buffer or bovine serum albumin in TBS buffer as a negative 
control. After a 10-min incubation at room temperature, an appropriate peptidyl-p - 
nitroanilide substrate solution was added to the mixture, and the residual enzyme 
activity was measured by monitoring the absorbance change at 405 nm with time (Jiang 
and Kanost, 1997). Bm-SPN-2 showed no inhibitory activity against bovine pancreatic 
trypsin, human plasmin, bovine pancreatic a-chymotrypsin and porcine pancreatic 
elastase, but very interestingly, inhibited the enzymatic activity of the human neutrophil 
cathepsin G and human neutrophil elastase in a dose-dependent manner (Fig 7-7). 
Comparatively, Bm-SPN-2 shows better activity against human neutrophil cathepsin G 
than human neutrophil elastase, cathepsin G activity and is able to almost completely 
inhibit at the highest concentration (100 ig).The inhibition of the neutrophil proteinases 
by Bm-SPN-2 is strikingly specific, considering that human neutrophil cathepsin G and 
bovine pancreatic cz-chymotrypsin hydrolyze the same substrates, N -succinyl-Ala-Ala- 
Pro-Phe-p -nitroanilide, and that human neutrophil elastase and porcine pancreatic 
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Figure 7-6. Two experiments on the effect of Bm-SPN-2 on processing and 
presentation of two M5 protein-specific CD4 T cell epitopes. The effect seen in panel 
A could not be repeated (Panel B). J774A. 1 macrophages were pretreated with different 
concentrations of purified recombinant Bm-SPN-2 for 1 h before challenge with viable 
streptococci (3 X 10 6/well; squares) or synthetic peptides (4.0 tg/ml; circles). After a 4-
h pulse with antigens, cells were fixed and T cell hybridomas added: HX17 specific for 
17-31 (closed symbols), HY2 specific for 308-319 (open symbols). T cell hybridoma 
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Figure 7-7. Concentration-dependent inhibition of human neutrophil cathepsin G 
and human neutrophil elastase activation by Bm-SPN-2. 10 il of purified recombinant 
Bm-SPN-2 at different concentrations was mixed with 5 pJ of human neutrophil 
cathepsin G (1 ig4il) or human neutrophil elastase for 10 min at room temperature, 
prior to addition of specific substrates (N -succinyl-Ala-Ala-Pro-Phe-p -nitroanilide for 
cathepsin G and N -succinyl-Ala-Ala-Pro-Leu-p -nitroanilide for elastase). Changes in 
the rate of substrate cleavage were used to calculate percent inhibition at each Bm-SPN-
2 concentration. Bm-SPN-2 showed no inhibitory activity against bovine pancreatic 




The wide distribution of serpins and their ability to regulate a variety of 
divergent proteinases show that they play a major regulatory role in a host of biological 
processes, and serpins from viruses have been implicated in pathogen evasion of the 
host immune system. For the first time, we report a functional serpin gene from 
nematodes which may function in this manner. Several prominent helminth parasites 
spend part of their life cycle circulating within the blood stream. It is surprising that 
localized thrombosis and the risk of thromboembolization are not associated with 
exposure to such living blood-borne parasites as filariae and schistosomes. The 
mechanisms by which blood-born Mf avoid activating the clotting cascades and 
maintain vascular fluidity and patency have yet to be studied in detail. Although we 
found that Mf extract significantly prolongs the APr!' of human blood coagulation and 
that inhibitory properties of Mf extract are localized to an early stage of the intrinsic 
clotting pathway before the participation of Stuart factor (factor X), Bm-SPN-2 had no 
effect on blood coagulation. Interestingly, Mf express at least two other serpins, and it 
would be worth investigating if either of these protein(s) inhibit human blood 
coagulation. 
Foreign protein antigens must be broken down within endosomes or lysosomes 
to generate suitable peptides that will form complexes with MHC II molecules for 
presentation to T cells. Thus T cell activation would be blocked if the proteinases 
involved in processing of II and exogenous protein antigens within APC are inhibited. 
The possibility that Mf produces Bm-SPN-2 to interfere with antigen processing and 
presentation was tested but Bm-SPN-2 did not, at least in a model system (Delvig and 
Robinson, 1998; Delvig and Robinson, 1998), block this pathway. However, recent 
work analyzing the antigen-presenting properties in mice deficient in either cathepsin B 
or cathepsin D indicates that multiple pathways of degradation exit. For exmple, 
cathepsin D deficiency resulted in lower presention of epitope 225-240 of ovalbumin, 
but increased presention of epitope 230-248 of ovalbumin and and 88-103 of pigeon 
cytochrome C. In cathepsin B deficiency, recognition epitope 323-339 of ovalbumin 
was decreased but that of epitope 74-88 of hen egg lysozyme increased (Deussing et 
al., 1998). The same work also found that epitope 273-288 of ovalbumin was 
presented with similar efficiency by cathepsin D knock-out and wildtype APC of the H- 
2'haplotype, whereas the same defect resulted in increased presentation of the same 
determinant by H2d APC. These results suggests that: i) different antigens require 
different proteolysis to yield presentable epitopes; ii) multiple proteinases can probably 
generate the same antigenic determinants; iii) MHC polymorphism influences whether 
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individual proteases are important in antigen presentation. Further work, therefore, 
should focus on the use of different antigen systems to observe the possible effects of 
Bm-SPN-2 on antigen processing and presentation pathway. 
A panel of mammalian serine proteinases were screened and Bm-SPN-2 protein 
was found to specifically inhibit enzymatic activity of human neutrophil cathepsin G 
and human neutrophil elastase, but not a range of other serine proteinases. Human 
cathepsin G and elastase are the major serine proteinases secreted by neutrophils 
(Travis, 1988); they are reported to play important roles in neutrophil-mediated 
proteolytic events. These two proteinases are also found on the plasma membrane of 
resting and activated neutrophils as noncovalently membrane-bound forms (Owen et 
al., 1995). Their expression is not restricted to neutrophils, and both soluble and 
membrane-bound forms have also been reported on monocytes and lymphocytes 
(Bristow et al., 1991; Campbell et al., 1989; Wakatsuki et al., 1995). Some viruses use 
serpins as a defense strategy in evasion of the host immune system (Brooks et al., 
1995; McFadden, 1998). The ability of Bm-SPN-2 to inhibit two human neutrophil-
derived serine proteinases, cathepsin G and elastase, may be important in this context. 
It is therefore possible that Bm-SPN-2 could function as a stage-specific serpin in the 
vascular environment of the microfilarial parasite in protection from human immunity. 
Neutralisation of Bm-SPN-2, for example by vaccine-induced antibodies, may 
therefore abolish the parasite's ability to avoid immune-mediated attack. 
Cathepsin G is a highly cationic serine proteinase that is contained within the 
azurophil granules of human polymorphonuclear neutrophils (Campbell et al., 1989). 
Genes encoding cathepsin G, cathepsin G-like lymphocyte granzymes B and H, and 
a/ö chains of the T cell receptor are closely linked on human chromosomal band 
14q1 1.2 (Caughey et al., 1993). Human polymorphonuclear neutrophils contain large 
quantities of cathepsin G (-1 tg/10 6 cells) (Campbell et al., 1989). Various 
physiological effects are ascribed to this enzyme (Travis, 1988): antimicrobial activity; 
regulation of inflammatory responses by degradation of C components and Igs (Starkey 
and Barrett, 1976); degradation of extracellular matrix; control of blood pressure and 
fluid homeostasis by converting angiotensinogen and angiotensin I to angiotensin II; 
induction of thrombogenesis via stimulation of platelet activation and aggregation, and 
release of plasminogen activator type I from endothelial cells (Pintucci et al., 1993); 
increasing of permeability of endothelial and epithelial barriers and inducing of marked 
intercellular gap formation in endothelial cell monolayers (Pintucci et al., 1993). 
Cathepsin G also exerts a major influence on the immune system. Stimulated 
polymorphonuclear neutrophils release cathepsin G concomitantly with neutrophil 
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elastase, and these proteinases mediate interleukin-8 processing (Padrines et al., 1994). 
Interestingly, it was reported that cathepsin G exhibits specific, saturable and reversible 
binding to T lymphocytes and NK cells (Chertov et al., 1997; Yamazaki and Aoki, 
1997) and exerts a mitogenic effect on T lymphocytes, which is dependent on retaining 
enzymatic activity (Hase-Yamazaki and Aoki, 1995). There is intriguing evidence that 
cathepsin G plays a direct role in neutrophil accumulation at sites of inflammation, since 
inhibitors of cathepsin G attenuate neutrophil migration in vitro (Stockley et al., 1990). 
Studies of active site mutants of al-antichymotrypsin, the cognate inhibitor of 
cathepsin G, indicate that only mutants that are efficient inhibitors of cathepsin G have 
the capacity to inhibit neutrophil chemotaxis. Moreover, recent work suggest that 
cathepsin G may be the most potent neutrophil granule-derived chemoattractant for 
monocytes and chemokinetic stimulant for T lymphocytes (Chertov et al., 1997). It is 
interesting to suggest that neutrophils, representing 55% of human blood leukocytes, 
would be the primary cell type to interact with B.malayi Mf, and that release of Bm-
SPN-2 neutralizes the stimulatory properties of cathepsin G. 
It is interesting to note a recent study which identified a human squamous cell 
carcinoma antigen, SCCA2, as a novel serpin which also inhibits cathepsin G (Schick 
et al., 1997). These data suggest that a possible common strategy between parasites and 
tumours may be the production of a cathepsin G inhibitor to counteract immune 
activation. 
In neutrophils, elastase is stored in azurophil granules along with other serine 
proteinases (cathepsin G, proteinase 3 and azurocidin). As a result of its capacity to 
efficiently degrade extracellular matrix, neutrophil elastase has been implicated in tissue 
destruction in a number of inflammatory disorders, including rheumatoid arthritis and 
cystic fibrosis (Snider, 1992). Previous in vitro data have shown a role of neutrophil 
elastase in host defense against bacteria (Thorne et al., 1976). Recent work shows 
neutrophil elastase gene knock-out mice have impaired host defense against gram 
negative (but not gram positive) bacterial sepsis (Belaaouaj et al., 1998). However, 
there seems no reasonable relationship between inhibition of Mf Bm-SPN-2 on human 
neutrophils elastase and the role of neutrophil elastase in host defense against bacteria 
Several membrane molecules with various functions are cleaved by endogenous 
proteases and then released into the extracellular medium in the form of soluble 
fragments (Bazil, 1995). Moreover, such shedding may explain the detachment of 
migrating leukocytes from the endothelium during extravasation. The constant flow of 
reports of new molecules removed from the cell surface by enzymatic cleavage and the 
presence of their soluble counterparts at high levels in blood plasma in many 
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inflammatory states (Gearing and Newman, 1993), indicate that this process occurs 
both in physiologic and pathologic conditions. Recent work found that human 
neutrophil elastase can cleave ICAM-1 (Champagne et al., 1998), CD4 and CD8 
(Doring et al., 1995), and CD43 (Remold-O'Donnell and Parent, 1995). It is possible 
that cleavage of CD4 and CD8, as well as ICAM- 1 by neutrophil elastase would 
interfere with interaction between T cells and APCs. Therefore, it would be interesting 
to see if Bm-SPN-2 could inhibit the cleavage of leukocyte antigens and costimulatory 
molecules by human neutrophil elastase. 
Recent work has found that al-antitrypsin, a physiological serpin which 
neutralizes neutrophil elastase, selectively up-regulates human B cell differentiation into 
IgE- and IgG4-secreting cells (Jeannin et al., 1998). This effect was not observed with 
other mammalian serpins. It would be interesting to see if Bm-SPN-2, which also 
neutralizes human neutrophil elastase, may act as a co-stimulus for IgE and IgG4 
switching, because human infection with filarial parasites induces unusually high levels 
of these two isotypes (Kurniawan et al., 1993; Ottesen et al., 1985). 
Insects are known to mount potent cellular and humoral innate immune reactions 
in response to infection by bacteria, fungi, and macroparasites. In recent years much 
progress has been made in the analysis of the humoral immune response in model 
insects. The humoral response of insects to bacteria and fungal pathogens is 
characterized by the transient synthesis of a battery of antibacteriaL/antifungal peptides 
(Hoffmann et al., 1996). In contrast, relatively little is known concerning the early 
stages of insect immune induction. Interestingly, recent work on molecular immune 
responses of mosquitoes to bacteria and malaria parasites found that two serine 
proteinases, ISPL5 (immune-related serine protease-like sequence 5) and ISP 13 
(infection-responsive putative serine protease) were strongly induced 24 h after 
infection with Plasmodium berghei (Dimopoulos et al., 1997), suggesting that some 
serine proteases may be produced by mosquitoes in response to parasitic infection. 
B.malayi Mf circulating in the bloodstream are in a state of readiness for uptake into 
mosquito vectors, and must negotiate the invertebrate body for development into 
infective U. Whether Bm-SPN-2 plays a role in neutralising the innate immune 
reactions of mosquitoes remains a very interesting possibility. 
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Chapter 8 
T cell antigenicity of Bm-SPN-2 and vaccination 
8.1 Introduction 
It is generally accepted that T cell-mediated immune responses are key 
determinants to the natural course of infections caused by intracellular or extracellular 
parasites. Thus T cell-activating proteins of these parasites generate intense interest 
(Mougneau et al., 1995), particularly in view of their possible role in the development 
of newer and more effective diagnostic tests and vaccines. The understanding of 
parasite-specific immune responses and development of vaccines requires a much 
greater level of identification and characterization of parasite antigens recognized by T 
cell populations. There is enormous scope for anti-helminth vaccines (Maizels et al., 
1999), for in the vast majority of helminth infections chemotherapy provides only 
temporary respite from infection. For lymphatic filariasis, researchers have been 
seeking for a vaccine for many years, spurred on by the established efficacy of 
vaccination with radiation attenuated infective larvae in permissive animal models 
(Oothuman et al., 1979), and the establishment of protective immunity through 'trickle' 
infection with infective larvae (Denham et al., 1992). Perhaps the most exciting 
development in vaccine technology in recent years has been the development of naked 
DNA gene transfection techniques (DNA vaccines). DNA vaccines are particularly 
interesting for several reasons: simple; antigen produced in mammalian post 
translaitional modification and conformation; DNA itself as an adjuvant (Roman et al., 
1997). Since the initial development of DNA vaccines more than 6 years ago, DNA 
vaccines have been shown to be effective at generating protective immune responses 
against a wide variety of diseases (Donnelly et al., 1997), however, much less is 
known about the potential of DNA vaccination to induce a protective immune response 
against multicellular parasites. Up to now a few helminth parasites antigen genes, 
Schistosoma mansoni glutathione S-transferase (Kayes et al., 1998), Schistosoma 
japonicum paramyosin (Yang et al., 1995) and SJ22 (Waine et al., 1999), and Taenia 
ovis 45W (Rothel et al., 1997), have been found to induce significant humoral 
immune response in mice and sheep by DNA immunization. Interestingly, a DNA 
vaccination using a gene encoding proline-rich protective peptide from Taenia 
crassiceps showed 58.6% protection which is similar to the protective level induced by 
the protein, demonstrating that DNA vaccination is an useful approach to induce a 
protective immune response against multicellular parasites if a defined protective antigen 
gene is used. Up to now, no DNA immunization has been reported from filariasis 
parasites. 
In filariasis, parasite-specific T cells have been implicated in mediating both 
pathogenic and protective immune responses, but the nature of the antigens inducing 
such responses remains poorly studied. It Chapter 3 and Chapter 4 it was shown that 
Mf protein-induced T cells can be used for identification of Mf-fractions purified 
biochemically (FPLC and SDS-PAGE electro-elution), and a novel serpin (Bm-SPN -
2) was identified from a fraction which induced stronger Mf-specific T cell responses 
(Chapter 5). Bm-spn-2 is one of the most abundant genes expressed in Mf. Despite its 
abundance in the microfilarial stage, Bm-spn-2 has not been found in any other point in 
the life cycle (chapter 5 and 6), which suggests it is Mf stage-specific gene. In several 
systems, serpins from infectious organisms have been identified as factors which help 
infectious organisms to evade the host defence system (Kettle et al., 1997; Leid et al., 
1986; Ray et al., 1992; Stassens et al., 1996). For the first time, we report a functional 
serpin gene from nematodes which may function in this manner. We found Bm-SPN-2 
inhibits two human neutrophil-derived serine proteinases, cathepsin G and elastase, 
which demonstrated a fascinating link between host enzyme and parasite inhibitor 
(chapter 7). In a word, Bm-SPN-2 seems a good candidate for protective vaccine. In 
this chapter, we attempt to investigate the T cell antigencity of Bm-SPN-2 in a mouse 
mode!, using protein vaccination in mice and jirds, and DNA immunization. 
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8.2 Results 
8.2.1 T cell antigenicity of Bm-SPN-2 
Bm-SPN-2 protein was expressed in E.coli and purified by affinity 
chromatography as described in Chapter 6. In a preliminary experiment, BALBIc mice 
were injected with Incomplete Freund's Adjuvant (IFA) and 10 days the popliteal 
lymph node cells were incubated with purified Bm-SPN-2, but no significant 
proliferatie response was observed, suggesting that Bm-SPN-2 is pure enough for in 
vitro T cell assays. 
To investigate the T cell antigenicity of Bm-SPN-2, female (8-week-old) 
BALB/c mice were injected sub-cutaneously with Bm-SPN-2 in Complete Freund's 
Adjuvant (CFA) and boosted at four weeks by footpad injection of Bm-SPN-2 in IFA. 
Mice were killed 10 days later and the popliteal lymph node cells were incubated with 
Bm-SPN-2. After incubation, the supernatant was removed for cytokine analysis and 
[3H] thymidine was added to the wells for T cell proliferation assays. Fig 8-1 shows 
that high level of IFN-y but no IL-4 were produced from popliteal lymph node cells 
when stimulated with Bm-SPN-2. Interestingly, cell proliferation is depressed below 
background when stimulated with high concentration of Bm-SPN-2. These results 
suggest that Bm-SPN-2 is a strongly Thi-inducing antigen, and that at high 
concentration the proteinase inhibitor may interfere with the cell cycle. 
To further investigate the T cell antigenicity of Bm-SPN-2, female (8-week-old) 
BALB/c mice were injected sub-cutaneously with Mf extract in CFA and boosted at 
four weeks by footpad injection with Mf extract in IFA. Mice were killed 10 days later 
and the popliteal lymph node cells were incubated with antigens (Mf extract and Bm-
SPN-2). After incubation, the supernatants were removed for cytokine analysis and 
[3H] thymidine was added to the wells for T cell proliferation assay. Fig 8-2 shows that 
substantial IFN-y and IL-4 release were observed from popliteal lymph node cells 
when stimulated with Mf extract but not medium alone. Interestingly, Bm-SPN-2 
stimulated popliteal lymph node cells to produce equivalent amounts of IFN-y, no IL-4 
secretion was induced. The amount of IFN-y stimulated by Bm-SPN-2 at 10 jig/ml 
concentration is about 70% of that stimulated by Mf extract. These results support the 
contention that Bm-SPN-2 act as a Thl-stimulating antigen. 
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Figure 8-1. T cell antigenicity of Bm-SPN-2. Proliferation and cytokine levels 
secreted by popliteal lymph node T cells from BALB/c mice immunized sequentially 
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with 20 .ig Bm-SPN-2 in association with CFA and WA. Proliferation was measured 
by tritiated thymidine uptake at 72 h in culture. Supernatants were taken after 60 h in 
culture and cytokines were measured by bioassay (IL-4) or ELISA (IFN-y). Data 
shown are the means ± SD of four individual mice. 
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Figure 8-2. T cell antigenicity of Bm-SPN-2 in Mf-immunized mice. Proliferation 
and cytokine levels secreted by T cells from BALB/c mice, immunized sequentially with 
Mf extract in association with CFA and IFA, stimulated with 20 jig Mf extract and 
purified Bm-SPN-2. Proliferation was measured by tritiated thymidine uptake at 72 h in 
culture. Supernatants were taken after 60 h in culture and cytokines were measured by 
bioassay (IL-4) or ELISA (IFN-y). Data shown are the means ± SD of four individual 
mice. 
8.2.2 Bm-SPN-2 vaccination in mice 
BALB/c mice (eight per group) were primed sub-cutaneously with Bm-SPN-2 
in CFA and boosted 4 weeks later by ip injection of Bm-SPN-2 in IFA. PBS buffer 
144 
was used instead of Bm-SPN-2 in the control group. All mice were i.v. challenged 
with 2.5 x 105 freshly isolated MI 10 days after the second immunization. Mice were 
bled periodically and the intensity of Mf quantified from 30 p1 blood samples (Fig 8-3). 
10 days after MI challenge, parasitaemias of Bm-SPN-2 immunized mice were 67% 
lower than control (mean ± SD 12 ± 10 vs 36 ± 10 mf/30 p1 blood, respectively). Mf 
in animals given Bm-SPN-2 recombinant protein remained 69% lower than control 
mice 25 days after parasite challenge. The data indicate that recombinant Bm-SPN-2, 
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Figure 8-3. Bm-SPN-2 protein vaccination in mice. Mice were immunized twice 
with 20 pg Bm-SPN-2, or with PBS for controls, and then challenged with Mf. The 
Mf number in 30 t1 of blood was quantified 10 and 25 days after parasite challenge. 
8.2.3 Bm-SPN-2 vaccination in jirds 
Jirds (eight per group) were primed sub-cutaneously with Bm-SPN-2 in CFA, 
and then boosted sub-cutaneously with Bm-SPN-2 in WA after 5 months. PBS buffer 
was used instead of Bm-SPN-2 in control group. All jirds were infected sub- 
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cutaneously with 100 L3/jird on d25 after the last boost. The Mf number in blood was 
quantified 2.5 months after infection. The results shown in Fig 8-4 suggest that there is 
no significant difference of Mf numbers between the control and vaccine groups (mean 
± SD 363 ± 432 vs 272 ± 424 rnf/100 t1 blood, respectively) and that there is a large 
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Figure 8-4. Bm-SPN-2 vaccination injirds. Jirds were immunized with 100 tg Bm- 
SPN-2 in the immunization group and PBS in the control group three times and then 
infected with L3 of B.malayi. The Mf number in 100 p1 of blood was quantified after 
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2.5 months after infection. Please note that two blood samples were tested from each 
jird. 
8.2.4 Construction of DNA vaccine vectors and expression of vectors in 
COS-7 cells 
A new expression vector pcDNA3.1(-) was obtained, into which target 
sequences for DNA vaccines could be cloned.The pcDNA3. 1(-) vector is designed for 
high-level stable and transient expression in mammalian hosts. 
For directional, in-frame cloning into the pcDNA3. 1 (-) vector, primers were 
designed which conformed to the mammalian Kozak sequence for translation initation. 
Thus, the forward primer PCDNA-SERPIN (CGGGCCCGCCACCATGGAGCfl' 
TTCGAAGTA) homologous to the bp 31-44 of Bm-spn-2 cDNA and reverse primer 
pcDNA3. 1 (2R) (TGGTGAATFCATAGACAA1TCGCGTGGATA) contains an EcoR 
I site and is homologous to the bp 1380-1361. The DNA produced by PCR using 
primers PCDNA-SERPIN and pcDNA3. 1 (2R) was subcloned into the pcDNA3. 1(-) 
Apa I and EcoR I sites to express Bm-SPN-2. The positive constructs were examined 
by DNA sequence to confirm that the cloned DNA was correct. 
Mammalian expression was then tested by transfection of COS-7 cells with 
LacZ/pcDNA3. 1. Significant 13-Galactosidase activity was found in COS-7 cells 
transfected by LacZ/pcDNA3.1 but not by pcDNA3. 1(-), demonstrating the efficacy of 
the expression system. Therefore, this system was used to express Bm-SPN-2. COS-
7 cells were incubated for 24 h and then transfected using a DNA-liposome complex by 
combining solution A [Bm-spn-2/pcDNA3.1(-) and OPTIMEM I] and solution B 
[LIPOFECTAMINETM reagent and OPTIMEM I]. The COS-7 were tested by Western 
blotting to observe Bm-spn-2 expression. Fig 8-5 shows that transfected COS-7 cells 
expressed Bm-SPN-2. 
At the same time, a set of other constructs were made to express 
immunologically stimulatory molecules, namely IL-4/pcDNA3. 1, CD40 ligand 
/pcDNA3. 1, B7. l/pcDNA3. 1 and B7.2/pcDNA3. 1. 
IL-4/pBR322, from Dr. David Fitzpatrick, Queensland Institute of Medical 
Research, Australia, was digested with BamH I to release the mouse IL-4 insert. The 
IL-4 insert was subcloned into pcDNA3.1(-) and the positive constructs []]-
4/pcDNA3. 1(-)} were confirmed by DNA sequence. COS-7 cells were transfected 
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with IL-4/pcDNA3. l(-) and the supernatant was measured for IL-4 activity by NK cell 
assay. Fig 8-6 shows that the supernatant from COS-7 cells transfected with IlL-
4/pcDNA3.1(-), but not pcDNA3. l(-), contains significant levels of IL-4 and that this 
I1-4 activity can be neutralized by the anti-IL-4 mAb 1113 11. 
CD40L/pCMEV, from Prof. Anneliese Schimpi, Institute of Virology and 
Immunobiology, Wurzburg, Germany, was digested with EcoR I to release mouse 
CD40L insert. The CD40L insert was subcloned into pcDNA3.l(-) and the positive 
constructs [CD40L/pcDNA3.1(-)] were confirmed by DNA sequence. COS-7 cells 
were transfected with CD40L/pcDNA3.1(-) and the expression of CD40L on the 
surface of COS-7 cells was measured by FACS using PE-mAB against mouse CD40L. 
Fig 8-7 showed 38.4% COS-7 cells expressed mouse CD40L on the cell surface after 
CD40LIpcDNA3. 1 (-) transformation. 
Figure 8-5. Brn-SPN-2 expressed in COS-7 cells. COS-7 cells were transfected 
with Bm-spn-2/pcDNA3.1 (-) (lane 2) or pcDNA3.l(-) (lane 1) as negative control, and 
then tested by Western blotting using antisera against Bm-SPN-2. The arrow marks the 
Bm-SPN-2 expressed in COS-7 cells. 
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Figure 8-6. Murine IL-4 expressed in COS-7 cells. COS-7 cells were transfected 
with IL-4/pcDNA3. 1 (-) or pcDNA3. I(-) as a negative control, and then the supernatant 
was tested for IL-4 activity by NK cell assay. The IL-4 activity in the supernatant can 
be neutrialzed by anti-IL-4 mAb 11 B 11. 
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Figure 8-7. Mice CD40 ligand (CD40L) expressed on the surface of COS-7 cells. 
COS-7 cells were transfected with CD40L/pcDNA3.l(-) [Fig C and D] or pcDNA3.l(-) 
as negative control [Fig A and B], and then the expression of CD40L was measured by 
FAGS using PE-mAb against mice CD40L (Fig B and D). Fig D shows that 38.4% 
COS-7 cells expressed CD40L on cell surface after transformation. 
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Mice B7. 1/p5G5 and B7.2/p5G5 plasmids were from Dr. James Hagman, 
Department of Immunology, University of Colorado Health Sciences Center. 
B7. 1/p5G5 was digested with EcoR I and Pme I to release mouse B7.1 insert. The 
B7.1 insert was filled in 5'-overhang by Klenow and then subcloned into Pme I-
digested pcDNA3. 1(-). The positive constructs [B7.1/pcDNA3.l(-)] were confirmed 
by DNA sequence. While B7.2/p5G5 was digested with Acc I to release mouse B7.2 
insert. The B7.2 insert was filled in 5'-overhang by Klenow and then subcloned into 
Pme I-digested pcDNA3. l(-). The positive constructs [B7.2/pcDNA3.1(-)] were 
confirmed by DNA sequence. 
Mouse invariant chain (Ii) cDNA came from Dr. Nilabh Shastri, Department of 
Molecular and Cell Biology, University of California at Berkeley. The E80 (aal-80) 
and Bm-spn-2 (aa 21-428) were subcloned into Apa I and EcoR I sites of pcDNA3. 1 
(-) so that a single fusion protein would be expressed. The positive constructs [1i80-
Bm-spn-2/pcDNA3. 1(-)] were confirmed by DNA sequence. 
A vector expressing mouse granulocyte-macrophage colony-stimulating factor 
(GM-CSF), GM-CSFIPRJB, came from Dr. Hildeqund C.J. Ertl, The Wistar Institute 
(USA). 
8.2.5 Bm-spn-2 DNA immunization 
For DNA immunization, the purity of DNA was estimated by measuring its 
absorbance at 260nm and 280nm in a spectrophotometer, with the criterion that the 
ration of 260/280 must be >1.8. Three different plasmid purification kits (Promega 
Wizard Plus Maxipreps, QIAGEN QiAfilter Plasmid Maxi kit, and QIAGEN EndoFree 
Plasmid Mega kit) were tested and only the QIAGEN EndoFree plasmid Mega kit 
purified plasmids satisfied this measure, while the plasmids from other two kits had to 
be further purified by phenol/chloroform/ethanol and then 260/280 >1.8. Therefore, all 
plasmids were purified using QIAGEN EndoFree Plasmid Mega Kits and eluted in 
0.9% sodium chloride solution (Sigma) of 1-2 mg/ml concentration of DNA. 
BALB/c female mice were anaesthetised and hair on the quadriceps muscles was 
removed. 100 jig of each plasmid construct, expressing Bm-SPN-2, I1L-4 and mouse 
granulocyte-macrophage colony-stimulating factor (GM-CSF) [in a final volume of 100 
jil of 0.9% sodium chloride solution] were injected into the quadriceps muscles. Two 
weeks later, the mice were boosted in the opposite leg with 100 jig of plasmid DNA 
and then killed at four weeks after immunisation when sera was collected. The Bm- 
SPN-2 antigen-specific antibody isotypes, total IgG, IgGi, IgG2a, IgG2b and IgG3, 
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were measured by ELISA for each of the individual mice. Fig 8-8 shows that DNA 
immunization using Bm-spn-2/pcDNA3.1(-), not pcDNA3.1(-), induced a very strong 
Bm-SPN-2-specific IgG response; and antibody isotype analysis showed high levels of 
JgG2a and IgG2b, intermediate levels of IgG 1, and undetectable amounts of IgG3. 
However, co-immunization with IL-4/pcDNA3. l(-) or GM-CSFIPRJB did not increase 
Bm-SPN-2-specific antibody levels. Moreover, 1i80-Bm-spn-2/pcDNA3.1(-) did not 
induce any significant antibody. 
8.2.6 Humoral immune response of microfilaremic subjects to 
Bm-SPN-2 
To test the antigenicity of Bm-SPN-2 in human, two groups of subjects, 21 
endemic normal and 21 microfilaraemics from Indonesia, were determined their 
antibodies against Bm-SPN-2. High levels of Bm-SPN-2 specific IgG4 and IgGi were 
found in microfilaraemics group, but not in endemic normal. All microfilaraemics 
patients were Bm-SPN-2 IgG4 positive (Dr. Agnes Kurniawan, personal 
communication). Interestingly, high level of Bm-SPN-2 specific JgG was also found in 
mice (BALB/c and C57) ip B.malayi MI or implanted with adults (Dr. Andrew 
MacDonald, personal communication). 
IgG isotpyes to Bm-SPN-2 in 13 microfilaraemics and 5 endemic normal 
subjects were compared before and after DEC treatment (Fig 8-9). Bm-SPN-2 specific 
IgG4 and IgG 1 decreased dramatically 2 years after DEC treatment. The antigenicity of 
Bm-SPN-2 on T cells from microfilaraemics and endemic normal subjects are now 
tested in Dr. Maria Yazdanbakhsh' s lab (Department of Parasitology, Leiden University 
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Figure 8-8. Bm-spn-2 DNA immunization. Mice (four per group) were immunized 
with, pcDNA3.1(-), Bm-spn-2/pcDNA3.1 and other plasmids (IL-4/pcDNA3.1 and 
GM-CSF/PRJB), and boosted two weeks later. The sera were collected four weeks 
after immunization and Bm-SPN-2-specific antibodies, total IgG, IgG 1, IgG2a, TgG2b 





































Figure 8-9. Changes in Bm-SPN-2 specific IgG4 and IgGi responses in 13 
microfilaremic subjects (-0-) and 5 endemic normal (-•--) from before to 2 years after 
beginning DEC treatment. 
154 
8.3 Discussion 
One of the remarkable features of the Mf stage of B.malayi is its longevity (>1 
year in the bloodstream), testimony to the effectiveness of immune evasion by this 
parasite. The survival of Mf provides a reservoir of infection in an endemic community, 
but also a clear target for intervention. Bm-SPN-2 seems to be an important component 
of the parasites survival strategy, and so it may prove to be an appropriate target for 
vaccination or pharmaceutical attack in order to clear infection both from afflicted 
individuals and endemic communities. Therefore, the T cell antigenicity and vaccination 
potential of Bm-SPN-2 have been tested in this chapter. 
The purified Bm-SPN-2 stimulated large amounts of IFN-y production by T 
cells from mice immunized with Bm-SPN-2 but no IL-4 was observed. Interestingly, 
Bm-SPN-2 produced similar results in T cells from mice immunized with Mf extracts 
although Mf lysate itself stimulated both IFN-'y and IL-4 production from the same cell 
population. The mechanisms for the selection ability of Bm-SPN-2 to stimulate IFN-y 
production is unclear, but a similar phenomenon has been found recently in a 
Leishmania model (Skeiky et al., 1998). These authors reported that lymph node cells 
from L.major-infected mice produced high levels of IL-4 and very little IFN-y when 
stimulated with soluble Leishmania antigens while the reverse (high IFN-y, but no IL- 
4) was found when cells were stimulated with LeIF, a recombinant Leishmania 
protein. It will be very interesting to follow future work on how Bm-SPN-2 stimulates 
exclusively IFN-y production. Indeed, previous work on filariasis in mice showed that 
Mf, but not other stages, drive a Thi response (Lawrence et al., 1994). It is possible 
that Bm-SPN-2, a Mf-stage specific antigen, is one of the molecules inducing the 
selective Th 1 response in the Mf-infected mice model. 
The question of whether Thi or Th2 trye responses are protective against 
filariasis is still far from resolved (Allen and Maizels, 1997). Infection of IL-4-deficient 
mice with B. malayi demonstrates that host resistance is not dependent on a T helper 
2-dominated immune response (Lawrence et al., 1995). Work on bancroftian filariasis 
also showed that Thi-like antifilarial immune responses predominate in antigen-
negative persons (Dimock et al., 1996). Likewise in onchocerciansis, vigorous Thi 
type responsiveness was encountered in endemic normals but such reactivity was not 
present in O.volvulus microfilaridermia-positive individuals (Luder et al., 1996). 
These results from both murine model and clinical work suggest that antifilarial 
immunity might be mediated by Thi responses. Therefore, Bm-SPN-2 was used for 
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vaccination in the mouse model, because Bm-SPN-2 provokes strong Thi-like 
response. We demonstrated that Bm-SPN-2 was able to provide partial protection of 
BALB/c mice against B.malayi Mf. However, vaccination in jirds did not show 
significant protection against Mf when infected with L3. It is possible that in the latter 
case, the adult worms stimulated a overwhelming Th2-like environment, preventing any 
Bm-SPN-2 induced-Thi response, thus abolishing anti-Mf immunity. 
Up to now, no reports of DNA immunization against filarial parasites have 
been published. In this chapter, we tried Bm-spn-2 DNA immunization. The Kozak 
sequence and the whole Bm-spn-2 ORF were cloned into pcDNA3. 1(-), and Bm-SPN-
2 was expressed well in COS-7 cells. Strong antibody responses were found after 
intramuscular injection with Bm-spn-2/pcDNA3.1, and the dominant isotypes are 
JgG2a and IgG2b. The reasons that Bm-spn-2 induced strong immune response could 
be due to 1) the Kozak sequence may increase the translation of non-mammalian genes 
such as Bm-spn-2 in mammalian cells; 2) Bm-SPN-2 is a secreted protein which could 
be more easy taken up by antigen-presenting cells (APC); and 3) Bm-SPN-2 is is 
highly immunogenic. 
A further development in DNA vaccination has been the incorporation of 
molecular adjuvants (cytokines) to drive responses. It was reported that CD4 T cell 
proliferative responses and CD8 Cit activity to a HCV core protein were enhanced 
after coimmunization with GM-CSF in a DNA expression construct, while the Th cells 
was ThO subtype after coimmunization with an IL-4-producing construct (Geissler et 
al., 1997). However, we did not find any significant change of antibody isotype after 
co-immunization with the constructs expression of IL-4 or GM-CSF. 
CD4 T cells recognize MHC 11-bound peptides that are primarily obtained 
from extracellular sources. Endogenously synthesized proteins that readily enter the 
MHC class I presentation pathway are generally excluded from the MHC II presentation 
pathway. Two major pathways by which antigens enter endosomal and lysosomal 
compartments for MHC II presentation to CD4 T cells have been described. The 
traditional pathway involves the phagocytosis or endocytosis of exogenous proteins 
into APC, followed by degradation by acid proteases in the endosomal or lysosome-like 
compartments. A second pathway involves the processing of membrane proteins 
endogenously synthesized by APC. These membrane proteins are believed to enter 
endosomal and lysosomal compartments by internalization from the cell surface. In 
certain experimental systems, cytoplasmic proteins may also enter this endogenous 
MHC II pathway, but normally these antigens are preferentially routed for MHC I 
presentation. At least two molecular approaches that directly route model antigens into 
the MHC II processing and presentation pathway have been reported: 1) the sorting 
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signal of the lysosomal-associated membrane protein LAMP-1 has been utilized to 
target HPV- 16 E7 protein (human papillomavirus 16 E7) into the endosomal and 
lysosomal compartments (Wu et al., 1995); 2) the endosomal targeting signal of the 
MHC 11-associated invariant chain (Ii) has been introduced to allow endogenously 
synthesized model proteins to efficiently enter the MHC 11 presentation pathway 
(Sanderson et al., 1995). It was reported that endogenously synthesized ovalbumin or 
hen egg lysozyme can be efficiently presented as peptide-MHC 11 complexes when they 
are expressed as fusion proteins with the E80 in COS-7 cells (Sanderson et al., 1995). 
It was reasoned therefore that 1180 might enhance the immune response by DNA 
immunization with an 1180-antigen chimeric gene. In this chapter, a 1i80-Bm-spn-2 
chimeric gene in pcDNA3.1(-) was described and tested by DNA immunization. 
Surprisingly, no significant antibodies were found after immunization with li80-Bm-
spn-2/pcDNA3.l(-). This suggests that E80 may inhibit antigen gene expression and/or 
antigen processing in DNA immunization. 
The mechanisms for DNA immunization are likely to be similar to traditional 
antigen presentation. In general, antigen must be processed and presented to T cells by 
professional APC for efficient stimulation of an immune response. Antigen is expressed 
at significant levels in the muscle following intramuscular inoculation of plasmid DNA. 
Muscle cells express or can be induced to express adhesion molecules, cytokines, and 
MHC I and II molecules, but they do not seem to express the costimulatory molecules 
required for efficient antigen presentation. The most important costimulatory molecules 
for T cell activation are B7.1 (CD80)/B7.2 (CD86) and for B cell activation CD40L. 
The B7.1 and B7.2 molecules interact with the CD28/CTLA4 molecules on T cells 
which provide an important second signal in addition to ligation of the T cell receptor to 
the MHC-peptide complex, while the CD40L molecule interacts with the CD40 
molecule on B cells to provide an important second signal in addition to ligation of the 
B cell receptor to the M}IC-peptide complex. Mammalian expression vectors expressing 
B7.1, B7.2 and CD40L have now been made and will be used in the future as 




Cloning, expression and enzyme activity of a novel 
homologue gene of human macrophage migration inhibitory 
factor from B.makzyi 
9.1 Introduction 
Genome projects represent a total departure from the way genes have been 
studied in the past. In recent years, the genomic sequences of at least eight pathogens 
(http://www.tigr.org/tdb/mdb/mdb.html),  yeast (Mewes et al., 1997) and more recently 
the first multicellular organism C.elegans (Consortium, 1998) have been completed. 
Although an entire field of functional genomics has developed around the use of these 
sequence data for evolutionary genetics, new drug discovery, etc, however, there has 
been much less attention paid to searching the new sequence data bases for genes of 
potential for immunological purposes. 
At present two helminth parasite genome projects are now well under way: 
Brugia malayi and Schistosoma mansoni (Johnston et al., 1999), which have already 
provided a substantial amount of sequence information. The genome size of B.malayi 
is about 100 Mb and the number of protein-coding genes is estimated to be about 
18,000. The expressed sequence tag (EST) analysis has been the major activity of the 
filarial genome project to date (Blaxter, 1999). Up to now, eight directionally cloned 
Brugia cDNA libraries have been constructed and served as substrates for EST analysis 
which is a rapid and informative method for analysing the expressed genes of an 
organism. The filarial genome project has submitted over 16,000 ESTs containing over 
5 million base pairs of Brugia sequence data to the public sequence databases (Blaxter, 
1999) (Blaxter, 1998). It is estimated that about 5,000 different Brugia genes are 
represented by these 16,000 ESTs. Based on this large proportion of the total gene 
complement already provided by the Filarial Genome Project, it is now timely to 
exploit filarial genomic information for immunology. 
The immune system is commonly divided into two major branches: innate and 
adaptive immunity (Fearon and Locksley, 1996). The innate response to an invading 
pathogen involves the rapid recognition of general molecular patterns such as 
carbohydrates or other post-translational modifications present on the pathogens 
themselves or in the infected cell. Confrontation of the innate immune system with 
pathogens leads to its activation and prepares the adaptive arm of the immune system to 
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respond appropriately. Adaptive immunity is conveyed by both cellular and humoral 
elements. Through their antigen specific receptors, B and T cells interact with 
pathogens or fragments derived from them, presented on antigen-presenting cells. The 
interconnections that exist between innate and adaptive immunity are crucial: cells and 
soluble mediators of both system interact for greater efficacy and survival value to the 
individual. However, these defences are not perfect, some viral pathogens having 
developed a battery of immune evasion strategies (Ploegh, 1998). Compared to viruses 
and bacteria, helminth parasites have much larger genomes, and therefore have the 
potential to exploit an even larger range of strategies. 
Amongst the most important issues relating to parasite-host interactions is our 
lack of understanding of the mechanisms that result in the induction and maintenance of 
the type of immunity that accommodates chronic, long-term filarial infection. The 
ability to persist in an immunologically competent host has led to the suggestion that 
filarial parasites have evolved specific measures to counter immune defenses. In 
addition to anatomical and physical defenses such as size, motility, and a thick outer 
covering, the cuticle, filarial parasites produce and release immune modulators such as 
proteases (Tamashiro et al., 1987), proteinase inhibitors (Lustigman et al., 1992) 
(Yenbutr and Scott, 1995) and antioxidant proteins (Cookson et al., 1992; Lu et al., 
1998; Tang et al., 1994). These molecules may work locally to neutralize or to interfere 
with the effector molecules of the innate and adaptive defense responses. Whatever 
impact these enzymes and enzyme inhibitors have on local effector mechanisms, it is 
unlikely that their actions account for the systemic immune effects that accompany 
filarial infections. 
This chapter describes a new approach to find possible immune evasion genes, 
such as homologues of human cytokines, from B.malayi by analysing the Filarial 
Genome Project and other databases. This revealed a novel gene Bm-mzf-2, a 
homologue of the cytokine macrophage migration inhibitory factor, from B.malayi. 
Bm-mif-2 gene expressed in most life stages. Recombinant Bm-MIF-2 proved to be 
extremely soluble with potential for structural crystallisation and ligand identification. 
Purified Bm-MIF-2 had extremely high levels of dopachrome tautomerase enzyme 
activity, suggesting Bm-MIF-2 has a role in immune-regulation. By protein 
sequencing, it was shown that the N-terminal methiomne of Bm-MIF-2 was cleaved 
and the next residue proline was exposed. By sequence alignment, the proline residue 
was shown to be invariant among all known members in MIF family, which suggested 
the N-terminal proline may serve as a key base for activity. These features provide a 
possibilities for further mutagenesis studies on the relationship between Bm-MIF-2 
cytokine activity and enzyme activity. 
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9.2 Results 
9.2.1 Analysis of filarial genome project databases revealed two 
homologue genes of human macrophage migration inhibitor 
factor 
The protein sequences of human cytokines and their receptors including IL- 1, 2, 
3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18 and their receptors, MIF, 
granulocyte-macrophage colony-stimulating factor (GM-CFS), tumor necrosis factors 
(TNFs) and their receptors, interferons (IFN) and their receptors, Fas and Fas ligand, 
intercellular adhesion molecules ICAM-1, 2 and 3, etc, have been BLAST searched 
against the filarial genome project database (http://www.ebi.ac.uk/ parasites/parasite 
_blast _server.html). 
Two homologues of the human cytokine MIF (macrophage migration inhibitory 
factor) were found among the B.malayi ESTs, one of which was recently reported as 
Bin -m if (Pastrana et al., 1998). The second homologue was novel and found in two 
EST clones, AA661223 and AA257577 (Fig 9-1). We designated this new homologue 
of human MIF as Bm-mif 2 and its protein as Bm-MIF-2. 
9.2.2 Bm-MIF-2: gene, homology with other MIFs and phylogenetic 
analysis 
The cDNA inserts, Bm-mif-2, in two EST clones (phage stock) were excised 
as pBluescript phagemid and their sequences were determined (Fig 9-2A and 9-213). 
The cDNA insert contained 460 bp and a single open reading frame (ORF) starting at nt 
13 and ending at nt 375 which was followed by a poly A tail. The ORF encoded a 120 
amino acid protein with 1 potential N -glycosylation site at asparagine 110 of the 
deduced amino acid sequence. The analysis of the sequence did not show a signal 
peptide at the N-terminus. The predicted Bm-MIF-2 mature protein would have a 
molecular mass of 13.2 kDa and an isoelectric point of 7.24. 
In GenBank searches for similar amino acid sequences, 19 significant matches 
were found by the BLAST algorithm (Gish and States, 1993) using the NCBI BLAST 
server, all of which belonged to the MIF family. The top 5 matches were C.elegans 
MW-like protein, and rat, mouse, human and bovine MIFs. GenBank, Protein 
Identification Resource and SWISS-PROT databases were searched and a total of 14 
members of the MW family so far have been found. Of these, 8 are from mammalian 
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Query= HumanMacrophageMigrat ionlnhibi toryFactor 
(114 letters) 
Database: /data/web/data/parasites/blastdb/brugia. fasta 
17,185 sequences; 6,546,097 total letters. 
Searching .................................................. done 
Smallest 
Sum 
Reading High Probability 
Sequences producing High-scoring Segment Pairs: 	Frame Score P(N) 	N 
AA848198 KJ4SLBY5B3SL JHU93SL-BmL4 (JHU) Brugia mal... +2 	167 8.le-35 	3 
AA848196 KJ4SLBY5B1SL JHU93SL-BmL4 (JHU) Brugia mal... +1 211 2.0e-33 2 
AA728001 KJ4SLBY6A6SL JHU93SL-BmL4 (JHU) Brugia mal... +2 	180 2.7e-33 	2 
AA542682 MB4SLY2AO8T3 Brugia malayi L4 JHU93SL-BmL4... +3 263 4.3e-33 1 
AA542691 MB4SLY2BO8T3 Brugia malayi L4 JHU93SL-BmL4... +3 	263 4.3e-33 	1 
AA848183 KJ4SLBY5C1OSL JHU93SL-BmL4 (JHU) Brugia ma... +1 263 4.4e-33 1 
AA542746 MB4SLY2HO2T3 Brugia malayi IA JHU93SL-BmL4... +3 	263 4.8e-33 	1 
AA842553 MBAFCW9GO2T3 Brugia malayi adult female CD... +1 263 5.0e-33 1 
AA257366 MB4SLM2A6T3 Brugia malayi L4 JHU93SL-13mL4 ... +3 	263 5.le-33 	1 
AA275427 MB4SLY1DO7T3 Brugia malayi L4 JHU93SL-BmL4... +1 263 5.le-33 1 
AA509091 MBAFCX7BO8T3 Brugia malayi adult female cD... +3 	263 5.le-33 	1 
AA257299 MB4SLM1D2T3 Brugia malayi L4 JHU93SL-BmL4 ... +3 263 5.2e-33 1 
AA275406 MB4SLY1BO7T3 Brugia malayi L4 JHU93SL-BmL4... +3 	263 5.8e-33 	1 
AA275421 MB4SLY1DO1T3 Brugia malayi L4 JHU93SL-BmL4... +3 263 5.8e-33 1 
AA216506 MB2SLJ1EO4T3 Brugia malayi second stage la... +3 	263 6.le-33 	1 
AA848188 KJ4SLBY5A4SL JHU93SL-BmL4 (JHU) Brugia mal... +1 260 l.le-32 1 
.kA257374 MB4SLM2B3T3 Brugia malayi L4 JHU93SL-BmL4 ... +3 	261 l.le-32 	1 
AA275431 MB4SLY1D11T3 Brugia malayi L4 JHU93SL-BmL4... +3 260 1.5e-32 1 
AA842420 MBAFCW8B06T3 Brugia malayi adult female cD... +3 	259 1.8e-32 	1 
AA275430 MB4SLY1D1OT3 Brugia malayi L4 JHU93SL-BmL4... +3 207 1.8e-32 2 
U88035 Brugia malayi macrophage migration inhibitor... +1 	257 2.7e-32 	1 
AA257274 MBAFCZ1A6T3 Brugia malayi adult female cDN... +3 258 3.le-32 1 
AA241467 MBL2SJOF3T3 Brugia malayi second stage lar... +1 	220 1.2e-31 	2 
N44370 SW3ICA1208SK Brugia malayi infective larva c. . +2 229 3.0e-28 1 
H21279 AS3ISB220SL Brugia malayi infective L3 JH1J93. . . +3 	234 3.3e-28 	1 
A1105730 SWAMCAC25AO9SK Brugia malayi adult male cD... +2 228 4.4e-28 1 
AF002699 Brugia malayi macrophage migration inhibit... +2 	181 6.2e-28 	2 
N43325 SW3ICA923SK Brugia malayi infective larva cD. . . +3 210 1.4e-25 1 
AA257613 MBAFCZ2A1T3 Brugia malayi adult female cDN... +1 	201 3.4e-24 	1 
AA257352 MB4SLN1G5T3 Brugia malayi L4 JHU93SL-BmL4 ... +3 187 3.6e-22 1 
AA275535 MBL2SK1AO6T3 Brugia malayi second stage la... +3 	111 l.le-19 	2 
AA275524 MBL2SK1HO8T3 Brugia malayi second stage la... +3 168 1.6e-19 1 
AA257342 MB4SLM1F1T3 Brugia malayi L4 JHU93SL-BmL4 ... +3 	161 1.8e-18 	1 
.AA661223 MB3D6V4C12T3 Brugia malayi day 6 post-infe... +2 151 2.7e-17 1 
AA508925 MBAFCW1C07T3 Brugia malayi adult female cD... +1 	153 6.6e-17 	1 
A1083362 RRAMCA507SK Brugia malayi adult male cDNA ... +1 146 1.8e-16 1 
R47572 SWAMCA075SK Brugia malayi adult male cDNA (5... +1 	138 1.8e-14 	1 
..AA257577 MBAFCZ1E9T3 Brugia malayi adult female cDN... +3 101 3.le-07 1 
AA257701 MBAFCZ3A7T3 Brugia malayi adult female cm... +2 	63 0.14 	1 
AA406735 MBAFCZ3AO7T3 Brugia malayi adult female cD... +2 63 0.17 1 
AA257244 MB4SLM2E1OT3 Brugia malayi L4 JHU93SL-BmL4... +3 	51 0.51 	1 
Figure 9-1. 	The protein sequence of human cytokine macrophage migration 
inhibitory factor (MIF) has been BLAST searched against the filarial genome project 
database. Total 38 significant matches (EST) were found and 2 (arrowed) of which 
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AGGCAGTTTCTAATGCCGCTGATAACGCTTGCTTCGAACGTTCCC 45 
XXZ-MIF2-F 
A S R F P S D F N V Q F T E L 	26 
GCGAGTAGATTTCCGAGTGATTTCAATGTTCAGTTTACGGAATTA 90 
MIF2-RT-F 
M A K M L G K P T S R I L L L 	41 
ATGGCGAAAATGCTAGGAAAACCAACGAGTCGGATACTTTTACTG 135 
V M P N A Q L S H G T T E N P 56 
GTAATGCCAAATGCACAACTATCACATGGCACAACTGAAAATCCA 180 
S C F T V V K S I G S F S A D 	71 
TCATGTTTTACAGTGGTTAAATCGATTGGATCATTTTCGGCTGAT 225 
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AAAAATATTGAATATTCCTCGTTAATATCAGAATTCATGAAGAAA 270 
T L D I D P A H C I I H F L N 	101 
ACATTGGATATC_ATCCAGCGCATTGTATCATTCATTTCTTAAAT 315 
MIF2-RT-R 
D PEN V G COG T TM K E 	116 
TTGGATCCAGAAAATGTTGGATGCAATGGAACAACAATGAAAGAG 360 
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Figure 9-2. 	A: nucleotide and deduced amino acid sequences of the Bm-mtf-2 
cDNA. Inferred amino acid numbering is in bold face. The potential N -glycosylation 
sites (amino acids 110) is circled. Primers used in PCRs are indicated with solid arrow: 
XXZ-MIF2-F (bp 13-29) and XXZ-MIF2-R (bp 372-352), MIF2-RT-F (69-90) and 
MIF2-RT-R (300-282). B: Hydrophilicity plot of the deduced protein sequence of Bm-
mtf-2. 
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and 6 from nematodes. 
The MacVector program version 6.0 was used to carry out multiple alignments 
of Bm-MIF-2 and all other MTFs (Fig 9-3). On this alignment, the amino acid sequence 
of Bm-MIF-2 shows 28 % sequence identity and 82% structural identity with human 
MIF Prof. M.Walkinshaw, personal communication). 7 residues are 100% conserved 
within the MW family, interestingly, 3 of which residues are proline. All MIFs have a 
proline following the initiating methionine. In SWISS-PROT PROSITE the "MIF 
family signature" is designated as [DE]-P-C-A-x(3)-[LIVM]-x-S-I-G-x-[LIVM]-G 
(http:// expasy.hcuge.chlcgi-binlget-prodoc-entry ?PD0C00892), which corresponds 
well to most (but not all) MWs; for example, the exceptions are found at P57 of 
W.bancrofti MIF, S63,T64 and T67 of C.elegans MIF2, and S69 of Bm-MIF-2. All 
of these features would be more clearly understood in the light of a structure for the 
protein. When the existing "MW family signature" is mapped onto the three- 
dimensional structure of human MIF, it is entirely located on 13-sheet 4. Because the 
"old" signature does not correspond to all MIFs, we think it should be modified to a 
"new" MW family signature. 
The three dimensional structure of human MIF has been solved (Sun et al., 
1996) and it provides a useful framework for analysing other members of the family. 
Display of these 100% conserved residues on the three-dimensional structure of human 
MW shows that around the N-teminal P2 (of Bm-MIF-2) are grouped P34 and S63, 
while P56, L88 and 197 cluster around N9 on the other site of the molecule (Fig 9-4). 
These 7 residues (about 6% of the sequence) are conserved across a broad range of the 
evolutionary spectrum, and these can be expected to serve important functional or 
structural roles. 
A phylogenetic comparison of all MIFs was carried out using PAUP, using 
maximum parsimony, excluding constant, and uninformative sites, to indicate the likely 
evolutionary relationship of Bm-mtf-2 to known genes (Fig. 9-5). This analysis 
divides all MIFs into three groups: group I comprising B.malayi MIF-2 and MWs 
from C.elegans; group II containing B.malayi MIF-1, Wbancrofti MW and MIFs 
from human, mouse, rat, jird, bovine, chick; and group III comprising DOPD from 
human, mouse and rat. 
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Figure 9-3. Amino acid sequences comparison of Bm-MIF-2 with all other MIFs: 
human MW and D-dopachrome tautomerase (DOPD), bovine MW, rat MW and DOPD, 
mouse MW and DOPD, jirds MW, chick MIF, C.elegans MIlE homologue 1 and 2, 
W.bancrofti MIlE, B.malayi MIF1 and 2. Gaps were introduced in sequences for 
optimal alignment. Identical residues are highlighted in black and similar residues in 
gray shading. The invariant residues within the MW family are marked with an arrow. 
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Figure 9-4 	Location of total conserved residues within MIF. By sequence 
alignment. 7 residues (about 6% of the sequence) were shown to be invariant across 
the whole MIF family (see Fig 9-3). Display of these residues on the three-
dimensional structure of human MIF (see Sun HW et al, 1996) shows that P2 (of 
Bm-MIF-2), P34 and S63 cluster around the N-terminal proline and N9, P56, L88 and 
197 cluster around N9 on the other site of the molecule. These invariant residues 
represent a broad range of the evolutionary spectrum, and can be expected to serve 















Figure 9-5. 	Phylogenetic trees showing the relationship between the predicted 
protein encoded by Bm-mif-2 and other all recorded MIFs. Numbers above branches 
show the percentage bootstrap support for each dade. 
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9.2.3 Transcription of Bm-mif-2 gene 
The two Bm-MIF-2 EST clones came from different cDNA libraries, 
AA661223 from day 6 post-infection L3 stage larvae SAW96MLW-BmL3d6 cDNA 
library and AA257577 from adult female SAW96MLW-BmAF cDNA library, 
suggesting that Bm-mtf-2 could be expressed at different stages. Expression was first 
investigated by PCR from a range of B.malayi cDNA Libraries. Two Bm-mf 2 gene-
specific primers, MIF2-RT-F (5-'CAATGTTCAGTVFACGGAATFA-3', nt 69-90) 
and MIF2-RT-R (5'-GATACAATGCGCTGGATCG-3', nt 300-282) were designed to 
amplify a 232 bp region of cDNA. PCRs were carried out on 2 p.1 aliquots of each 
cDNA library from B. malayi L3, adult males, adult females and Mf, with two 
primers. 40 cycles of amplification were performed under the following cycling 
conditions: 94 °C for 1 mm, 50°C for 1 min and 72 °C for 1 mm, with a final 10-minute 
extension period at 72 °C. Transcription of Bm-mif-2 was found in every stage. RT- 
PCR was then done. Total RNA from L3, adult males, adult females and MI was 
isolated and reverse transcription was carried out using oligo(dT) as the first primer 
with 1 p.g of total RNA according to the GeneAmp RT-PCR kit protocol. Amplification 
of Bm-mif-2 cDNA was performed using 2 p.1 of first strand cDNA, with the gene- 
specific primers as above. This generated a product of the expected length (232 bp) in 
every stage (Fig 9-6). 
Parallel PCRs were carried out with primers specific for another B.malayi 
gene, tumour protein homologul-1 (tph-1), which is known to be expressed in all 
stages (Gregory et al., 1997). Primers for the tph-1 used published sequence : 5'-
AATGTTGATCTTCAAGGGATGCATTCAC-3' and 5'-TTTGTTVVFCTTCAATGA 
GTGCCTCCTT-3'. A tph-1-specific 575 bp band was found in all RNA preparations 
from the four stages. (Fig 9-6). 
9.2.4 Constructing of Bm-MIF-2/pET-29 vector and expression of 
Bm-MIF-2 protein in E.coli 
The prokaryotic expression vector pET-29c(+) vector was employed to express 
the Bm-MJF-2 ORF as a translational fusion in E.coli with a 8aa His-tag. For 
directional, in-frame cloning into the pET-29c(+) vector, the following primers (Fig 9-
2A) were synthesised: forward primer XXZ-MIF2-F (GGAA1TCCATATGCCG 
CTGATAACGCTTGCT) contains Nde I site and homologous to the bp 13-29 of Bm-
spn-2 cDNA, XXZ-MIF2-R (CCGCTCGAGmCYT'CATAAGCT CTITCAT) 
contains Xho I site homologous to the bp 372-352. The DNA produced by PCR using 
IM 
B'n-inzf-2 
L3 	r/if 	M 	F 
" 	232 l 
tph-1 
L3 	Mf 	NI 	F 
-0-  575 1)1) 
Figure 9-6. 	Transcription of' B,n-ini/-2 at different development stages of B. 
nzalayi tested by RT-PCR. RNAs isolated from L3, Mf, adult males (lane M) and adult 
females (lane F) were processed to obtain double-stranded cDNA. The cDNAs were 
then used as templates to amplify a 232 bp fragment from Bin-,nif-2 or a 575 bp 
fragment from B. ,nalayi tph-1. 
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primers XXZ-MIF2-F and XXZ-MIF2-R was subcloned into pET-29c(+) Nde I and 
Xho I site to express Bm-MJF-2. 
The positive constructs were examined by DNA sequence to confirm that the 
cloned DNA were correct, and then transformed into E.coli strain BL21 (DE3). 10 ml 
of LB containing kanamycin was innoculated with a single transformed colony and 
grown overnight at 37°C. The following day 200-fold dilutions of culture into LB 
containing kanamycin were made and grown at 37°C for 60-120 mm. Cultures were 
then induced with 1 mM IPTG for 3- 5 h. Protein expression was analysed by SDS-
PAGE. This showed that the recombinant Bm-MIF-2 was extremely soluble at a very 
high level when expressed in bacteria. 
9.2.5 Bm-MIF-2 protein purification and N-terminal sequencing 
Purification of Bm-MIF-2 protein was performed according to the new protocol 
as described in detail in chapter 2, modified from Holzinger' s protocol (Holzinger et 
al., 1996). The cell-free extract containing soluble protein was applied to a Ni 2 -NTA 
affinity resin column, and the column then washed with binding buffer, wash buffer, 
and Tris-buffered saline (TBS, 150 mM NaCl; 20 mM Tris-HC1, pH 7.9). The bound 
Bm-MIF-2 protein was eluted with TBS containing 50 mM EDTA (TBSE) and then 
dialysed against TBS for 24-48 h at 4°C to remove the EDTA. Fig 9-7A depicts the 
purified Bm-MIF-2 protein as visualised on a SDS-PAGE gel. 
The purified Bm-MIF-2 protein was sent to Dr. Lu Jiang, the Center for 
Protein Technology, University of Edinburgh, for high-performance liquid 
chromatography (HPLC) analysis. HPLC analysis showed that no obvious impurity in 
the Bm-MIF-2 preparation (Fig 9-7B). 
Direct N-terminal sequencing of native MW from two species (bovine and 
murine) reveals that the initiating methionine is removed in both cases, resulting in a 
protein with a proline at the N-terminus (Bernhagen et al., 1994; Galat et al., 1993). 
Therefore, the purified recombinant Bm-MIF-2 protein was sent to Dr. Andrew 
Cronshaw, Department of Biochemistry, University of Edinburgh, for the N-terminal 
protein sequencing. The results (Fig 9-8) showed that > 95% of the first residue is 
proline and < 5% is methionine. Subsequent residues were leucine, isoleucine, 
threonine and leucine, compliate to the N-terminal protein sequence. These results 
demonstrated that the initiating methionine of recombinant Bm-MJF-2 protein, like 
bovine and murine native MIFs, was cleaved so exposing the next residue, proline. 
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Figure 9-7. Recombinant Bm-MIF-2. A: purification of the Bm-MIF-2-HM-tag 
fusion protein from E.coli BL21 (DE3) cells with Ni 2 -NTA affinity chromatography. 
Coomassie blue-stained SDS-PAGE of purified Bm-SPN-2 protein and molecular mass 
standards as indicated on the left. B: high-performance liquid chromatography analysis 
of purified Bm-MW-2 protein. 
171 
AMINO ACID * 	2 	 ( 26 Jar, 999 	6;0S2m J 	
.I*Ø FU 
r1t,.a o.t. 	 I 
15.0 	 26.0 
Retention Time; MinLitee 
AMINO ACID * 	 E 20 Jn 1999 	7;300m 3 	 .05.010* Eu 
r;ttrd DM*  
15.0 	 iLl 
Ret.ntimn Tam.; MtnLit.0 
- - 	 - 	 .' 	 . '- - I 	 UI  
Retntion Tim.; Mint. 
Retention Tim.; Mtniee 
172 
- o1ied BleasustAmn iT?D Protein Sem,ennar Chrnr.etnnree Renur-t 
SAMPLE : BM-MIF-2 1(2 
C Initiated 26 Jan 1999 	4:49pm 1 
CYCLE SUMMARY 
Reaction cycle 	z FAST-R2- 	 aat'colIec* fjpje : 0.0 to 22.0 min 
Conversion cycle : FAST-1 Data interval 	1.0 eec 
Gradient 	 : FAST--2 	 Inject volume 50 of 159 uL 
Retention Time: 	Minutes 
PEAK TABULATION : C 100% injection I Calibration : S-987 
Peak R.Tima C.Time Height Pi'rnl I Peak R.Time C.Time Height Pmol 
ID (min) (min) (uAU) I 	ID (mm) (min) (UAU) 
ASP 4.17 4.25 135 0.15 FNET 14.47 14.95 4347 7.21 
ASN 4.52 4.83 585 0.82 I 15.48 2550 
5.07 1428 I 	OPT 16.03 16.43 240 0.51 
SEA 5.37 5.47 531 1.51 I 16.32 27987 
THR 5.58 5.82 702 1.99 I 16.73 373638 
SLY 5.82 6.18 873 2.00 I 	TAP 17.93 18.48 18381 29.62 
SLU 5.43 6.72 2220 2.00 1 PHE 18.77 19.12 492 1.01 
OtIP 6.80 7.15 15 0.21 I 	ILE 19.12 19.45 507 3.43 
HIS 7.83 8.12 60 5.60 I LEU 19.83 20.18 21 0.04 
ALA 8.17 8.55 897 1.73 I 	LYS .20.18 20.55 501 1.38 
ARS 10.02 10.35 282 5.59 I 
TYR 11.02 11.33 114 0.17 I 
12.27 2583 I 
PRO 13.48 13.72 62091 108.29 I 
CYS 14.07 14.65 27 0.06 I 
Tabulation threshold 1 999 uAU 
Figure 9-8. The N-terminal protein sequencing of purified recombinant Bm-MIF-2. 
The results showed that the first residue, > 95% is proline and < 5% is methionine, 
followed by leucine, isoleucine, threonine and leucine, demonstrating that the initiating 
methionine of recombinant Bm-MIF-2 protein, like bovine and murine native MIFs, 
was cleaved so that the next residue proline was exposed. 
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recent work on human MIF demonstrated that an exposed N-terminal proline is required 
for both enzymatic and cytokine activity (Swope et al., 1998). 
9.2.6 Dopachrome tautomerase activity of Bm-MIF-2 
One of the most striking features of MW is the catalytic activity described as D-
dopachrome tautomerase (Rosengren et al., 1996). Recently work revealed a direct link 
between this activity of MW and its cytokine properties (Swope et al., 1998). Purified 
Bm-MIF-2 was sent to Dr. David Meyer, Department of Infectious and Tropical 
Diseases, London School of Hygiene and Tropical Medicine, to dertermine if Bm-MJF -
2 possessed dopachrome tautomerase activity. Interestingly, purified Bm-MIF-2 
showed extremely high levels of this enzyme activity with specificity for D-
dopachrome, but not for L-dopachrome and L-dopachrome methyl ester (Fig 9-9), 
suggesting that Bm-MIF-2 may have a role in immune-regulation. 
9.2.7 Immune-cross reaction between Bm-MIF-1 and Bm-MIF-2 
Bm-MIF-1 was found recently to be expressed by all stages as an excretory-
secretory product (Pastrana et al., 1998). Mouse antisera against Bm-MIF-1 and 
purified Bm-MIF- 1 from Dr. Alan Scott, Department of Molecular Microbiology and 
Immunology, School of Hygiene and Public Health, Johns Hopkins University were 
used for Western blotting to test for immunological cross-reaction between Bm-MW- 1 
and Bm-MIIF-2. Fig 9-10 shows that antisera recognized Bm-MIF-1, but not Bm-MIF-
2 and Bm-SPN-2. 
9.2.8 Mutants of Bm-MIF-1 and 2 
The pET-29c(+) vector was employed to express the Bm-MIF-1 ORF as a 
translational fusion in E. co/i with a 8aa His-tag. For directional, in-frame cloning into 
the pET-29c(+) vector, the following primers were synthesised: forward primer XXZ-
MW1-F (CCATATGCCATATYFTACGATTGATAC) contains Nde I site and XXZ-
MIF1-R (CTCGAGTCCCAAAGTAGATCCATTAAAAGC) contains Xho I site. The 
DNA produced by PCR using primers XXZ-MIF1-F and XXZ-MIF1-R was 
subcloned into pET-29c(+) Nde I and Xho I site to express Bm-MIF-1. The 
recombinant Bm-MW- 1 was purified using the same protocol as Bm-MW-2. Fig 9-11 
depicts the purified Bm-MIF- 1 protein as visualised on a SDS-PAGE gel. 
To make the mutants of Bm-MIF-1 and 2, primers XXZ-MIF1-G2 (CCATA 
TGGGATAT1TFACGATI'GA) instead of XXZ-MIF1-F and XXZ-MIF2-G2 (CCAT 
174 
ATGGGGCTGATAACGCTTGC) instead of XXZ-MIF2-F were used in PCR to 
express the Bm-MIF-1 ORF (P2 to 02) and Bm-MIF-2 ORF (P2 to G2) as 
translational fusion in E.coli with a 8aa His-tag. The two recombinant mutants, Bm-





I 	 I 
0 	 2500 5000 	 7500 	 10000 
Bm-MIF-2 Dopajase actiuitg 
(pmol/min/mg) 
Figure 9-9. Dopachrome tautomerase activity of Bm-MIF-2. The purified Bm- 
MIF-2 showed extremely high levels of dopachrome tautomerase enzyme activity with 
specificity for D-dopachrome, but not for L-dopachrome and L-dopachrome methyl 
ester. 
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Figure 9-10. Lack of immunological cross-reaction between Bm-MJF-1 and Bm-
MIF-2. Western blot of purified Bm-MW-1 (lane 1), purified Bm-MIF-2 (lane 2) and 
purified Bm-SPN-2 (lane 3 negative control) probed with mouse antisera against Bm-
MW- 1. Recognition of the Bm-MIF- 1 band in lane 1 is arrowed. 
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Figure 9-11. Purification of the Bm-MIF-1 protein from E.coli BL2I (DE3) cells 
with Ni" -NTA affinity chromatography. Coomassie blue-stained SDS-PAGE of 
BL2 1 (DE3) cells containing the Bm-SPN-2/pET-29 plasmid prior to (lane 1) and 
following (lane 2) IPTG induction. Purified Bm-SPN-2 protein is shown in lane 3. 










M 	1 2 	3 4 
Figure 9-12. Expression of Bm-MIF-l(G2) and Bm-MIF-2(G2) in E.coli. Lane 
M: molecular mass standards; Lanes 1 and 2 show total cell extracts before and after 
IPTG induction and the arrow makes the Bm-MIF- 1 (G2) recombinant protein band in 
lane 2; Lanes 3 and 4 show total cell extracts before and after IPTG induction and the 
arrow makes the Bm-MIF-2(G2) recombinant protein band in lane 4. 
178 
9.3 Discussion 
In order to survive immune attack, pathogens have adopted a variety of 
strategies to evade or modify immune responses. There is an increasing appreciation 
that one of the approaches used by pathogens is to produce homologues of host 
molecules that are important in immune signalling to blunt or divert inflammation. This 
approach has been best documented with viruses (Ploegh, 1998). Cytokines are 
secreted proteins that regulate immune and inflammatory responses, and many viruses 
would benefit from antagonism of cytokine activity. Cytokines can be either positive or 
negative regulators of the immune response, and for this reason, some viruses encode 
their own cytokines. E-B virus encodes a protein homologous to the cellular cytokine 
IL-10 (Zdanov et al., 1997), which is a negative regulator of IL-12, itself a cytokine 
that both promotes IFN-y production and has a profound impact on the development of 
Thi- and Th2-like cytokine-producing cells. EBV-encoded IL-10 can also down-
regulate TAP expression, as does its cellular counterpart (Zeidler et al., 1997). 
Poxviruses secrete chemokine-like molecules and chemokine binding factors that result 
in altered trafficking of infiltrating leukocytes into areas of virus infection (Krathwohl et 
al., 1997; Lalani and McFadden, 1997). While herpesvirus-8 encodes IL-6 homologue 
which shares functional properties with endogenous IL-6 protein (Nicholas et al., 
1997). 
There is remarkably little information available about cytokine-like molecules 
from parasites. Using human cytokine sequences to search the Filarial Genome Project 
database, it is reported here that a novel homologue of the human cytokine macrophage 
migration inhibitory factor is expressed by B.malayi. This gene, Bm-mif-2, encodes a 
120 amino acid protein with 1 potential N -glycosylation site. Like other MIPs which 
are secreted proteins, Bm-MIF-2 does not contain a conventional signal peptide at the 
N-terminus. Interestingly, recombinant Bm-MIF-2 protein was extremely soluble 
when expressed in bacteria and purified by affinity chromatography, which provides a 
possibility for structural studies, crystallisation and ligand identification in the future. 
The three dimensional structures of human MW (Sun et al., 1996) and rat MW 
[Suzuki, 1996] have been solved and extremly similar providing a useful framework 
for analysing other members of the family. The human MW is a trimer of identical 
subunits. Each monomer contains two antiparallel a-helices that pack against a four- 
stranded p3-sheet. The monomer has an additional two j3-sheet that interact with the 3- 
sheets of adjacent subunits to form the interface between monomers. By sequence 
alignment, we found that 7 residues are 100% conserved within the IvllF family and, 
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by reference to the three-dimensional structure of human MIF, two conserved clusters 
can be discerned. The N-terminal site around P2 was recently found to be the base for 
catalytic activity (Swope et al., 1998a; Swope et al., 1998a). However, no any 
functional data has been reported for the cluster around N9 revealed in this chapter. It 
should be noted that, in the crystal structure (Rosengren et al., 1996), MW clearly has 
several possible ligand-binding sites, so it would be interesting to see if the second 
cluster has some specific functions. 
MIIF is unique among known cytokines in that it also catalyzes chemical 
reactions. It has been reported to possess at least three catalytic activities: D-
dopachrome tautomerase (Rosengren et al., 1996), hydroxyphenipyruvate tautomerase 
(Rosengren et al., 1997), and enzyme activity toward oxidized catecholamines 
(Matsunaga et al., 1999). D-dopachrome tautomerase, a nonphysiological reaction 
which involves the conversion of D-dopachrome methyl ester to 5,6-dihydroxyindole-
2-carboxymethylester, was discovered fortuitously during the study of melanin 
biosynthesis (Rosengren et al., 1996). Subsequently, hydroxyphenlpyruvate 
tautomerase, which catalyzes the keto-enol isomerization of both p-
hydroxyphenlpyruvate and phenylpyruvate, was discovered in an attempt to identify 
natural ligands for MW (Rosengren et al., 1997). More recently it was shown that MW 
is able to catalyze the conversion of 3,4-dihydroxyphenylaminechrome and 
norepinephrinechrome, toxic quinone products of the neurotransmitter catecholamines 
3,4-dihydroxyphenylamine and norepinephrine, to indoledihydroxy derivatives that 
may serve as precursors to neuromelanin (Matsunaga et al., 1999). Interestingly, recent 
work demonstrated by mutagenesis a direct link between cytokine activity (neutrophil 
priming) of human MW and its dopachrome tautomerase activity (Swope et al., 1998). 
In this chapter, purified Bm-MIF-2 is shown to have extremely high levels of 
dopachrome tautomerase enzyme activity, suggesting Bm-IVIIF-2 has a role in immune-
regulation. Moreover, by protein sequencing, the N-terminal methionine of Bm-MIF-2 
was found to be cleaved and the next residue proline was exposed. By sequence 
alignment, this proline residue was shown to be invariant among all known members in 
MW family, which suggests that it may serve as a key base for activity. These results 
provide a system for mutagenesis studies on the relationship between Bm-MIF-2 
cytokine and enzyme activities. The two mutants of Bm-MIFs will be used for such 
studies. 
MW was one of the first cytokine to be identified, having been described 
originally as a I lymphocyte factor that inhibited the random migration of macrophages 
(Bloom and Bennett, 1966; Davia, 1966). With the cloning of genes encoding human 
and mouse MW (Mitchell et al., 1995; Weiser et al., 1989), its perception as a T-cell- 
derived molecule that simply functions to inhibit macrophage migration has been 
expanded to an appreciation that the sources of IvllF are diverse and its actions are 
complex. Macrophages, in addition to T cells, have been shown to be both an important 
target for, and a major source of, IvllF (Calandra et al., 1994). MTF is also produced 
by eosinophils (Rossi et al., 1998), the 3 cells of the islets of Langerhans (Waeber et 
al., 1997), the differentiating cells of the eye lens (Wistow et al., 1993), the 
corticotrophic cells of the anterior pituitary gland (Bemhagen et al., 1993), and the cells 
of the basal layer of epidermis and keratinocytes (Shimizu et al., 1996). 
As the cellular sources of MJF have become increasingly complex, so too have 
the MW-related immune functions. MIF has a direct effect on T cell activation and 
antibody production (Bacher et al., 1996), plays a critical role in the innate host 
response to staphylococcal and streptococcal exotoxins (Calandra et al., 1998), 
associated with the macrophage infiltration in delayed-type hypersensitivity lesions 
(Bernhagen et al., 1996), B cell apoptosis (Takahashi et al., 1999), 
glomerulonephritis (Lan et al., 1996), rheumatoid (Onodera et al., 1999) and collagen-
induced arthritis (Mikulowska et al., 1997), and acute respiratory distress syndrome 
(Donnelly et al., 1997). Recently MW has been shown to inhibit NK-cell-mediated 
cytotoxicity by preventing the release of perform (Apte et al., 1998). The T-cell-derived 
glycosylation inhibition factor that regulates 1gB synthesis by B cells has been shown to 
be identical to MW [Mikayama, 1993]. Preformed MW is released from macrophages 
and other cells after stimulation with LPS, IFN-y and TNF-a (Calandra et al., 1994) 
(Hirokawa et al., 1998). Glucocorticoids also induce the release of MW from 
macrophages and T cells, and in this context MW functions to override the strong 
suppressive action that steroids have on T cell proliferation and cytokine production 
(Bacher et al., 1997). MW appears to fill an important gap in our understanding of how 
the host initiates and controls the immune response. Because glucocorticoids are an 
integral part of the host's metabolic "stress" response to infection or tissue invasion, the 
role of MW is to act at an inflammatory site or lymph node to counterbalance the 
inhibitory effects of steroids on the immune response. 
The important role of MW in immune responses and in disease pathogenesis 
makes the finding of two MW molecules from the parasite B.malayi particularly 
important. These findings raise the question of why a parasite would release a molecule 
that functions in attracting cells important in immune signalling and defense. 
Interestingly, recent work showed that large number of macrophages are recruited into 
the peritoneal cavity when B.malayi are implanted into mice (MacDonald et al., 1998). 
It is possible that the parasites produce MW to attract host macrophages as the first step 
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in a process that leads to alterations in their induction and/or effector functions. MIF or 
other ES molecules may change the levels of certain cytokines produced by antigen-
presenting cells, creating an immunological environment that promotes parasite 
survival. This may, in part, explain the strong Th2 bias seen in the majority of 
chronically infected individuals. Further studies on the filarial MW homologues will be 
aimed at addressing these questions. Another potential reason for manipulation of the 
cytokine profile may be to obtain host-derived factors necessary for parasite 
development. Cytokines have been shown to be essential for growth and reproduction 
in both protozoan (Bakhiet et al., 1996) and helminthic parasites (Amiri et al., 1992). 
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Chapter 10 
General discussion and future work 
10. 1 Identifying T cell antigens: needles in haystacks 
T cells are key players in the induction and regulation of immune responses and 
in the execution of immunological effector functions. Specific immunity against 
infectious agents and tumours is dependent on these cells and they are believed to 
contribute to the healing of injuries. On the other hand, failure to control specificity and 
activity of these cells can lead to autoaggression. Elucidation of the rules that control 
antigen recognition by T cells is prerequisite for understanding the specificity of T-cell 
mediated immunity in general, as well as the basis for rational approaches to vaccine 
development, immunotherapy of cancer, and autoimmune diseases. 
The clonotypic antigen-receptor (TCR) of virtually all CD8 or CD4 T cells is 
engaged by peptide-MHC class I or class II complexes, respectively, and the TCR 
ligand thus requires the identification of both the particular MHC molecule and the 
peptide that it presents to the T cell. Each individual animal expresses only a few types 
of MHC molecule, but each of these MHC molecules normally displays thousands of 
distinct antigenic peptides derived from a large set of donor proteins. In contrast to the 
relatively simple problem of identifying which one of the available MHC molecules is 
part of the TCR ligand, the problem of identifying the unique peptide sequence is far 
more challenging, particularly because only a few peptide copies are sufficient for T-cell 
stimulation (Kageyama et al., 1995; Malarkannan et al., 1995). 
During the past few years it has become generally accepted that T cell-mediated 
immune responses are key determinants of the natural course of infections caused by 
intracellular or extracellular parasites. Thus T cell-activating proteins of these parasites 
continue to generate active interest, particularly in view of their possible role in the 
design and development of newer and more effective diagnostic tests and vaccines. The 
understanding of parasite-specific immune responses and development of vaccines 
inevitably requires identification and characterization of parasite antigens recognized by 
T cells. Although parasite-specific T cells have been implicated in mediating both 
pathogenic and protective immune responses in a number of filarial infections, the 
nature of the antigens inducing such responses remains poorly studied. The apparent 
lack of knowledge about these antigens may be partly attributed to low protein recovery 
when classical purification techniques are used; in addition, the availability of crude 
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parasite antigen is limited. Selection of candidate antigens for vaccine against human 
lymphatic filariasis is a difficult problem for both practical and theoretical reasons. The 
helminth B.malayi contains multiple stage-specific and shared antigens in its 
developmental stages. Identification, isolation, and chemical analysis of putative 
protective molecules are complicated by the structural and biochemical complexity of 
this multicellular organism. 
In this thesis, the T cells from a desired immune response profile (mixed 
Thl/Th2) against Mf proteins were used to screen for Mf T cell antigens from fractions 
separated by FPLC and SDS-PAGE electro-elution. A novel serpin (Bm-SPN-2) was 
found to be a T cell antigen. The Bm-spn-2 gene was abundantly and exclusively 
expressed by the Mf stage, demonstrating a stage-specific antigen in B.malayi. 
Interestingly, Bm-SPN-2 specifically inhibited enzymatic activities of human neutrophil 
cathepsin G and elastase. In the future work I would like to answer how Bm-SPN-2 
may directly interfere with immune function by inhibiting of activities of neutrophil 
cathepsin G and elastase in vivo. 
10.2 Novel strategy for directly identifying T cell antigens 
Compared to viruses and bacteria, parasites have much larger genomes, and 
arguably will contain more T cell-stimulating antigen genes. However, the major T cell 
antigens of most parasite species are still undefined, due to present difficulties 
identifying CD4 T cell-stimulating epitopes [Shastri, 1996] (Walden, 1996). The use 
of antibodies present in "immune" serum to screen cDNA libraries has so far been the 
major tool for identifying T cell antigens, based on the view that B cell antigens should 
also contain T cell epitopes. While the presence of serum antibodies against parasite 
antigens is certainly proof that the antigens are "seen" by the host's immune system 
during natural infection, the complexity of the serum response is such that it is generally 
impossible to select any particular antigen among the vast array of antigens recognised. 
It is quite likely that many predominant T cell antigens have been missed by antibody 
screening. Therefore, some new approaches have been tried to directly screen T cell 
determinants, and so far only two T cell antigens, Ldp23 from Leishmania donovani 
(Campos-Neto et al., 1995) and LACK from Leishmania major (Mougneau et al., 
1995), have been identified from parasites by such means. We believe that there is a 
urgent need to develop a novel approach for direct identification of CD4 T cell 
antigens from parasites. 
One of my future plans is to set up a novel high-throughput approach to directly 
screen for CD4 T cell antigen genes. This system will consist of several elements and 
steps: 1) B. malayi-specific CD4 T cells or/and T cell hybridomas from mice implanted 
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with B.malayi; 2) B.malayi cDNA library in bacterial palsmid vectors such as pET-29 
or pTrcHis2 TOPO-TA which are designed for inducible, high level intracellular 
expression of genes; 3) individual pool of 10-50 clones of B.malayi cDNAlplasmid 
library to be plated into each well of 96-well plates and the expression of recombinant 
proteins to be induced by IPTG; 4) thioglycolate-recruited peritoneal macrophages to be 
plated into each well and to be fed with irradiated recombinant bacteria expressing the 
antigen genes; 5) B.malayi-specific CD4 T cells or T cell hybridomas to be plated into 
each well and to incubate for 1-3 days; 6) the IL-2 or IL-4 released in supernatant from 
the incubation to be measured by NK cell assay; 7) single T cell antigen gene would be 
finally cloned and characterized. Preliminary experiments using Bm-SPN-2 as a model 
antigen has suggested that this new approach works (Fig 10-1). As an alternative to 
B.malayi cDNA/plasmid library expressed in bacteria, cell-free, single step, coupled 
transcription-translation system would be explored to express proteins, which would 
make the whole system much simpler. 
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Figure 10-1.Peritoneal macrophages (10 5/well) were activated by 100 U/mi IFN-y 
overnight, and fed with 106  dead E.coli expressing Bm-SPN-2 (Bm-spn-2/pET-29), 
Bm-CPI-1 (Bm-cpi-1/pET-29), or recombinant Bm-SPN-2 (50 ig/ml) for 3 h. 
Extraceliular bacteria were washed off and purified CD4 T cells 
(105  /well) from mice 
immunized with Bm-SPN-2IIFA were added. ConA, 2 mg/ml as positive control. CD4 
T cell proliferation and cytokines were tested. 
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10.3 Cytokine genes from parasites: what can immunologists learn 
from genome projects? 
Genome projects represent a total departure from the way genes have been 
studied in the past. In recent years, the genomic sequences of at least eight pathogens 
(http://www.tigr.org/tdb/mdb/mdb.html),  yeast (Mewes et al., 1997) and more recently 
the first multicellular organism C.elegans (Consortium, 1998) have been completed. 
Although an entire field of functional genomics has developed around the use of these 
sequence data for genetic evolution, new drug discovery, etc, however, there has been 
much less attention on the use of these sequence data in immunology. 
At present two helminth parasite genome projects are now well under way: 
Brugia malayi and Schistosoma mansoni ( Johnston et al., 1999), which have already 
provided a huge amount of sequence information. The filarial genome project has 
submitted over 17,000 ESTs containing over 5 million base pairs of Brugia sequence 
data to the public sequence databases (Blaxter, 1999) (Blaxter, 1998). It is estimated 
that about 5,000 different Brugia genes were found from these 17,000 ESTs. Based on 
that the Filarial Genome Project has already provided a large number of sequences, we 
believe it is well worth pursuing to exploit filarial genomic information in immunology. 
One part of work on this thesis seeks to find possible immune evasion genes 
such as homologues of the human cytokine genes from B.malayi by analysing the 
Filarial Genome Project and other databases. This revealed a novel gene Bm-mtf-2, a 
homologue of the human cytokine macrophage migration inhibitory factor, from 
B.malayi. Bm-mzf-2 provides a good template for further study in detail of parasite-
derived possible immune evasion genes. Over the coming few years, I expect an 
explosion of using genomic information for immune evasion genes. 
10.4 Structure and immune-regulation of Bm-MIF 
The vertebrate body is an ideal breeding ground for parasites and provides the 
conditions that promote their growth, survival, and transmission. The immune system 
has evolved to deals with this challenge. Mutually assured destruction is not a viable 
evolutionary strategy; thus, the study of host-parasite interactions provides not only a 
glimpse of life at immunity's edge, but it has also illuminated essential functions of the 
immune system, in particular, the area of antigen presentation and T cell development. 
The most likely immune evasion genes from parasites would be those encoding 
cytokines and receptor-like molecules such as Bm-MIF. 
10. 
I propose in future to analyse the structure and function of Bm-MIF- 1 and 2. 
Recombinant Bm-MIIF-1 and 2 was extremely soluble when expressed in bacteria and 
purified by affinity chromatography, which provides the possibility of crystallisation 
for structural studies. The 3D structure of Bm-MIF-1 and 2 should give a sharper 
profile of the degree of molecular mimicry of the host protein which may have evolved 
in the parasite to evade immune responses. The 3D structure would also provide a 
template for the design of inhibitory ligands and may provide leads for new antiparasitic 
drugs. 
Surprisingly, the receptor or ligand for MW has not been found yet, while Bm-
MIF-2 has high activity and contains a small His.tag, so purified recombinant Bm-MIF-
2 could be an excellent molecule for screening possible MW receptor or ligand. 
By protein sequencing, we found that the N-terminal methionine of Bm-MIF-2 
was cleaved and the next proline residue was exposed. We also found, by sequence 
alignment, the proline residue to be invariant among all known members in the MW 
family, which suggested the N-terminal proline may serve as a key base for activity. 
These results provide a basis for further mutagenesis studies on the relationship 
between Bm-MIF-2 cytokine activity and enzyme activity; for example, the N-terminal 
proline was mutated to glycine to see if the activities of Bm-MW- 1 and 2 is lost. 
Recombinant Bm-MIF-2 showed extremely high levels of dopachrome 
tautomerase enzyme activity with specificity for D-dopachrome, suggesting Bm-MIF-2 
has a role in immune-regulation. There are two main areas to be exploited. First, the 
effect of Bm-MIF on the antigen processing pathway in APC (macrophages and 
dendritic cells) will be assessed; and secondly the impact of Bm-MIF on the 
development of naive T cell differentiation will be exploited. 
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PHAGOCYTES 
A Novel Serpin Expressed by Blood-Borne Microfilariae of the Parasitic 
Nematode Brugia malayi Inhibits Human Neutrophil Serine Proteinases 
By Xingxing Zang, Maria Yazdanbakhsh, Haobo Jiang, Michael R. Kanost, and Rick M. Maizels 
Serine proteinase inhibitors (serpins) play a vital regulatory 
role in a wide range of biological processes, and serpins from 
viruses have been implicated in pathogen evasion of the 
host defence system. For the first time, we report a func-
tional serpin gene from nematodes that may function in this 
manner. This gene, named Bm -sprit -2, has been isolated from 
the filarial nematode Brugia malayi, a causative agent of 
human lymphatic filariasis. Polymerase chain reaction (PCR) 
and Western blot experiments indicate that Bm -spn -2 is 
expressed only by microfilariae (Mf), which are the long-lived 
blood-dwelling larval stage. A survey of the greater than 
14,000 expressed sequence tags (ESTs) from B malayidepos-
ited in dbEST shows that greater than 2% of the ESTs 
sequenced from Mf cDNA libraries correspond to Bm -spn -2. 
Despite its abundance in the microfilarial stage, Bm -spn -2 
has not been found in any other point in the life cycle. The 
predicted protein encoded by Bm -spn -2 contains 428 amino 
acids with a putative signal peptide. Antibodies to recombi-
nant Bm-SPN-2 protein react specifically with a 47.5-kD 
S ERINE PROTEINASE inhibitors (serpin) genes comprise a large gene family.' and their protein products regulate a 
wide variety of proteinase-dependent physiological functions, 
such as blood coagulation, 2 fibrinolysis. 3 activation of comple-
ment, and the inflammatory response. 4 In addition to these 
fluid-phase reactions, serpins have critical roles in cell interac-
tions and mobility, eg, maspin suppresses invasion and motility 
of mammary tumor cells-; plasminogen activator inhibitor I 
(PAl- I) blocks migration of smooth muscle cells, 6 whereas 
PAI-2 can prevent apoptosis in cells exposed to tumor necrosis 
factor-(x (TNF-). 7 
Infectious organisms have evolved an array of specific 
adaptations to evade the host defence system. 69 In view of the 
potency of serpin regulation of biological processes, it seems 
likely that pathogens may themselves encode serpins and use 
them to block host defense functions. For example, virus-
encoded serpins prevent the proteolytic activation of interleu- 
From the Institute of Cell, Animal and Population Biology, University 
of Edinburgh. Edinburgh, UK: the Department of Parasitology, Leiden 
University Medical Center Leiden, The Netherlands: and the Depart -
ment of B,ochenzistrv. Kansas State University, Manhattan, KS. 
Submitted November /1, 1998: accepted April /9, 1999. 
Supported by grantsfroin the European Union (INCO-DC 1C18-C795-
0014) and from the National Institutes of Health (GM41247). 
The nucleotide sequence data reported in this paper are available in 
GenBank database under the accession nos. AF009825 and AF009826. 
Address reprint requests to Rick M. Maizels, PhD, Institute of Cell. 
Animal and Population Biology, University of Edinburgh, Edinburgh 
EH9 3JT UK: e-mail: rrnaizels@ed.ac.uk  
The publication costs of this article were defrayed in part by page 
charge payment. This article must therefore be hereby marked "adver-
tisement" in accordance with 18 U.S.C. section 1734 solely to indicate 
this fact. 
© 1999 by The American Society ofHeniatology. 
0006-4971/99/9404-0003$3.O0/0  
native protein in Mf extract. Bm-SPN-2 is one of the largest 
of the 93 known serpins, due to a 22 amino acid carboxy-
terminal extension, and contains the conserved serpin signa-
ture sequence. Outside these regions, levels of homology are 
low, and only a distant relationship can been seen to a 
Caenorhabditis elegans serpin. The Bm -spn -2 gene contains 
6 introns, 2 of which appear to be shared by both nematode 
species. The B malayi introns have an extended and con-
served 3 splice site and are relatively large compared with C 
elegans. A panel of mammalian serine proteinases were 
screened and Elm-SPN-2 protein was found to specifically 
inhibit enzymatic activity of human neutrophil cathepsin G 
and human neutrophil elastase, but not a range of other 
serine proteinases. It is possible that Bm-SPN-2 could func-
tion as a stage-specific serpin in the blood environment of 
the microfilarial parasite in protection from human immunity 
and thus may be a good candidate for protective vaccine. 
1999 by The American Society of Hematology. 
kin- 113  (IL-I )3). 
Ui 2 block granzyme activity,' and protect 
infected cells from Fas- and TNF-induced apoptosis.' 2 ' 4 Less is 
known of serpins from parasitic agents, but protease inhibitors 
have been described that inhibit a diverse range of host 
functions, such as neutrophil cheniotaxis, 15 blood coagula-
tion,'' 8 and antigen processing. 19 
Lymphatic filariasis is one of the most important human 
tropical diseases, with an estimated 120 million people infected 
and a further 900 million at risk of infection.  2021  It is caused by 
a mosquito-transmitted nematode, Brugia mala 	 mi - 
grates 
which  
t s to the lymphatic vessels, where sexually reproducing 
adult worms produce millions of microfllariae (Mf) that migrate 
into the bloodstream, where they can reside for long periods 
( ~!I year). The mechanisms by which circulating Mf avoid host 
immune defenses are poorly understood. 
Most serpin family members so-far characterized are from 
mammals, insects, and viruses. Although a few serpin cDNA 
sequences have been reported from helminth parasites.  22.23  only 
in the free-living nematode Caenorhahditis elegans has the 
genomic sequence of a serpin been determined . 21 As part of our 
ongoing research on identification of vaccine candidates from 
the human filarial nematode B ,nalavi, we have found a novel 
serpin gene from the Mf stage of B malavi. We report here the 
isolation, sequencing, and expression of this novel serpin gene, 
Bm-spn-2. Moreover, we show that recombinant Bm-SPN-2 
inhibits the enzymatic activity of 2 serine proteinases from 
human neutrophils. cathepsin G and elastase. suggesting a 
functional interaction between parasites and host cells in the 
same blood environment. 
MATERIALS AND METHODS 
Antigens and cDNA expression libraries. Mf were obtained from B 
,nalavi-infected jirds (Meriones unguiculatus) purchased from TRS 
Laboratories (Athens, GA). Mf obtained by extensive lavage of the 
peritoneal cavities of infected jirds were separated from host cells over 
lymphocyte separation media and then passed through a Sephadex G-25 
1418 	 Blood, Vol 94, No 4 (August 15),1999: pp 1418-1428 
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column. 25 Fractions containing Mf without host cells were pooled. Mf 
proteins were separated by sodium dodecyl sulfate-polyacrylamide gel 
electrophoresis (SDS-PAGE), and the protein fraction of molecular 
weight 33-55 kD was recovered by electro-elution. Protein concentra-
tions were measured using the Bradford assay (Pierce. Rockford, IL). 
Six B rnaiayi stage-specific cDNA expression libraries from L3, adult 
males, adult females, and Mf were supplied by the Filarial Genome 
Project (Williams et al, unpublished data: and Scott et a), unpublished 
data). 2627 Further details on construction of these libraries and their 
availability are posted at http://helios.bto.ed.ac.uk/mbx/fgn/nec/fgpre-
source.html.  
Mice and immunization. Eight-week-old female BALB/c mice 
were injected with SO pig of either Mf proteins with molecular weight 
33-55 kD or Bm-SPN-2 recombinant protein (see below) in complete 
Freund's adjuvant and boosted 4 weeks later. Mice were killed at 6 
weeks and antisera were collected. 
Isolation and sequencing of Brn-spn-2 eDNA clone. A B rnalavi Mf 
cDNA expression library was screened using immune sera. preadsorbed 
against Escherichia coil lysate, obtained from BALB/c mice immu-
nized with Mf proteins of molecular weight 33-55 kD. The immunore-
active plaques, detected using peroxidase -conjugated rabbit antimouse 
lgG (DAKO. Glostrup, Denmark) and the TMB membrane peroxidase 
substrate system (KPL. Gaithersburg, MD), were purified to homogene-
ity by 2 subsequent rounds of screening. Bluescript phagemids were 
then excised from positive clones using the manufacturer's protocols 
and sequenced. 
Isolation and characterization of Bm-spn-2 gene. Genomic DNA 
was isolated from B ?nala.Yi parasites. Mf were lysed and digested in 
lysis buffer (100 mmol/L NaCl, 50 mmoVL EDTA. I % SDS. 1% 2-ME. 
10 pig/mL RNase. 100 pig/mL proteinase K. 100 mmol/L Tris-Cl. pH 
8.5) at 65°C for 30 minutes and then extracted with phenol, phenol! 
chloroform, and chloroform. The DNA was precipitated and washed 
with ethanol, and then resuspended in TE buffer. Genomic DNA (100 
pg/mL) was heated at 100°C for 10 minutes, put on ice for It) minutes. 
and then used as template for polymerase chain reaction (PCR) 
amplification using the following primers: SF1 (nt 1-26 of Brn-spn-2 
cDNA), 5 '-AATA'fl'GGCAATFCGCAATFATCCTC-3'; and SR4 (nt 
780-761). 5'-ACGGTAGCGACACCGCTFGC-3': or SF4 (nt 564-
584), 5'-GGAGCCCGTAATATCGCTAGC-3'; and SRI (nt 1418- 
1391 ). 5'-AAATfAATGCAITflTFA'ITCAACATCA-3'. The PCR 
reactions were performed 94°C for 5 minutes and 30 cycles of 94°C for 
40 seconds. 55CC for 4() seconds, and 65°C for 2 minutes. with a final 
10-minute extension period at 65°C. The resulting products (SFI/SR4. 
1.524 bp; SF4/SRI, 1.456 bp) were purified (GENECLEAN II: BlO 
101. La Jolla. CA) and subcloned into pMOSBIue T-vector (Amersham, 
Buckinghamshire, UK). At least 4 independent clones of each target 
fragment were picked and sequenced. Introns and exons were identified 
by comparing genomic sequence and cDNA sequence. 
Library PCR. PCRs were performed on 1-piL aliquots of each 
cDNA library from B malavi L3. adult males, adult females, and Mf, 
with the following gene-specific primers: SF3 (n( 261-280). 5'-
GCCAGAGGTOAAACTGAGCG-3': and SR4 (as above). Primers for 
the B malavi tumor protein homolog-1 (tph-l) corresponded to the 
published sequence 18 : 5 '-AATGll'GATCTFCA AGGGATGCATF-
CAC-3' and 5'-1TrGtTflTCYFCAATGAGTGCCTCCTr-3'. Forts 
cycles of amplification were performed under the following cycling 
conditions: 94°C for I minute, 50°C for 1 minute. and 72°C for 50 
seconds. 
Reverse rran.rcriptase-PCR (RT-PCR). Total RNA from L3, adult 
males, adult females, and Mf was isolated using RNAzoI B Isolation of 
RNA kits (AMS. Witney, Oxtbrdshire, UK). Reverse transcription was 
performed using oligo(dT J as the first primer and I pig of total RNA 
according to the GeneAmp RT-PCR kit protocol (Perkin-Elmer. Branch-
burg. NJ). Amplification of Bm-spn-2 cDNA was performed using I PL 
of first-strand cDNA. with the following gene-specific primers: SF5 (nc  
886-906), 5'-GTGCACTTGACTCATCTCACG-3'; and SR2 (nt 13 10-
l283), 5-CTAACCTVrGTCITITIT iCGGTGTVFCC-3'. Primers for 
the iph-1 were used as described above. Thirty-five cycles of amplifica-
tion were performed under the following cycling conditions: 94°C for I 
minute. 55°C for I minute. and 72°C for 2 minutes. 
5' rapid amplification of cDNA ends (5' RACE). Total RNA from 
Mf was isolated using RNAzoI B. Reverse transcription was performed 
using SR4 (as described above) as the first primer and 2 lag of total RNA 
according to the 5/3' RACE kit protocol (Boehringer Mannheim. 
Mannlieim, Germany). Amplification of the 5' end of Sm -spn-2 cDNA 
was performed using 5 piL of dA-tailed first-strand cDNA. with oligo 
dT-anchor primer and a gene-specific primer SR5 (nt 571-553) 5'-
CGQGCTCCATAA1TCATAC-3'. The resulting products were purified 
(Microcon. Beverly. MA), suhcloned into pGEM T-vector (Promega, 
Madison, WI), and then sequenced. 
Expression and purification of Bin-SPN-2 protein. A cDNA frag-
ment encoding Bm-SPN-2 without the putative N-terminal signal 
peptide (amino acid residues 1-20) was amplified by PCR from the Mf 
cDNA library using the following primers: SF2 5'-CAACAGTACTT-
TAAACCATFGTTCTG-3' and SR2 (as described above). These prim-
ers were designed with an additional 5' nucleotide for insertion and 
in-frame expression with the pET-29 T-Vector (Novagen. Madison, 
WI). PCR conditions were 35 cycles of 94°C for I minute. 55°C for 
I minute. and 72°C for 2 minutes. The resulting 1.226-bp product was 
purified (GENECLEAN II: BIO 101). ligated into pET-29 T-Vector. 
sequenced completely, and then transformed into BL2 I (DE3) strain of 
E coli. 
Transformed BL2I(DE3) cells were incubated in LB containing 
kanamycin (50 pig/mL) at 37°C for 4 hours and then I mmolfL 
isopropyl-l-13-D-galactopyranoside (IPTG: Stracagene, La Jolla. CA) 
was added. The cells were incubated for an additional 4 hours at 37°C 
and then at 4°C overnight. Cells were harvested and sonicated. The 
recombinant Bm-SPN-2 containing 6 C-terminal histidine residues 
(His-Tag) was purified by affinity column chromatography over His-
Bind resin (Novagen( under native conditions. 
Geno,nic Southern blot. Amplification of a B malavi genomic 
fragment was performed by PCR using genomic DNA and gene-specific 
primers SF4 (as described above) and SR4 (as described above). A 
408-bp PCR product, spanning exon 4. intrpn 4, and exon 5. was 
32P-labeled by random hexanucleotide priming and then used as probe. 
Five micrograms of B ma/avi genomic DNA was digested with Ba,nHI, 
EcoRI, Xba I. and Xho I. Digested DNA was fractionated on a 0.8% 
agarose gel, transferred to nylon membranes (Hybond-N), and hybrid-
ized with 32P-labeled probe. Blots were hybridized for 24 hours at 65°C 
in a rotary hybridization oven (Hybaid) in 3X standard sodium Citrate 
(SSC). 1% SIDS. and 0.2% skimmed milk Containing 100 pig/mL 
sonicated herring sperm DNA. Washes were performed at 65°C in 2X 
SSC, 1% SDS for 30 minutes and then at room temperature in 0.1 X 
SSC for 30 minutes, before autoradiography at —70C. 
Western blot. Lysates of L3. adult males, adult females. Mf. and 
BL2I(DE3) cells containing the pET-29/Bni-spn-2 plasmid after IPTG 
induction were prepared by resuspending pellets in denaturing SDS-
PAGE sample buffer and boiling for 10 minutes. Insoluble cellular 
debris was removed by centrifugation at 13.000 rpm for 30 minutes, and 
SDS-soluble proteins were separated by SDS-PAGE and transferred to 
nitrocellulose membranes. Blot strips were incubated with mouse 
antisera to recombinant Bm-SPN-2 protein, diluted 1/4.000. and then 
with peroxidase-conjugated rabbit antimouse lgG DAKO. The bound 
antibodies were detected by chemiluminescence on the addition of the 
luminol-based ECL substrate (Amersham). 
Sequence analysis. All sequencing was performed on a Applied 
Biosystems 377 automated sequencer by the ABI PRISM Dye Termina-
tor cycle sequencing method (Perkin-Elmer). Sequence analysis was per-
formed using Mac Vector program version 6.0 (Oxford Molecular Group. 
Oxford. UK). Sequence searching was performed with the BLAST 
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A 
M 	K 	L 	F 	E 	V 	I 	F 	I 	V 	V 	A 	V 	L 14 
AATATTGGCAATTCGCAATTATC C TCATGAAGCTTTTCGAAGTAATATTTATTGTGGTGGCAGTACTC 68 
SF1 
G 	G 	S 	S 	R 	A 	' 	S 	T 	L 	N 	H 	C 	S 	E 	N 	N 	D 	D 	S 	N 	K 	L 37 
GGTGGTAGTTCCCGTGC T CAGTACTTTAAACCATTGTTC TGAAAACAATGATGATTCAAACAAGCT 136 
10 SF2 
L 	I 	T 	K 	A 	Q 	M 	N 	F 	A 	L 	E 	L 	L 	R 	Y 	S 	S 	Q 	A 	D 	E 59 
ACTGATAACTAAGGCGCAAATGAATTTCGCATTGGAACTATTGCGCTATTCTTCGCAAGCTGATGAAA 204 
T 	S 	L 	L 	S 	P 	F 	A 	I 	A 	S 	V 	N 	S 	L 	L 	Y 	E 	G 	A 	R 	G 	E 82 
CCTCGCTATTATCGCCATTTGCAATCGCTTCCGTAATGTCATTATTATATGAAGGAGCCAGAGGTGAA 272 
T 	E 	R 	E 	M 	G 	H 	V 	L 	S 	A 	D 	Q 	P 	K 	N 	A 	F 	G 	A 	Y 	I 	S 105 
ACTGAGCGTGAGATGGGGAGGGTGCTTTCAGCAGATCAACCAAAAAATGCATTTGGAGCTTACATAGA 340 
SF3 
C 	A 	I 	K 	N 	I 	H 	K 	Q 	S 	K 	R 	N 	D 	Y 	S 	L 	Y 	Y 	L 	T 	K 127 
GTGCGCTATCAAAAATATTCACAAGCAATCAAAGCGAAATGATTATTCTTTGTACTATTTAACCAAAT 408 
F 	F 	V 	Q 	Q 	N 	S 	L 	K 	S 	D 	F 	K 	D 	I 	T 	R 	R 	R 	Y 	P 	Y 	E 150 
TTTTTGTGCAACAAAATTCTTTGAAGTCTGATTTTAAAGATATTACTCGTCGACGATATCCTTATGAG 476 
L 	T 	Q 	I 	N 	F 	A 	S 	P 	L 	Q 	V 	K 	S 	I 	R 	S 	I 	F 	I 	K 	W 	I 173 
TTGACACAAATCAATTTCGCTTCACCTCTGCAAGTGAAGAGTATAAGAGAAATATTTATTAAATGGAT 544 




SR5 	 'SF4 
F 	N 	G I 	H 	F 	T 	D 	D 	W 	M 	Y 	E 	F 	L 	P 	L 	N 	H 	I 	L 	P 	F 218 
TTAATGGAATACATTTCACTGATGATTGGATGTACGAATTTCTTCCGCTCAATCACATATTACCGTTC 680 
Y 	S 	P 	R 	L 	R 	V 	T 	D 	N 	P 	M 	M 	E 	R 	T 	A 	K 	F 	P 	Y 	Y 	E 241 
TATTCACCACGGCTACGTGTAACTGATATGCCAATGATGGAAAGAACGGCCAAATTTCCTTACTATGA 748 
N 	Q 	H 	M 	Q 	A 	V 	S 	L 	P 	F 	K 	D 	S 	E 	M 	Q 	N 	L 	I 	I 	L 263 
AAACCAACACATGCAAGCGGTGTCGCTACCGTTCAAAGATTCCGAAATGCAAATGTTAATTATTTTGC 816 
SR4_44 
P 	K 	K 	T 	F 	D 	L 	A 	K 	F 	E 	D 	K 	L 	T 	G 	E 	E 	L 	F 	S 	Y 	I 286 
CCAAAAAAACCTTTGATCTAGCAAAGTTTGAAGATAAACTTACGGGAGAGGAACTATTCAGTTATATT 884 
SAL 	D 	S 	S 	H 	HIT 	V 	TIP 	K 	F 	K 	YEN 	Q 	IC 309 
AGTGCACTTGAC TCATC TCACCAAATTACCGTTACAATTCCAAAATTTAAGTACGAAAATCAAATATC 952 
10 SF5 
L 	L 	N 	G 	L 	K 	P 	N 	G 	V 	Q 	S 	M 	F 	H 	E 	S 	N 	D 	F 	S 	C 331 
TTTGTTAAATGGATTGA.AGAGGATGGGAGTGCAATCAATGTTCCACGAATCGAATGATTTTTCCGC A 1020 




lG 	I 	NI'J 	EQS 	S 	M 	P 	V 	R 	N 	D 	M 	V 	M 	D 	K 	G 	S 	FF 377 
GTGATATGGTAATGGATGGAGGCAII 1156 
IRAN 	H 	P 	F 	L 	Y 	A 	III 	D 	N 	H 	G 	TV 	LW 	I 	G 	H 399 F :TCC ::: :11 FTGATAACCACGGGACTGTACTATGGATTGGTCGTT 1224 
F 	T 	G 	K 	N 	R 	S 	T 	I 	V 	S 	N 	S 	D 	D 	S 	M 	Q 	C 	E 	E 	T 	P 422 
TCACCGGAA.kAAACAGAGAAACAATTGTCGAAAACTCGGATGACTCTATGCAATGTGAGGAAACACCG 1292 
K 	K 	R 	Q 	R 	L 	* SR2 40 428 
AAAAAAAGACAAAGGTTATAACAGATACGAATGTTTCAGGAACGATTGAACAATATATCATTTGATTA 1360 
TATCCACGCGAATTGTC TATTTTTGAAATATGATGTTGAATAAAAAATGCATTAATTTAAAAAAAAAA 1428 
SR1 90 1438 
AAAAAAAAAA 
Fig 1. 	(A) Nucleotide and deduced amino acid sequences of the Bm-spn-2 cDNA. Inferred amino acid numbering is in boldface. The putative 
hydrophobic signal peptide (amino acids 1-20) is underlined and 2 potential N-glycosylation sites (amino acids 21 and 360) are circled. The serpin 
motif (amino acids 353.357) and serpin signature (amino acids 377-387) are boxed. The position of a potential polyadenylation signal (nucleotide 
1398-1404) is in boldface. Primers used in PCRs are indicated with solid arrow. The nucleotide sequence has been deposited in GenBank with the 
accession no. AF009825. (B) Schematic of the gene structure of Bm.spn.2. The gene spans 2.7 kb and is split into 7 exons and 6 introns, as 
depicted. The nucleotide sequence has been deposited in GenBank with the accession no. AF009826. 
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B Serpin Signature 
Reactive Site Loop 
Signal I 	 Polyadenylation 
Peptide Serpin Motif' 	Signal, 
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Fig 1 (Cont'd). 
algorithm 29 using the NCBI BLAST server. The GCG program PILEUP 
(Genetics Computer Group, University of Wisconsin, Madison. WI) and 
BOXSHADE were used to perform multiple alignments. The tree 
reflecting evolutionary relationships was constructed by PAUP 3.1.130 
using maximum parsimony, excluding constant, and uninformative 
sites. 
lp,hibitorv actii'itv assay. To investigate the inhibitory activities of 
Bm-SPN-2, 5 iL of each individual serine proteinase was incubated 
with 10 liL of Bm-SPN-2 (0.4 1g/(jL) in TBS buffer (150 mniol/L NaCl, 
20 mmolJL Tris-HCI, pH 7.8) or bovine serum albumin (0.4 (lg4lL) in 
lBS buffer as negative control. After 10 minutes of incubation at room 
temperature, 01 niL of an appropriate peptidvl-p-nitroanilide substrate 
solution) 100 pmol/L in 50 mmol/LTris-HCI, pH 7.8. 50 mmol/L NaCI) 
was added to the mixture, and the residual enzyme activity was 
measured by monitoring the absorbance change at 405 with time. 3 ' The 
enzymes and their substrates used in the tests were bovine pancreatic 
trypsin (50 ng4iL; Sigma, St Louis. MO) and D-Phe-L-pipecolyl-Arg-p-
nitroanilide (Sigma); human plasmin (0.1 pg4iL: Athens Research & 
Technology. Athens. GA) and Z-D-Phe-Pro-Arg-p-nitroanilide (where 
Z stands for benzyloxycarbonyl; a gift from Dr J. Tomich. Microchemi-
cal Core Laboratory. Kansas State University); bovine pancreatic 
ct-chymotrypsin (0.1 .1gI1L: Sigma) and N-succinyl-Ala-Ala-Pro-Phe-p-
nitroanilide (Sigma): human neutrophil cathepsin G 0 .ig4iL: Athens 
Research & Techology, Inc) and N-succinyl-Ala-Ala-Pro-Phe-p-
mtroanilide (Sigma); porcine pancreatic elastase (0.1 ig/pL; Worthing-
ton. Lakewood, NJ) and N-succinyl-Ala-Ala-Pro-Leu-p-nitroanilide 
(Sigma): and human neutrophil elastase (I ig/p.L; Athens Research & 
Techology. Inc) and N-succinyl-Ala-Ala-Pro-Leu-p-nitroanilide (Sigma). 
Where the proteinase activities in the presence of the Bm-SPN-2 were 
lower than the control, a possible scrpin-enzyme interaction was further 
examined. Aliquots of the proteinase l.I) jig4iL. 4.0 1.tL) were mixed 
with 0.5. 10. IS. and 20 pL of the concentrated Bm-SPN-2 (5.0 jig/PL). 
Different amounts of bovine serum albumin (0.4 peJ,.tL) were also 
included to stabilize the enzyme and to adjust the final volume up to 25 
il... After incubation, residual enzyme activities were determined as 
described above. 
Cloning assays were performed with an activated partial thromboplas-
tin time (AFfl') kit (Sigma) to test whether Bm-SPN-2 inhibits the 
activity of senne proteinases in the human coagulation pathway. Pooled 
normal plasma (0.1 mL) and 0.1 niL of various concentrations of 
Bm-SPN-2 or TBS buffer alone were incubated at 37°C for 5 minutes, 
and then 0. 1 mL of prewarmed AP'VF reagent was added. After 3 
minutes. 0.1 mL of prewarmed 0.020 molfL calcium chloride solution 
was added and the clotting time was recorded. 
Assays of macrophage antigen processing and presentation were  
performed to investigate whether Bm-SPN-2 inhibits the activity of 
serine proteinases involved in the major histocompatibility complex 
(MHC) class II pathway within macrophages. The murine macrophage 
cell line J774A. 1 was treated with various concentrations of Bm-SPN-2 
for 30 minutes, and then viable Streptococcus pyogenes or synthetic 
peptides aa 17-31 or aa 308-319 of the S.pvogenes MS protein were 
added and incubated for 3 hours. The macrophages were fixed and 
incubated with the 1-cell hybridoma, HXI7 recognizing peptides an 
17-31, and HY2 recognizing peptides an 308-319 for 24 hours. The 
culture supernatants were collected for IL-2 assay. 32 
RESULTS 
Isolation and characterization of a cDNA fr Bm-spn-2. 
Studies of B nzala.yi Mf proteins were undertaken to identify 
prominent antigens recognized by the host immune system's T 
lymphocytes. One fraction from Mf, containing proteins of 
35-55 kD, proved highly potent at inducing antigen-specific 
T-cell proliferation and cytokine production (Zang et aJ, unpub-
lished data). Antibodies were raised against this fraction by 
immunizing BALB/c mice and were used to screen an Mf 
cDNA expression library to identify the principal antigenic 
proteins. Three positive clones were isolated, one of which was 
found to be a novel eDNA insert and was analyzed as described 
below. 
The sequence of the full-length eDNA was determined and is 
shown in Fig IA. The eDNA insert contained 1.438 bp and a 
single open reading frame (ORF) starting at nt 27 and ending at 
nt 1311. which was followed by two more stop codons and a 
potential polyadenylation signal sequence (AATAAA, nt 1398-
1404) IS to 20 nt upstream from a poly A tail. Like most B 
ma/mi cDNAs, the GC content was low (35.1%). The ORF 
encoded a 428 amino acid protein with 2 potential N-
glycosylation sites at asparagines 21 and 360 of the deduced 
amino acid sequence. Residues I through 20 formed a very 
strong hydrophobic region consistent with a signal peptide 
function. The predicted mature protein, without this signal 
sequence. would have a molecular mass of 47.5 kD and an 
isoelectric point of 6.9. 
In GenBank searches for similar amino acid sequences, 85 
significant matches were found by the BLAST algorithm, 29 all 
of which belonged to the serine proteinase inhibitor, or serpin, 
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superfamily. One member of this superfamily from B nzalayi, 
previously described by Yenbutr and Scott. 23 encodes a distantly 
related gene we now refer to as Sm-spit-I. In light of this 
similarity, the novel protein was designated Bm-SPN-2, and its 
gene was designated Bin-spn-2. 
Isolation and characterization of the Bm-spn-2 gene. The 
Bm-spn-2 cDNA clone contained a 26-bp 5-untranslated region 
(UTR) and a 105-bp 3'-UTR. which allowed us to isolate the 
genomic copy of Bm-spn-2 by PCR. The Bin-spn-2 gene 
spanned 2572 bp (Fig I B) and, on comparison to the cDNA 
sequence, was found to consist of 7 exons and 6 introns with the 
intronlexon boundaries conforming to the normal pattern (exon/ 
GT. . .AG/exon) of splice acceptor and splice donor sites. Intron 
lengths were remarkably uniform, varying from 182 to 210 bp. 
At position —5 at the 3' end of the introns, T was present in all 6 
intronS. Digests of B mala.vi genomic DNA with Ba,nH 1, 
EcoRl. Xba I. and Xho I all yielded single bands that hybridized 
with the 32P-labeled probe (data not shown), indicating that 
Bin-spn-2 is either a single copy gene or is represented by 
copies in identical genomic environments. 
A comparison was made between Bm-spn-2 and the 12 genes 
from B ma/a i for which full genomic sequence information is 
available in GenBank. These contained a total of 99 exons and 
86 introns, with each gene containing between 2 and 27 exons. 
The majority of both exons and introns range from 60 to 240 hp, 
with only 3/86 introns being smaller than 60 bp (Fig 2). In this 
respect. Bm-spn-2 appears to be a typical B mala
-vi gene. in 
marked contrast to C elegans in which more than half of the 
introns are shorter than 60 bp. 33  Although other lower eukary-
otes show a marked shift towards AT abundance in intronic 
sequences. 34  the AT-richness of exons in the 13 known B ,nalayi 
genes attenuates this effect. B ma/avi exons and introns are 62% 
and 69% AT. respectively, whereas the corresponding figures for 
C elegan.s are 54% and 709c. 33 Although B ma/avi introns 
conform to the GT-AG rule, in rare instances. GC or TI were 
used as 5' splice sites and AC used as 3' splice site (Table I). B 
malai introns have an extended and conserved 3' splice site  
consensus sequence. TT1'CAG, in which the —5 position is Tin 
93% of the cases (Table 1). 
Mf-specific abundant transcription of Bin-spn-2 gene. Two 
Bin -spn-2 gene-specific primers. SF3 in exon 2 and SR4 in exon 
5, were designed to amplify a 520-bp region of cDNA. Using 4 
B malavi stage-specific cDNA expression libraries from L3. Mf, 
adult males, and adult females as templates, transcription of 
Bm-spn-2 was shown to be restricted to the Mf stage (data not 
shown). The identity of a 520-bp PCR product from the Mf 
cDNA library was confirmed by sequencing. First-strand cDNA 
were then prepared from these 4 stages and RT-PCR was 
performed with 2 gene-specific primers. SF5 in exon 5 and SR2 
in exon 7, and generated a product of the expected length (425 
bp) only in Mf-stage (Fig 3). The absence of a Bin-spn-2 
product in the adult female implies that embryonic M1 within 
the uterus do not transcribe this gene. Parallel PCRs were 
performed with primers specific for another B ma/avi gene, 
tph-I, which is known to be expressed in all stages. 2t A 
tph-I—specific 575-bp band was found in all 4 stages from 
cDNA expression libraries or RNAs. In this respect, Bm-spn-2 
differs quite markedly from Bm-spn-I, which is expressed in all 
life-cycle stages. 23 
To date, the Filarial Genome Project has sequenced a total of 
approximately 14,351 expressed sequence tags (EST5). includ-
ing 2.334 ESTs from Mf. Of these. 49 ESTs corresponded to 
Bin-spn-2. all of which were isolated from the Mf cDNA library. 
This suggests an abundance level of 2.1% of Mf mRNAs. These 
data are consistent with our PCR results and confirm that 
Bin-spn-2 is an unusually highly expressed transcript in the Mf 
stage. 
The trans-spliced leader (SL) primer and a reverse primer in 
exon 5 were designed for PCR using the Mf cDNA library or 
first-strand cDNA from Mf as templates. Even after 40 rounds 
of amplification, no band was detected in ethidium-stained gels 
(data not shown). Moreover, 2 reverse primers in exon 5 and 4 
were designed for 5' RACE and no SL was present at the 5' end 
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Length (bp) of exon or intron 
Fig 2. Length distribution of 
exons and introns of all 13 B 
malayi genes so far character-
ized. The survey included 99 ex-
ons and 86 introns. Each bar 
represents the number of exons 
and introns in each size class. 
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Table 1. Intron/Exon Boundaries of 13 B malayiGenes So Far 
Characterized 
5' Splice Site 
Base -3 -2 -1 *1 	+2 +3 +4 +5 +6 
G 23 7 62 99 	0 13 6 50 7 
A 41 65 15 0 0 58 53 14 14 
T 7 10 17 1 	98 26 29 27 70 
C 29 18 6 0 2 3 12 9 9 
3' Splice Site 
Base -6 -5 -4 -3 	-2 -1 +1 +2 -3 
G 2 1 12 1 	0 99 57 23 21 
A 7 3 23 6 	100 0 24 26 30 
T 82 93 52 38 0 0 10 25 32 
C 9 3 13 55 	0 1 9 25 1 
The survey included 99 exons and 86 introns. Splicing occurs at the 
vertical lines. Positions are numbered with respect to the splice sites, 
and figures represent the percentage of each nucleotide at each 
position. 
trans-spliced. This forms another contrast to Bin -spn-1. which 
is known to contain the spliced leader sequence in its mRNA. 23 
Expression of Brn-SPN-2 in E coli and purification q,I (lie 
recombinant protein. The Bm-spn-2 eDNA ORF without the 
signal peptide was subcloned into the pET-29 E co/i expression 
vector, and recombinant Bm-SPN-2 was expressed as a fusion 
protein containing a C-terminal hexahistidine-tag for affiiiit 
purification. The recombinant fusion protein was expressed 
very high levels on induction with WIG, and soluble maleri,d 
was purified by affinity chromatography. The purified reconilu 
nant Bm-SPN-2 had an apparent molecular mass of 52 kD ui 
SDS-PAGE (Fig 4). 
Native protein. Specific antibodies obtained from iiiicc 
immunized with recombinant Bm-SPN-2 bound the reconihi-
nant Bm-SPN-2 protein and also recognized a single endog-
enous Bm-SPN-2 protein in Western blots of Mf proteins as 
antigens (Fig 4, lane 2): no reactivity was seen with normal 
mouse sera. The native Bm-SPN-2 had an apparent molecular 
mass of 47.5 W. This result was in good agreement with the 
predicted molecular weight of the mature protein encoded by 
Bm-spn-2 ORF. Western blot analyses were also performed with 
proteins from L3, adult males, and adult females. hut no 
reactivity was found (Fig 4, lanes 3 through 5). The', 
confirm that Bin -spn-2 is expressed only in the Mf stage 
Homology with other serpins. The amino acid seqtlece H 
Bm-SPN-2 shows a low level of overall similarity with the oil 
identified serpins at the level of 20% to 26%. However, ccii. 
characteristic features of serpins are evident, and of the 
residues identified as highly conserved within the seir -
superfamily. 35  33 are identical in Bm-SPN-2 and several ni 
show conservative substitutions (Fig 5A). Figure 5A cornpii 
Bm-SPN-2 with 5 known serpins, namely human a I -antitryp-
(al-AT). 35 human squamous cell carcinoma antigen 
(SCCAl). 6 C e/egan.s serpin (Cc-spn), 24 chicken ovalhumiii-
like gene Y protein (gene Y), 37 and mouse proteinase inhibitor 
(SPI3). 35 
The serpin signature of FRANHPFLYAI (aa 377-387. Fig 
IA) corresponds well to that, for example. of chicken gene \ 
FRADHPFLFFI. The serpin motif or hinge is less well con- 
served, with only E353 and G355 conforming to the consensus. 
Between these two motifs is the reactive site loop of serpins, a 
stretch of approximately 14 amino acids containing the cleav-
able bait attacked by proteases. Serpin sequences here show 
extensive variation, 3139  and Bm-SPN-2 is dissimilar to any 
known serpin in this region. Other novel structural features of 
Bm-SPN-2 include the absence of a highly conserved dipeptide 
lle-Asn from within helix F and the proximity of a potential 
N-glycosylation site between the serpin motif and the reactive 
loop. Most interestingly, of all 93 serpin sequences deposited in 
public databases, Bm-SPN-2 is one of the largest and has the 
longest C-terminus other than antiplasmin. 35 All of these 
features would be more clearly understood in the light of a 
structure for the protein. The 3-dimensional structures of 
serpins such as al-AT, 4° PAl-I. 41 and antithrombin 111,42 have 
been solved, and these provide a useful framework for analyz-
ing other members of the superfamily. 
At the level of gene structure, Bin-spn-2, which contains 6 
mntrons, also made an interesting comparison with S other 
Bm-spn-2 
13 	Mf 	\1 	F 
425 lip 
tph-1 
1,3 	\lf 	l 	I 
7 75 l)() 
Fig 3 Transcription of Brn-spn-2 at different development stages 
of B malayl. RNAs isolated from L3, Mf, adult males (lane M), and 
adult females (lane F) were processed to obtain first-strand cDNA. 
The cDNA5 were then used as templates for PCR amplification of a 
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1 	2 	3 4 5 kDa different substrate specificities. Bm-SPN-2 inhibited the enzy-
matic activity of the human neutrophil cathepsin G and human 
ticutrophil elastase in a dose-dependent manner (Fig 7). but 
showed no inhibitory activity against bovine pancreatic trypsin, 
human plasmin, bovine pancreatic a-chymotrypsin, and porcine 
pancreatic elastase. The inhibition of the neutrophil proteinases 
h Bm-SPN-2 is strikingly specific, considering that human 
ucutrophil cathepsin G and bovine pancreatic a-chymotrypsin 
hydrolyze the same substrates as do human neutrophil elastase 
and porcine pancreatic elastase. 
To test whether Bm-SPN-2 inhibits the activity of serine 
proteinases in human coagulation pathway, the AVVF was 
measured in the presence of Bm-SPN-2, but no prolongation of 
the APT!' was observed (data not shown). This suggests 
Bm-SPN-2 dose not inhibit the serine proteinases of the clotting 
pathway such as factor X and Hageman factor. 
Serine proteinases are involved in processing and presenta-
tion of 2 epitopes of the S pvogenes M5 protein to CD4 T 
lymphocytes. 32 To investigate whether Bm-SPN-2 inhibits this 
antigen-processing pathway, the ability of macrophages to 
present these epitopes from Sprogenes to T cells was measured 
in the presence of Bin-SPN-2. No change in stimulation was 
ibserved (Delvig et al, unpublished observation). This suggests 
that Bm-SPN-2 does not inhibit the activity of serine protein-






Fig 4. Recombinant and native Bm.SPN.2 protein. Western blot of 
lysates of BL21(DE3) cells containing the pET-2918m-spn-2 plasmid 
after IPTG induction (lane 1) and extracts of Mf (lane 2), 13 (lane 3), 
adult males (lane 41, and adult females (lane 5) probed with mouse 
antirecombinant Bm.SPN-2. Recognition of a 52413 band in lane 1 
and of a 47.5-kD band in lane 2 is arrowed. 
serpins (Fig SB). Introns E and F of Bin-.spn-2 are positioned 
exactly as introns C and D in Ce-spn, supporting a close 
relationship between the nematode genes, but no vertebrate 
serpins contained introns at the same point. The genes for 
chicken gene Y protein. murine SPI3 and human SCCAI, had 5 
identical intron positions. but these were not found either in the 
mammalian of 1-AT gene or in either of the nematode sequences. 
Phvlogenetic analysis. Of the 93 members of serpin super-
family currently in accessible databases, 62 are vertebrate 
(mainly mammalian) and 11 are from invertebrates, including 
insects, crayfish, horseshoe crabs, and nematodes, whereas 5 are 
from plants and 15 are from viruses. A phylogenetic comparison 
of all invertebrate serpins was performed using PAUP to 
indicate the likely evolutionary relationship of Bin-spn-2 to 
known genes (Fig 6). This analysis divides invertebrate serpins 
into 2 groups (91% bootstrap confidence): group I comprising 
serpins from Tachvp!eus tridentatus (horseshoe crab), and 
group 11 containing serpins from B malavi, C elegans, Bornhvx 
mar, (Silkworm). Manduca se.vla (tobacco hornworm). and 
Pacifastacus leniusculus (signal crayfish). Within the latter 
group, Bin-spn-I and Ce-spn form a subgroup that is quite 
distant from Brn-spn-2. 
Jthibjto : activity of recombinant Bm-SPN-2. To screen for 
potential inhibitory function of Bm-SPN-2, we tested its ability 
to inhibit a panel of mammalian serine proteinases with 
The wide distribution of serpins and their ability to regulate a 
variety of divergent proteinases show that they play a major 
regulatory role in a host of biological processes. We describe 
here the isolation, characterization, expression, and inhibitory 
function of a new serpin gene. B,n-spn-2, from the human 
lymphatic filarial nematode B ,nalayi. The Bin-spn-2 gene, 
which appears to be a single copy in the genome and consists of 
7 exons, was found to have Mi stage-specific expression. The 2 
serpins that have been found in B ma/an, Bin-spn-1 and 
Bm-spn-2, are quite different. They share low homology and are 
not closely related, as shown by phylogenetic analysis. Bin-
spit-I is expressed in most life stages and its mRNA contains the 
22 nt nematode 5' SL, whereas Bmn-spn-2 is expressed only in 
the Mf stage and its mRNA does not contain SL. At present, the 
gene structure of Bin-spn-I is not available. It will be of interest 
to compare the gene structure, chromosome position, and 
physiological roles of these two serpins. 
We analyzed 13 B rnalavi genes for which complete sequence 
is available and found that Bmn-spn-2 was typical of this set. B 
malavi genes have relatively large introns compared with the 
nematode model Celegans33 and, like Celegans. the introns are 
markedly AT-rich. This is a property shared with introns of other 
invertebrates and plants 3443 that is possibly related to effective 
recognition and splicing of introns. 43 It is interesting to note that 
B mnakiyi introns have an extended and conserved 3' splice site 
in which T at —5 position is very highly conserved, a feature 
noted previously only in C elegans.33 In contrast, introns from 
most other organisms have only a combination of an upstream 
polypyrimidine tract and a YAG consensus at their 3' bound-
aries. This suggests that the 3' intron boundary may be a more 
important element in B mnalavi intron recognition than in most 
other organisms. Unusually, the exon sequences in these 13 B 
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Fig 5. Comparison of Bm-SPN-2 with other serpins: human cr1-
antitrypsin (cr1-AT). C elegans serpin (Ce'spn), chicken gene V protein 
(gene Y), mouse proteinase inhibitor 3 (SPI3), and human squamous 
cell carcinoma antigen 1 (SCCA1). (A) Amino acid sequences: the 
alignment of amino acid sequences using PILEUP and BOXSHADE 
programs was based on the al-AT crystal structur& 5 - 4° in which the 
conserved helices and strands are defined and was manually adjusted 
to give the best fit. Gaps were introduced in sequences for optimal 
alignment. The al-AT sequence is given without the signal sequence 
(MPSSVSWGILLLAGLCCLVPVSLA). Identical residues are highlighted 
in black and similar residues in gray shading. The 51 starred residues 
are those categorized as conserved in the larger serpin superfamily. 
The scissile bond is marked with an an-ow. (B) lntron/exon positions in 
serpins. Thick lines indicate coding regions, thin lines indicate Untrans-
lated regions, and gaps have been introduced to optimize alignment; 
arrows marked by uppercase letters indicate positions of introns. 
Sequences were aligned on the basis of amino acid similarity with the 
scale showing amino acid positions beginning with the first methio-
nine of Bm-SPN-2. lntrons are shaded according to their phase: open 
(phase 0). shaded (phase 1), and solid (phase 2). Vertical lines connect 
introns considered to be in Identical positions. 
B A 	 B 
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malavi genes are also AT-rich, much more so than C elegans 	more than 1.200 million years old.'" Based on vertebrate serpin 
exons. and no explanation is yet available for this finding, 	gene organization, it has been proposed that the ancestral gene 
The serpin gene family predates the common ancestor of 	would have had a large number of introns and that modern 
nematodes. arthropods, and chordates and may consequently be serpin genes derived from this by duplication have undergone 
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	B. mont antitrpsin 
80 	 100 	 B. mon antichymotrypsin H 
M. sexta serpin-1 
91 	 I 	76 	I M. sexta serpin-2 
B. mori antichmotrypsin 
P. leniusculus proteinase inhibitor It 
Fig 6. Phylogenetic trees showing the relationship between the predicted protein encoded by Bm-spn-2 and all other recorded invertebrate 
serpins. Numbers above branches show the percentage of bootstrap support for each dade. GenBank, Protein Identification Resource, and 
SWISS-PROT accession numbers of the sequences used were as follows: T tnidentatus intracellular coagulation inhibitor 2, A55533; Ttnidentatus 
intracellular coagulation inhibitor, 014483; Bm-spn1 (Bm-SERPIN). U04206; Ce-spn (C elegans serpin), U50301; B mori antitrypsin, 000738; B 
mori antichymotrypsin Il. P80034; M sexta serpin-1, tJ58361; M sexta serpin-2. U79184; B mon antichymotrypsin, D13895; P leniusculus 
proteinase inhibitor II, X82642; Bm-spn'2. AF009825. 
varied intron deletion. 45 This model, consistent with the general 
mtrons-early hypothesis, 46 contrasts with a gain-and-loss expla-
nation, which would envisage an ancestral serpin gene with 
between 0 and 3 introns. A comparison of the intronlexon 
structure of Bm-spn-2 with 5 other serpins show sets of introns 
found only in nematode genes and others present only in 
100 
1J 	Cathepsin C 
•—O---- Elastase 
20 	40 	60 	80 	100 
Bm-SPN-2 (nM) 
Fig 7. Concentration-dependent inhibition of human neutrophil 
cathepsin G and human neutrophil elastase activation by Bm-SPN-2. 
Recombinant Bm-SPN-2 at different concentrations was mixed with 
human neutrophil cathepsin G or human neutrophil elastase before 
the addition of specific substrates. Changes in the rate of substrate 
cleavage were used to calculate the percentage of inhibition at each 
Bm-SPN-2 concentration.  
vertebrate genes. Several serpin genes also possessed unique 
introns. Under the introns early mechanism, the ancestral serpin 
gene would have needed nearly 20 introns to account for the 
pattern observed in just 7 extant genes. Therefore, it seems that 
intron gain-and-loss is a more likely explanation of serpin gene 
evolution, as postulated for other gene fami lies . 47 We hope that, 
as more genes encoding serpin become available, the serpin 
family can be divided into subgroup on the basis of gene 
organization and position, and this may provide an alternate 
way to advance our fundamental knowledge of evolutionary 
relatedness. 
The serpin super-family has been constructed on the basis of 
sequence similarities at the protein level. 48 All members of the 
serpin superfamily are thought to share a common highly 
ordered tertiary structure, defined by x-ray diffraction for the 
prototype molecule o I -AT 3530 which consists of 9 -helices 
and 3 p-sheets. Although the predicted amino acid sequence of 
Bm-SPN-2 has a low overall homology to the sequences of 
serpins from other species, its sequence is identical or con-
served at most of the characteristic amino acid positions. The 
serpin signature, which includes the hinge distal to the reactive 
loop. is, for example, well conserved. However, analysis of the 
serpin motif (in the proximal hinge) is ambiguous. Two residues 
in Bm-SPN-2 (E353 and G355) are those found in 100% of 
functional serpins. 49 Few of the other residues in Bin-SPN-2 
follow the consensus for small nonpolar sidechains. which are 
thought to be necessary to allow the conformational change 
associated with inhibitory function. 495° Further work will 
establish whether the consensus sequence requires redefinition 
in the light of phylogenetically removed genes such as those 
from nematodes and trematodes. 22 
Genes that are expressed in a stage-specific manner have 
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provide targets for the development for novel immunoprophy-
lactic or chemoprophylactic agents. It is significant that Bm-
spn-2 is an abundant transcript restricted to the Mf stage, and 
the presence of a putative signal peptide (amino acids 1-20) 
indicates that that the mature protein could be released as a 
secretory product to perform some function in parasite survival. 
In several systems, serpins from infectious organisms have been 
identified as factors that help infectious organisms to evade the 
host defence system. 10-  The ability of Bm-SPN-2 to inhibit 
2 human neutrophil-derived serine proteinases. cathepsin G and 
elastase, may be important in this context. Genes encoding 
cathepsin G. cathepsin G-like lymphocyte granzymes B and H, 
and csTh chains of the T-cell receptor are closely linked on 
human chromosomal band 14q 11.2. 11 Stimulated polymorpho-
nuclear neutrophils release cathepsin G concomitantly with 
neutrophil elastase, and these proteinases mediate antimicrobial 
activity. 52 degradation of extracellular matrix, vasoregulation. 
and IL-8 processing. 53 Furthermore, cathepsin G binds to T 
lymphocytes and NK cells- 4 -51 and exerts a mitogenic effect on 
T lymphocytes, which are dependent on retaining enzymatic 
activity. Cathepsin G is also known to he a chemokinetic 
stimulant for T lymphocytes and chemoattractant for mono-
cytes. We suggest that neutrophils. representing 55% of 
human blood leukocytes, would he the primary cell type to 
interact with B makivi Mf and that release of Bm-SPN-2 
neutralizes the stimulating properties of cathepsin G. It is 
interesting to note a study that identified a human squamous cell 
carcinoma antigen. SCCA2. as a novel serpin that also inhibits 
cathepsin These data suggest that a possible common 
strategy between parasites and tumors is the production of a 
cathepsin G inhibitor to counteract immune activation. 
One of the remarkable features of the Mf stage of B mala-vi is 
its longevity (>1 year in the bloodstream), which is testimony 
to the effectiveness of immune evasion by this parasite. The 
survival of Mf provides not only a reservoir of infection in an 
endemic community. but also a clear target for intervention. 
Bin-SPN-2 seems an important component of parasite survival 
strategies, so it may prove to be an equally appropriate target for 
vaccination or pharmaceutical attack to clear infection both 
from afflicted individuals and endemic communities. Our 
preliminary results show that specific immune responses against 
Brn-SPN-2 do indeed mediate the clearance of B ,nalavi Mf, 
supporting the contention that this serpin may be a critical 
component of the host-parasite relationship. 
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